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CHAPTER I 
SUMMARY AND COMMENTS 
This report compiles in a somewhat abbreviated fash~on the bulk 
of, the radiobiologic studies carried out with joint (AEC) ERDA and NASA 
support during the years 1964 to 1974 at the Medical Division of Oak 
Ridge Associated Universities. Their termination was directed by a 
de~reased urgency on the part of NASA for broadly focused human 
radiobiologic data and on the part of ERDA for a redirection of ORAU's 
Medical Division efforts away from radiotherapy toward occupational 
medical problems that are being generated by the increasing demands for 
energy from non-nuclear sources. 
The physiologic data generated by this study were similar in many 
ways to those previously observed in other medical radiobiologic 
experiences. They differed, however, in the methods of data acquisition 
and analysis. Instead of more conventional analytical methods, pulmonary 
impedance was recorded and quantitated as a measure of radiation-induced 
gastrointestinal distress and fatiguability. 
While refinements in dose response related to gastrointestinal 
distress were accomplished we also found that through the use of Fourier 
analysis of pulmonary impedance waveform GI distress could easily be 
recognized and quantified even when the initial stages of nausea were 
below the subjects subjective level of recognition. Our results demonstrate, 
that change in pulmonary impedance waveform closely parallel well-defined 
stages of GI distress, 1. e., initial nausea, a progressive increase in 
nausea, and finally vomiting episodes. These stages of GI distress are 
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i f similar when induced chemically or by exposure to ionizing radiations 
although that induced by radiation is often sudden in onset and little 
I nausea may proceed the actual emetic episode. Throughout the study 
I period, pulmonary impedance waveform analysis never failed to recognize 
radiation-induced GI distress. Finally, these data demonstrate that 
I real-time analysis of GI status with continuous data update can be 
accomplished using Fourier analysis of the pulmonary impedance waveform 
" monitored from a remote, isolated environment. 
I Attempts to measure and quantify radiation-induced physical deconditioning using pulmonary impedance waveform analysis were not as 
I clearly delineated as in the case of gastrointestinal distress. Pulmonary 
impedance measured before, during, and after controlled exercise stress 
I' (ergometry) correlated very well with periods of physical stress. 
I Increased respiratory demand during submaximal exercise !:ltt"~!3S was accompanied by increased pulmonary impedance variance and within stress 
I periods an increase or decrease in workload was accompani.ed by rf.!spective 
shifts in pulmonary impedance waveform. However, exposure to ionizing 
\ I radiations resulted in amplified (increased) pulmonary impeciance variance 
I ~ i 
in over 80% of those humans studied although the ergometric workload 
remained unchanged. Thus, it would appear that expo~ureto radiation 
I resulted in ~ncreased respiratory demand to perform at a constant, non-
varying workload. Analysis of cardiac rate during controlled exercise 
I ~~ .. stress in control volunteers and therapeutically likewise demonstrated 
:( inoreased response in over 70% of those patients who participated in the 
study. We believe that these amplified cardiac rates are indicative of 
'I ~' diminished cardiovascular efficiency since workloads were non-varying 
r 
! 
, f ' . 
i 
t i I t -'il lc iii -~~-~~---
r 
I 
I 
I 
I~· • , ~ 
I 
I 
[ 
E 
l ~· \. , .. 
I 
J 
3 
throughout each patient study period. Since some radiobiologists believe 
that venodilation and decreased venous compliance occur during early 
postirradiation periods (hours to several days) a PGQling of blood in the 
venous system could account for increased cardiac rates and increased 
pulmonary impedance (increased mediastinal blood mai;s) postirradiation. 
Efforts to model these data with those of other physical 
deconditioning experiments led to 02 consumption measurements. Using 
bedrpst. as a typical model we found that a remarkable similarity exists 
between the decrement cause by 21 days of bedrest and exposure to 100 R 
irradiation. Unfortunately~ we were able to study only one therapy patient 
in the time period' between developing our capability for 02 consumption 
mel!~mt'!imlt~nt and the termination of the inpatient therapy program of our 
Division. 
The important question remains unanswered as to whether or not 
radiation-induced physical deconditioning and that induced by bedrest 
(weightlessness) are additive. If they are the threshold radiation dose 
would be lowered as mission length was increased unless strong counter-
measures were used to prevent or retard zero-G deconditioning. Another 
facet of this physiologic problem that remains to be considered is whether 
the level of physical training (vigorous in astronauts) can affect the 
degree of physical deconditioningi Some studies, needing to be confirmed, 
suggest that the well-conditioned individual may react more strongly and 
recover more slowly than a non-conditioned person. Our study of performance 
after radiation exposure using controlled exercise stress in physically 
trained and untrained ponies supports this suggestion in that the 
conditioned animals responded with a greater degree of decrement than the 
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unconditioned ones. The biochemical mechanisms underlying this phenomenon 
need to be ~tudied without necessarily any reference to radiation 
exposure because of its general applicability to everyday life as well as to 
disease. 
Our hematologic studies concerning the changing patterns of 
peripheral blood cell numbers after irradiation produced significant 
improvement in the quantitative aspects of the problem, particularly in 
defining the doubling times for human leukocytes in terms of repair kinetics • 
The laboratory studies showed that rapid cell sizing techniques 
provided an additional parameter to hematologic studies that improved 
speed of quantitation and diagnosis. In polycythemia rubra '!~ra1 for 
example, changes in RBC morphology proved to be extremely useful in 
appraising the relative sizes of the iron and erythroblastic pools after 
radiation exposure. The unique observation of serum CPK rise after a large 
accidental radiation exposure in a man could not be confirmed in subsequent 
study in animals. Nevertheless, it led us to evaluate serum CPK levels 
before and after radiation exposure. The results of this study suggested 
that changes in muscle CPK as reflected in serum CPK levels may be related 
to fatigue and ability to perform physical work. This lead needs to be 
pursued further. 
The simultaneous studies of human and mouse hemic responses to the 
same low dose rates and daily dose point up the threefold greater radiation 
resistance of mouse over man while suggesting what the basic lethal 
mechanisms may be for man under various conditions of low dose-rate 
irradiation as it approaches about one rad per day. 
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These studies are, of course, not to be considered definitive and 
without need for substantiation and extension. Only changing priorities 
places them, in our opinion, on "the back burner" for the moment. 
R. c. Ricks 
c. C. Lushbaugh 
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CHAPTER II 
OBJECTIVES AND SCOPE 
The objective of this study was to glean from human accidental 
and therapeutic irradiation case histories all pertinent radiobiologic 
information for reappraising and improving our knowledge of man's 
radiosensitivity. Thv~ study was cooperative with an ERDA supported 
study of total-body irrc.,diation as a therapeutic modality for human 
blood dyscrasias. Where the AEC/ERDA study concerned itself with 
clinical aspects, this NASA study was directed toward extracting measur-
able inf01mation on biologic endpoints of radiation effects. Study areas 
that received major emphasis were: hematology, gastrointestinal side 
effects, dosimetry, and physiologic monitoring for performance decrement. 
The need for more quantitative information on the effects of low 
radiation doses and low-dose-rate exposures was generated by NASA program 
planning that involved manned space flights. The plans for space 
laboratories expanded the number of persons at risk from the low doses 
of natural space radiation and included the possibility that an additional 
risk might arise from manmade radiation associated with the use of nuclear 
power generating systems. Our studies were intended to strengthen the 
confidence we presently have in our knowledge of man ',s ability to repair 
radiation damage so that ERDA, NRC, NASA, and other governmental agencies 
could establish nonoccupational permissible radiation exposure levels and 
continually review and update NASA occupational career limits for radiation 
exposure of astronauts as required for engineering design of advanced 
systems. While knowledge of the effects of larger radiation exposures at 
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high and low dose rates is growing substantially, it is as yet inadequate 
for deriving dose/response equations that allow high-confidence 
predictions of the amount of acute and chronic damage that can be expected 
from small doses to the total body or its parts. Extrapolations that 
estimate effects from extremely low exposures accumulated over long 
periods of time on the basis of studies of high exposure sustained in 
short periods of time, derive all of their justification from radiobiological 
studies of lower mammals (chiefly mice). Some observations indicate that 
after a 5 to 10 rad dose, for examp1e,the probability of a serious 
consequence occurring in an individual's lifetime is so low that a 
threshold, concept is valid for practical regulatory purposes. Confidence 
was limited on previous conjectures concerning the levels of radiation 
that, could cause detrimental human reactions.' The inherent difficulties 
in evaluating voluminous clinical data containing numerous variables 
however have now been largely overcome. Modern research methods using 
computers with large memory ~torage capacity have enabled us to construct 
a human radiation injury data bank containing clinical data from more 
than! 3000 human total body irradiation exposures in the United States. 
These charts have been extracted, encoded, and were analyzed by modern 
mathematical electronic computer methods. The Oak Ridge Associated 
Universities (ORAU) patient studies obtained in a radiotherapeutic program 
sinc,e 1957 and additional human studies ('V 3000 cases) obtained from other 
hospital centers with similar studies were incorporated into a study to 
determine dose re1ations1iips in man for anorexia, nausea, vomiting, 
diarrhea, fatigue, weight loss, fever, erythema, epilation, lymphopenia, 
granulocytopenia, anemia, thrombocytopenia, cytogenetic damage, decreased 
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l'esistanc~ to infection, decre~sed antibody synthesis, increased aging, 
and carcinogenesis. The values were assessed for degree of clinical and 
mathematical confidence to permit their use in predicing man's reaction 
to the ambient radiations of space, and to direct further clinical 
exploration on the effect of ionizing radiation upon cancerous 2,ud normal 
processes. 
Additionally, there were multiple reasons for this study overall. 
Therapeutic total-body irradiation is efficacious in controlling some cases 
of leukemia and lymphoma and ameliorating symptoms in others. The possibility 
that low dose rates may favor repair of normal tissue in contrast to 
malignant processes had not been evaluated in the present modern era of 
radiotherapy and radiobiology; we proposed to test this hypothesis with a 
radiation facility producing an isotropic flux of uniform radiation giving 
low rates of exposure. This irradiator was large enough for patients to 
live in comfortably for several weeks. Because of expanding programs in 
nuclear energy and space exploration, the need was more acute than ever 
for data derived directly by observation of man's reaction rather than 
assumed from animal studies. The retrospective accumulation of such data 
as was availgble showed that the old data suffered from lack of modern 
dos~etry, tissue depth dose knowledge, biased recording of ~ymptomatology, 
and incomplete and inaccurate records. Finally, these additi~mal unbiased 
clinical observations were sorely needed to defend existing environmental 
and occupational radiation exposure constraints from attack by well-meaning, 
but impractical, theorists. 
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~HAPTER III 
RETROSPECTIVE STUDIES 
A. Human Radiation Effects Data Bank 
Initial efforts were directed at establishing a case origin for 
human radiobiologic experiences from therapeutic or accidental exposures. 
Contacts were made through the University of Cincinnati and City of Hope 
(Duarte, California) Hospitals to secure human radiotherapy data to 
compliment the 100 case experiences previously accumulated at the ORAU 
Medical Division. This data base of cases of human clinical experiences 
was ultimately expanded to over 2500 therapeutic exposure experiences from 
45 contributing institutions (see Appendix A). In addition, data were 
accumulated from reports of ORAU staff medi.cal assistance in accidental 
radiation exposures at both national and foreign levels. 
The actual clinical data recorded in all human whole body radiation 
exposures obtained was extracted and encoded in such a form that the volume 
of data and its complexity was ,minimized bY,modern mathematical electronic 
computer methods. First, emphasis was placed on developing an analytical 
system basic to probit analysis to determine where apparent dose-response 
relationships existed that could be used in probit regression equations 
and effective doses (EDSO) with acceptable fiducial confidence limits. 
Although probit analysis was neither designed nor intended to be used in 
retrospect so that deviations from implied assumptions are not ascertainable 
r 
with it, our use of it appears jur;tified by its widespr{.!ad use in experimental 
radiobiology and allowed re,lat'.l..ve comparisons to be made between sick and 
well persons and various species of small and large animals. We applied 
methods used in testing of inanimate engineering components for reliability 
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and durability. The Weibull density function that describes wear out 
failure, predicting the time that any rate of failure will be evident, 
seemed promising, since most symptoms and signs of biological distress can 
be considered as evidence for "wear out" of a homeostatic physioiLogic 
system. These data were th~n used to appraise the extent to which 
probability estimates of what doses, rates, and quality of radiation of 
energies will be met during two-week to two-year missions. 
B. Dosimetry 
The single most important factor affecting the validity of our 
retrospective determination of human dose-response relations was the 
accuracy of each dose estimate. The statistical analysis commonly used in 
such studies contains the assumption that the i~dependent variable~ dose, 
is known precisely while the biological response may not be accurately 
measured. 
The retrospective study was divided into four phases. Phase I was 
a pilot study of only 100 single exposures of less than 24 hr in patients 
at the Medical Division. Phase II was an extension of this study to test 
the feasibility of using data from other hospitals and also included only 
single radiation exposures. Phase III included single and fractionated 
exposures (greater than one day and less than eight days). Phase IV 
evaluated protracted exposures where exposure time was greater than eight 
days. 
Phase I. Phase I was composed of 93 single":'exposure cases of 
therapeutically admini@t~red total-body irradiation (TBI) and seven cases 
of accidental TBI (Y-12 accident). Eighty-four of these were treated 
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with the Division J s med:3.um-exposure-rate total body irradiator (METBI) j and the other nine were treated with the Division's coba1t-60 irradiator 
I (Barnes teletherapy unit). The dose estimates for the 93 patients were based on a dosimetry 
J study by Hayes et a1. (Int. J. App1. Radiat. 15: 313-318, 1964). The 
dosimetric system consisted of an aqueous ferrous sulfate solut;lon (Fricke 
I dosimeter) within a p1exig1ass phantom. The absorbed dose to the solution 
I was taken as the patient's dose when he was exposed to the same amount of radiation. 
I Using this technique we determined the whole-body average dose (WBAD) 
and the midepigastric dose for all 93 patients. The WBAD is an estimate of 
I .. the average energy absorbed per gram of tissue, where the average is taken 
I .. for every gram of tissue in the body. The midepigastric dose is an estimate of the average energy absorbed per gram in the upper abdominal 
I compartment. 
The dose estimates for the seven Y-12 accident cases were determined 
1 
~ by a mock-up of the accident at its site (a complete description of this 
MI1' accident can be found in several reports relating to various catagorica1 
'1, 
.. '" aspects) • 
"'''' !l 
~;. 
Phase II. Phase II extended the pilot study by the addition of 11 
new ORAU cases, 29 from Cincinnati G~nera1 Hospital, Cincinnati, Ohio and 
.~'~ 
'ti; 
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23 from the City of Hope Medical Center, Duarte, California, bringing the 
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total number of patients in the study to 163. 
The dose estimates for the new ORAU cases were made with the same 
technique described in Phase I. However, all the ORAU dose estimates were 
modified for patient size. The size-correction factors were determined 
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from the experimental measurements of the absorbed dose in three phantoms 
representative of an adult, an adolescent, and a child. 
The dose estimates for the Cincinnati and City of Hope cases were 
based on a comparison of phantom depth-dose measurements made at each 
facility. 
Phase III. The addition of about 600 patients from 24 institutions 
with both single and fractionated exposures brought the total number under 
study to more than 750. Approximately 50 treatment techniques were used 
and 'dosage' was recorded in more than 15 different units. To make these 
doses comparable to those in Phase I and II it was necessary to convert the 
variously reported doses to total-body average dose. 
Table 1 shows the dose distribution of the 504 cases for whom 
total-body average dose were originally estimated. 
Of the 600 new cases only 66 were treated with gamma rays from 
isotopic sources and 39 of these were from institutions included in Phase II • 
We estimated the absorbed dose for 40 of these on the basis of experimental 
phantom measurements made at each facility. No dose estimates for the other 
26 patients could be made owing to lack of phantom data. 
Doses were estimated for 310 of 535 cases of X-ray TBI with the use 
of a method developed by Mayneord (1). Mayneord's method was experimentally 
verified by phantom measurements before its use. With it we estimated the 
total-body average dose for all cases of bilateral X-ray TBI having qualities 
expressed as half-value layers of from 0.5 mm to 4.2 mm of copper. For 
most of the other cases of X-ray TBI, the free-air exposure is the only 
'dosage' parameter avai1ab1e.-
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Whole-Body Average Dose (in rads) 
0-25 
26-50 
51-75 
76-100 
101-125 
126-150 
151;...200 
201-250 
251-300 
301-400 
401-500 
501-700 
701-900 
901-1100 
1101-1300 
Number of Cases 
149 
108 
90 
19 
17 ' 
36 
19 
26 
4 
15 
7 
7 
2 
3 
_2 
504 
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There were only 34 cases of the 757 single exposures to be considered 
in Phase III for whom we were not able to estimate either the total-body 
average dose or. the free-air exposure, less than a 5% loss of cases due 
to insufficient dosimetry data. 
Since the completion of these early effects to establish a human 
radiobiologic data bank efforts have continued to add to an update infor-
mation for future retrieval. Considerable additional therapy experience 
at ORAU Medical Division and data from radiation accidents have resulted in 
a data bank containing information on 2063 cases of radiation exposure. Of 
these, 16 are cases of accidental exposures and are encoded as single 
exposures. The remaining 2047 cases are therapeutic exposures and these 
data were obtained from the records of the hospitals identified in Appendix A. 
There are five types of exposures in the data bank. A "single 
exposure" was defined as any number of short exposures within a 24 hr period 
with any number of time intervals between exposures or any exposure of a 
continuous nature lasting less than 36 hr. A single or continuous exposure 
was generally a "Heublein exposure" if it was greater than 36 hr in 
duration. A "multiple exposure" was any treatment which the patient was 
treated with more than one single exposure within a six-week period. The 
isotope and portal exposure data was taken only from ORAU patients. 
The NASA Retrospective Data Bank is composed of mUltiple records 
keyed by record type, hospital number, patient number, date, and hour. 
Be~ause of the retrospective nature of the data collection (some treatments 
go back to 1931), all possible data are not available on every case or 
treatment. The data are stored on six magnetic tapes and may be described 
as follows: 
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Tape 1--Identification (87,343 records) 
AO Patient name, sex, race, etc. (1,803 records) 
A1 Total body exposure data (19,928 records) 
12 Isotope exposure data (432 records) 
DO Death information (1,076 records) 
TO General exposure information such as source, distance, etc. (10,016 rec.) 
T1 General exposure information (18,995 records) 
T2 Original dose reported & alternate calculated doses (19,001 records) 
T3 Heublein type dose information (207 records) 
P1 General portal exposure dose information (5,777 records) 
P2 Portal site exposure information (1,108 records) 
Tape 2--Nursing Notes (168,455 records) 
These records contain data on appetite, nausea, emesis, bowel 
movement, and strength. 
Tape 3--Vita1 Signs (172,346 records) 
These records contain information on temperature, pulse, respiration, 
height, weight, and blood pressure. 
Tape 4--C1inica1 Data (145,180 records) 
co Clinical chemistry (37,330 records) 
C5 Cytology (126 records) 
HO,H2,H3 Hematology (85,305 records) 
UO Urology ,(4,615 records) 
SO Serology (1,855 records) 
MO Microbiology (3,663 r,ecords) 
AS Antibiotic sensitivity (6,816 records) 
B5 Blood transfusions (5,470 records) 
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Tapes 5 and 6--Medications (277,235 records) 
These records contain information on all patient medications 
from dressings to drugs. 
The data are so voluminous (850,559 records) that composite infor-
mation is kept on a separate tape. This tape is used to produce sunnnary 
reports and to judge availability of data for specific studies. The tape 
c9Ptai~s abbreviated case identification, dose information, and frequency 
of other records such as nursing notes in the time vacinity of each 
treatment. 
c. Dose/Response Models 
1. Prodromal syndrome 
Nausea and vomiting are not considered a significant clinical 
problem in patients who have received less than 200 r to the 
abdomen, as partial or total-body therapeutic irradiation. Most! 
radiologists and radiobiologists would not debate the view that an 
exposure of about 200 r is required to cause nausea and vomiting in 
man but few, if any, can predict with any stated degree of. certainty 
for man what the probability is that any exposure to less than 200 r 
of total body irradiation will elicit nausea or vomiting. Recently 
it has become urgent to obtain such information as precisely as 
possible to predict the probability of total mission failure for 
manned space flight because of detrimental physiologic .responses of 
I th~ astronaut. Vomiting, per se,or nausea if e;evere enough, is 
conceivably an effect of radiation exposure, which, if not 
anticipated, could be disastrous in space flight. 
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The case histories of 94 patients who had received total-
body irradiation in the course of therapy, or as the result of a 
criticality accident (Y-12 accident), were encoded and processed to 
determine the incidence of anorexia, nausea, and vomiting. As 
shown in Table 2, the patients were divided into five dosage groups 
for which geometric mean doses of 49.6, 105.2, 300, 370.3, and 
540.5 r were determined. In Table 3 the percentage of cases in 
each group that showed anorexia, nausea, and vomiting are shown. 
Probability (probit) analyses were then done with these data to 
estimate the total-body irradiation dose required to produce the 
particular response in 50% of the patients. Table 4 contains the 
probit equations, the chi-square confidence limits, and the 
effective dose (EDSO) for these responses. The values are expressed 
as common logarithm to define the standard deviations of the 
estimates anc. the midline air dose (roentgens) and the absorbed dose 
(rads) to the gastrointestinal tract. 
These results appear to indicate that, if it is true that the 
chance of an astronaut in space receiving 10 rads to the abdomen is 
less than 1 in 1000, the chance that radiation-induced severe 
nausea and vomiting will occur is less than 1:100,000. 
The studies were refined by the collection of additional 
observations of human total-body irradiation and were extended to 
include similar estimates of the occurrence of diarrhea, fatiguability, 
erythema, alopecia, hematologic injury, infections, cataracts, and 
death. 
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TABLE 2 
Distribution of Single-exposure Patients in the Division's 
Radiotherapy Study Including Those in the Y-12 Accident 
Dose Group Dose (r) Number Cases 
I 35* 1 
49 1 
50 24 
60 1 
II 100 34 
104* 2 
162 1 
200 1 
206 1 
III 300 12 
IV 349 1 
350 1 
357 1 
358* 1 
360 1 
362 1 
384 1 
409* 1 
410 1 
V 473 1 
495* 1 
514* 1 
527 1 
553* 1 
616 1 
624 1 
*Y-12 accident patients. 
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TABLE 3 
Frequency of Anorexia, Nausea, and Vomiting in the Division's 
Radiotherapy Study of Single-exposure Patients, 
Including Division's Therapeutic and Y-12 Accident Patients 
Geometric Total Anorexia Nausea Vomiting 
Mean Dose (r) Cases Yes % Yes % Yes % 
49.6 27 4 14.8 4 14.8 2 7.4 
105.2 39 19 48.7 13 33.3 9 23.1 
300.0 12 11 91. 7 8 66.7 7 58.3 
370.3 9 9 100 •. 0 7 77 .8 5 55.5 
540.5 7 7 100.0 7 100.0 6 85.7 
TABLE 4 
Estimate of Effective Doses for Gastrointestinal Responses 
To Total-body Irradiation in Man 
Response 
Anorexia 
Nausea 
Vomiting 
Anorexia 
Nausea 
Vomiting 
Equation 
P = a (dose) + b 
(a) (b) 
3.389 -1. 849 
2.244 +0.066 
2.102 -0.005 
Midline 
ED50 ± S.D. Air Dose 
(Log10) (r) 
2.0208 : 0.2951 104.9 
2.1984 ~ 0.4455 157.9 
2.3810 : 0.4758 240.5 
Chi-square 
Confidence 
(%) 
91.2 
82.4 
87.6 
Absorbed Dose 
to GI Tract 
(rads) 
69.2 
104.2 
158.7 
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Of particular importance in this retrospective analysis was 
onset time for occurrence of anorexia, n~nU;ga, and vomiting, the 
systemic responses to irradiation manifested by patients who 
received portal radiation therapy. These symptoms constitute a 
syndrome that has been called radiation sickness or in those exposed 
in radiation accidents, the prodromal syndrome. In this retro-
spective analysis based on 194 patients who were irradiated on 346 
different occasions (each treatment being regarded as a separate 
entity) we attempted to establish quantitative estimates on the 
onset of each type response in the radiation syndrome. These 
patients were selected according to the following criteria: 
(1) They were irradiated b~tween 1956 and 1965. (2) They were 
hospitalized "at Oak Ridge Associated Universities Medical Division. 
(3) Irradiation was given to one part of the body only, excluding 
total-body irradiation. (4) Observations were available for the 
duration of the treatment course plus three days before and three 
days after the irradiation. 
The basic information was coded from nurses' notes. For 
instance, a recorded observation like. "patient ate poorly" or 
"refused supper" was encoded as anorexia: YES. Nausea, another 
subjective symptom, was recorded from the nursing notes when the 
patient had told the nurse that he was nauseated, either by 
volunteering the information or by being asked. Vomiting was 
accompanied by liquid objective evidence, and it was recorded with 
greatest faithfulness to actual occurrence. All information for 
each patient on anyone day was reduced to either YES or NO for 
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anorexia, nausea., and 'vomiting, no matter how many times a 
particular response occurred on that day. 
The question we wanted .to answer was: When, in the course 
of a treatment series, will the patient first complain of anor.exia, 
of nausea, and of vomiting? Any contributing factor other than 
time and his preirradiation status was ignored, specifically the 
kind of disease, where he was treated, and how much radiation he 
was given. The dat.a for anorexia are sununarized in Table 5. This 
table was prepared in a manner to permit an acturial analysis, as 
is done to calculate survival rates. The first column lists the 
days which irradiation was gi.ven, including any pauses for weekends or 
any other reason. Day 1 is the first irradiation day. The second 
column, headed N, recorded the number of patients that on the 
designated days had not yet responded. Each entry is the number of 
nonresponders on the preceding day minus those who the preceding day 
either first responded or were withdrawn from observation. The 
third column, R, is the number of patients who first responded on 
the designated day. Patients withdrawn from observation, W, are 
those who were followed up to the designated day without responding. 
The number at risk was obtained by subtracting one half of W from N. 
The 6th column is probability or response for each day (R/at risk), 
and the 7th column the.probability of not responding for each day. 
Next to it is the cumulative probability of not responding, which 
is obtained by transmultiplYing all the entries in the preceding 
column. Finally, the 9th column is the cumulative probability of 
responding, calculated by subtracting each entry on the preceding 
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Treatment 
DaY N R 
1 346 155 
2 191 36 
3 155 27 
4 128 13 
5 115 8 
6 106 11 
7 95 7 
8 87 5 
9 77 2 
10 69 ·9 
11 58 3 
12 55 2 
13 52 2 
14 44 1 
15 43 2 
16 41 1 
18 34 2 
21 27 1 
22 24 2 
26 21 1 
29 12 2 
30 8 1 
40 6 1 
49 1 
TABLE 5 
Onset of Anorexia 
All Cases 
w 
1 
1 
5 
6 
2 
1 
6 
6 
5 
2 
1 
8 
2 
1 
4 
1 
At risk 
346 
191 
155 
128 
114.5 
106 
94.5 
84.5 
74 
68 
58 
54.5 
49 
44 
43 
38 
31.51 
26 
23.5' 
17 
11 
7.5 
4 
f{& 
.4480 
.1885 
.1742 
.1016 
.0699 
.1038 
.0741 
.0592 
.0270 
.1324 
.0517 
.0367 
.0408 
.0227 
.0465 
.0263 
.0635 
.0385 
.0851 
.0588 
.1818 
.1333 
.2500 
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1-P(R) Cum 1-P(R) Cum peR) 
.5520 .5520 .4480 
.8115 .4480 .5520 
.8258 .3.699 .6301 
.8984 ,,3:324 .6676 
.9301 .3091 .6909 
.8962 .2771 .7229 
.9259 .2565 .7435 
.9408 .2414 .7586 
.9730 .2348 .7652 
.8676 .2038 .7962 
.9483 .1932 .8068 
.9633 .1861 .8139 i ~ 
.9592 .1785 .8215 
I .9773 .1745 .8255 .9535 .1664 .8336 
.9737 .1620 .8380 i 
.9365 .1517 .8483 I 
.9615 .1459 • 854.l 1 
.9149 .1334 .8666 1 j 
.9412 .1256 .87~4 I 
.8182 .1028 .8(H2 1 .8667 .0891 .9109 
.7500 .0668 .9332 
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column from 1. The information contained in the last column is 
better visualized if plotted graphically (Fig. 1) where the treat-
ment day is plotted on a logarithmic scale and the ctnnu1ative 
probability of responding is plotted on a probability scale. In 
this fashion all data points arranged themselves along a straight 
line. 
The high incidence of anorexia on the first day of treatment 
might not represent a radiation effect, but rather continuatio.n of 
a preexisting condition. Many of the treated patients actually 
had anorexia because of their illnesses. Conceivably these pat~ents 
responded differently to irradiation; they might respond to a 
greater degree because they were already prone to become anoretic, 
or they might respond less because irradiation partially relieved 
the pathological condition that made them anoretic. 
We decided, therefore, to subdivide the patient into two 
[ groups: those w
ho had anorexia before irradiation and those who did 
not. The first group includes all patients who on any of the three 
days preceding irradiation had been anoretic one or more times. 
There were 176 patients in the first group and 170 patients in the 
second group. The cumulative incidences are graphed in Fig. 2. 
r I .. 
The response of nausea was analyzed in the same fashion as 
anorexia. First, all patients Were taken together and then two 
I ! I 
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r. , 
groups were treated separately: patients who had nausea before 
irradiation and those who had not. Again, a patient was included in 
the first group if he had had nausea at way time during the three 
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days preceded the beginning of the radiation course. The data are 
summarized in Fig. 3. 
The vomiting response was evaluated as in the two preceding 
sections. The data are summarized in Fig. 4. 
Of the three symptoms of radiation sickness, anorexia appeared 
earliest, next nausea, and vomiting last. The time of onset for each .~. 
response depends considerably on whether the patient had any of 
those symptoms before irradiation. If he did, his chances of having 
more of the same during the treatment course are very high and if 
the treatment time lasts as long as two weeks the majority of 
patients will respond. Patients free of these symptoms before 
irradiation fare better. Yet their risk of having anorexia, nausea, 
or vomiting, at least once, is high. It is highest for anorexia; 
at 40 days, 88% of the patients will have had this symptom at least 
once. 
Nausea generally appears later and the risk of developing it 
does not increase as fast as for anorexia. Still, at the 40th day 
of treatment, 60% of the patients will have experienced it. 
Initially the risk of vomiting is only slightly below that of 
naJsea, but as time passes the increment rate for vomiting is less 
than for nausea. At the 40th day 43% will have vomited sometime 
since irradiation was started (Figs. 5 and 6). 
It should be underscored that the tables and graphs present 
cumulative probabilities. On a day-to-day basis, the probability 
of response decreases with time. For instance, for previously 
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nonresponders the risk of developing anorexia on the first day is 
0.18, on the second day it is 0.12 (0.18 + 0.12 = 0.30), on the 
third day it is 0.08, etc. 
The time scale, in effect, is proportional to radiation dose. 
Longer treatment times tend to correspond to high total radiation 
doses, although the clinical data include high single doses and 
low-dose fractionated courses. The remarkably good fit of most of 
the curves, however, indicates that there is, indeed, a good 
correlation between onset of symptoms of radiation sickness and 
length of radiation course. It should be stressed that we have 
commented only on the onset of symptoms. 
Further analysis of these data indicated that the patterns 
of response can be well described by a Weibull distribution of the 
form 
S S-l -at 
f(t) = aSt e (1) 
Although these data were fitted to a log it or probit distribution 
the Weibul1 distribution was used here because of somewhat greater 
mathematical simplicity and especially because the beta exponent 
in equation 1 indicates,without further calculations, the rate of 
change in probability of response as a function of time. When 
beta was less than 1 (as in most of our data) the probability of 
response decreases with time. 
In a Weibul1 distribution the cumulative probability of 
response is given by 
S 
-at 
e 
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~ where alpha and beta are parameters of the equation and t 
I represents days after beginning of treatment. Figure 7 shows that 
the values calculated by equation 2 fit well the experimental data. 
I Of greater interest than the cumulative probabilities were 
4 I , t~e conditional probabilities defined as the probability that a response will occur at a certain time provided that it has not 
I occurred before. The conditional probabilities were calculated by 
subtracting the cumulative probabilities of occurrence in two 
I f successive days and dividing by the cumulative probability that the 
I response had not yet occurred in the earlier of the two days being compared. Equation 2 was used to compare the cumulative probabilities. 
I Figure 8 shows the conditional probabilities for the onset of anorexia, 
nausea, and vomiting. It clearly shows that an irradiated patient is 
[ 1 more apt to respond on the very first day of treatment than at any 
[ other time. If no response occurs on the first day, the risk of 
responding on the next 10 to 20 days steadily decreases and beyond 
I'!';-Ll that time is almost constant. 
This analysis can also be carried out for responses other ir \, :", 
'. ~ . 
than the first one. For instance one may wish to determine what is 
.... 
If 
:-
the ,probability that a certain response will occur provided it has 
already occurred once and only once before. Figure 9 shows the 
r ' i; · f 
" 
conditional probability for an irradiated patient to develop 
anorexia, nausea, or vomiting for the second time during a radiation 
U · if , l, · ~: treatment course. It is clear that if the patient previously 
, 
n I ' If, {; r' c .'-
, 
c, n r i t;, ! 
responded he is at a much greater risk to respond again than if he 
had not had anorexia, nausea, or vomiting once before. Yet, the 
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~ 
conditional probability of responding for the second time also 
decreases with time. In general, this is true for any response 
; 
I :1 ~ $ ~ i 
" 
1 
.j 
J " 
number, either first, second, or nth. '.~ 
• 
') 
~ 
The overall pattern of responses in a population receiving 
radiation therapy is shown in Fig. 10, where the conditional , 
, 
probabilities of responding for the first, second, or nth t~e have 
.~ 
been summated for each day, weighing those conditional probabilities 1 ~ 
by the relative number of people that at anyone day are responding 
for the first, second, or nth time. Figure 10 shows that the 
overall probability of response decreases little with time. This 
is not in contradiction with the earlier conclusion that a patient's 
risk of manifesting a resp.onse steadily decreases with time. That 
is true so long as we consider a certain response number (first, 
second, nth) by itself. However, wi.th the passage of time, patients 
are exposed to new risks which increase the overall probability of 
responding. For instance, the risk of vomiting for the 10th time 
does not begin until the 10th treatment day and only for those who 
have vomited daily for the past 9 days. For these patients the risk 
of vomiting again is very great, although overall this is an uncommon t 
1 
occurrence. To put it another way, after a few days of ra~ation 
treatments, almost all the patients who vomit consist of a rather 
t: 
i 
small population of patients who have vomited several times earlier ~: 
and who have high risks of vomiting again. 
The results of these studies on prodromal responses were in-
corporated within the text of Radiobiological Factors in Manned Space 
Flight of which Wright Langham (2) was the editor and are discussed 
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at length in Chapter X, Human Radiation Tolerance (3). 
2. Acute hematopoietic damage 
We have attempted to make quantitative analyses of the 
radiation-induced hematologic responses of patients who received 
total-body irradiation at some time during the course of therapy 
for neoplastic diseases. Our results have not yet been any more 
quantitative or less narrative than those of numerous other investi-
gators working on this problem. The need for quantitating these 
effects does not stem from any immediate clinical problems since 
available descriptions of the time-course of radiation-induced 
hematologic events afford abundant information to aid in the medical 
management of any patient irradiated either accidentally or thera-
peutical1y. Quantitative formulae are needed, however, to help 
predict, with some known level of precision, how hematologic damage 
may be caused by chronic 10w-dose-rate exposures of normal men. 
We collected the clinical case histories of 2310 patients 
from hospitals in the United States and Canada, encoded these records 
for manipulation and programmed retrieval by computer, graphed the 
time-course of the changes in ~eriphera1 blood cell counts after 
each TBl and determined the percent survival of leukocytes and 
platelets after specific single and multiple radiation exposures. 
Our efforts concentrated on studying only the most complete 
hematologic records, culling out those having uncertainties about 
exposure (total roentgens, fractional doses, total treatment time, 
intervals between exposures, etc.) and with blood studies insufficient 
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to determine the nadir of peripheral blood cell values and its 
time of occurrence. We found that at least seven blood cell counts 
done at weekly intervals for 6 weeks are needed to estimate the 
percent survival of most blood cells after an exposure, to be certain 
that a true nadir was observed. Many patients were too ill to 
afford hematologic data that were not biased heavily by their 
diseases and terminal infections; these were identified by these 
data searches and eliminated. In addition, we evaluated the 
clinical and laboratory evidence that defined the diagnosis in order 
to group together only patients with the same disease. Only four 
general disease categories were found that contained sufficiently 
numerous patients who had received single or multiple exposures to 
form groups for study. Second and third series of exposure were 
not included since the responses might be influenced by the previous 
irradiations. In these ways the single-exposure cases that total 
1085 in our data bank were reduced to only 151; the 1225 mu1tip1e-
exposure cases to 395. Table 6 shows the composition of this study 
material divided into the four hematologic-disease groups and 
according to single and multiple types of exposures. The average 
doses and the exposure duration of the multiple exposures are shown 
for each diagnostic group. The isolation of a so-called "normal" 
group was a fundamental need of this problem. The patients in this 
normal group,however, were not actually normal but either had 
disseminated solid (but not hematologic) tumors or were in late 
stages of nonmalignant diseases of the bone, joints, and the 
genitourinary system. However, in the absence of recorded hemato-
pOietic abnormalities the patients in this group were considered to 
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TABLE 6 
Number of 
Diagnostic Patient Studies 
Group Single Multiple 
(II) 
"Normal" 92 29 
Chronic 
myelogenous leukemia 15 116 
Chronic 
lymphatic leukemia 28 200 
Lymphosarcoma 16 50 
*Incomp1ete 
Average 
Average Length of 
Total EXEosures Multiple 
Single Multiple Exposures 
(R) (Days) 
195 232 27 
117 152 28 
* 116 36 
108 217 31 
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have "normal" (nonleukemic) marrow and lymphatic systems. The 
presence in this "normal" group of serious systemic diseases, even 
though not primarily hematologic, makes our apparent assumption. of 
the existence of completely normal peripheral blood-cell kinetics 
unquestionably naive. The implication should not be accepted 
unequivocally that the mathematical description of the response 
pattern of this "normal" group can be used to describe exactly that 
or normal young men in the prime of life. It is difficult, however, 
to believe that normal young men would respond worse than this group 
did rather than better. 
In the first step of the statistical analyses of this data, 
we chose to ignore the influence of the number of fractions of 
exposure, for the time being, to simplify our confirming the appli-
cability of multivariant analysis to this problem. Accordingly, we 
related the individual nadir (%S) of the total leukocyte counts 
(expressed as percent of the initial total that survived) with the 
total exposure in R and the total time (days) required for the total 
exposure to be made. Slope constants (bl ) and (b2) for a multi-
varient regression formula were computed first for the single 
exposures and then for the multiple exposures fo~ each disease 
group. No radiation dosage groupings within these four diagno~tic 
groups were needed with this method of computation and fitting the 
regression. In the equation 
%S = 100 (D)lbl '. (T) b3 •••••••••••••• (3) 
K is the constant required for the regression line for percent 
survival to intercept the ordinate at zero dose. This interception 
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~oint is greater than 100% of initial WBC survival because no 
effect was observed on cell survival after exposures of less than 
50 R; D is exposure in roentgens; T is total length of exposure 
time in whole days; F is the number of fractional exposures made. 
For the purpose of this initial analysis the variable F was not 
used. In single exposures, T by definition is ignored and the 
equation becomes 
K • 100 • Tb2 %8 = ----~~-----(D) 
For exposures longer than one day (as multiple exposures are 
defined here) the equation is then 
K • 100 • Tb2 %8 = ----~~--~-(D) 
(4) 
(5) 
The computed slope constants for the four diagnostic types 
of h~ato1ogic statuses analyzed here are listed in Table 7 along 
with the test values for the significance of the first of the data 
to the equations 4 and 5. 
These results seemed encouraging. They showed that this 
method of analysis is applicable to our problem and that the data 
were statistically well described by the equations. These mUltiple' 
regression correlation coefficients were exceptionally good for 
analyses of clinical data. The values for the slope constants 
appear to have interesting biological implications that are medically 
logical and acceptable. For example, in Table 7 the negativity of b1 
indicates that as dose increases the percent survival by peripheral 
WBC decreases. The correspondence of this value for each group to 
1.0 may indicate that in the leukocytic systems difference in 
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TABLE 7 
Slope Constants and Tests of the Statistical 
Significance of the Models 
Single Exposures 
Correlation 
Multiple Exposures 
Diagnostic 
Group 
"Normal" 
CML 
CLL 
LS 
b1 Coefficients 
1.04 0.57 
0.999 0.82 
0.9l? 
1.119 0.42 
0.63 
0.392 
0.221 
0.231 
Correlation 
Coefficients 
0.535 
0.569 
p 
Value 
<0.025 
<0.0001 
0.583 <0.0001 
0.567 <0.0005 
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radiosensitivity is not a significant factor. This result is 
surprising in view of the widely-held clinical belief that the 
leukocytes in chronic lymphocytic leukemia, for example, are much 
mo.re radiosensitive than the cells comprising the WBC in chronic 
granulocytic leukemia or in "normal" persons. This apparent 
deviation from clinical "fact," however, can be explained by the 
significant differences found in the values of b2• The larger this 
positive slope constant is, the more effective is the length of 
protraction of exposure in increasing the level of cellular survival; 
according to these values, in the "normal" the white blood cell 
level is protected by dose protraction three-fold over that afforded 
to it in CLL and lymphosarcoma. According to this analysis, dose 
protraction in the latter groups should not decrease the effective-
ness of the total dose as much as in the "normal" group or in the 
CGL group. These interpretations are in agreement with most 
clinical observations and suggest, in keeping with experimental 
observations,that dose protraction aids normal tissue to recover 
and regenerate more rapidly than pathologic tissues. This concept 
is, in fact, the rationale for fractionation and protraction of 
radiation therapy of malignant tissues. Clinically observed 
differences in WEC survival after the same radiation exposure 
result more from difference efficiencies of recovery mechanisms 
than they do from inately different cellular radiosensitivities in 
these diseases. 
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CHAPTER IV 
PROSPECTIVE STUDIES 
A. Irradiation Facilities and Dosimetry 
During the operation of a clinical/medical facility for the care 
and treatment of patients with leukemia, lymphoma, and related disorders 
the Medical Division of ORAU had operable two total-body therapeutic 
irradiation facilities. One, built in 1960, was a room with eight cesium-137 
sources initially capable of exposures ranging from 300 R/hr down to 
1.B R/hr. This facility was generally operated at exposure rates of 
1.5 R/min (90 R/hr) for therapeutic irradiation and is identified as METBI 
(Medium-Exposure-Rate Total-Body Irradiator). Another, built in 1967, 
consisted of 10 cobalt-60 sources geometrically arranged. so to produce an 
isodose level of 1.5 R/hr anywhere within the treatment room and is 
identified as LETBI (Low-Exposure-Rate Total-Body Irradiator). The total 
number of patients treated in these facilities is shown in Table 7a. 
1. . METBI 
Figure 11 shows a cutaway model of the total-body irradiation 
room. A 2 x 2 x 6 ft virtual volume was suspended over a bed by four 
posts that are out of the exposure field. The bed was made of two 
sheets of 1/32 in aluminum separated by approximately an inch and a half 
of honeycomb cardboard. The material is usually used for the extreme 
strength necessary in airplane fuselage construction and has no sag 
when a patient is placed on the bed. The bed is slightly trough-shaped 
so that patients cannot easily roll off. A nylon net surrou~ded the 
bed. A television set with remote controls was placed so that a 
patient lying on the bed can view television~ 
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TABLE 7a 
TBI TREATMENTS OF 50 R AND GREATER THROUGH 1974 
E~posure 
per 
treatment 
(Rx) 
METBI (1.5 R/min) LETBI 1(1.5 R/hr) LETBI n (O.8/hr) 
50 
100 
120 
150 
Single 
acute 
exposures 
15 
20 
10 R/day 
(3 days/ 10 R 30 R 60 R 10 R 
week) day day day- day 
1 
1 
Chronic Lymphocytic Leukemia 
1 
30 R 
day 
4 
Lymphosarcoma and Lymphosarcoma Celf Leukemia 
16 R 
day 
2 
50 
100 
150 
250 
5 
22 
1* 1 
It 1 131/ 3~ 
1 1 2f 
1 411 
Chronic Granulocytic Leukemia 
50 
60 
100 
120 
150 
200 
250" 
8 
4 1§ 
16 
1 
3 
1 
2 
Polycythemia Rubra Vera 
100 
150 
250 
7 
5 
Idiopathic Thrombocythemia 
100 
150 
1 
Totals 82 
* Patient received 60 R 
5 
t Pa.tient received only 90 R 
2 
2 27 
f One patient received only 140 R 
§ 25 R/day 
1I0ne patient had lymphosarcoma cell leukemia 
3 
11 Two patients had lymphosarcoma cell leukemIa 
o One patient received only 222 R 
lOne patient received 230 R 
7 
6 
1 
9 
80 
5 
~I 
1" 
7 
60 
1 
1 
1 
8 
Totals 
15 
27 
1 
1 
7 
31 
4 
5 
8 
3 
11 
1 
27-
2 
9 
14 
14 
4 
2 
9 
194 
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The room is constructed of poured concrete, but theimdde wall 
is covened with an acoustic tile, which has no effect on the radiation 
characteristics. The floor is of vinyl tiles. Ventilation is arranged 
so that the air enters through the maze and leaves through a ventilator 
funnel on the wall opposite. Heating is done with electric wall 
heaters. In summer, air is drawn through a louvered door from an 
air-conditioned corridor. Two steel rails at the ceiling over the 
bed support an instrument trolly. The instrument cables go through 
a conduit in the ceiling. Preliminary investigations showed no 
appreciable scatter from the accessories. 
The bed is placed in the center of an 8 ft (plus entry) cuLical 
room. Eight teletherapy machines (four each side of the therapy 
space, near the corners) all point toward the center of the irradiation 
volume. Each source contains 500 ± 0.5 c of cesium-137. With all 
sources "ON" the exposure to the 2 x 2 x 6 ft irradiation volume 
ranges from 308 to 318 r/hr without the final filter covers in place. 
The exposure rate drops off slowly (about 8 r/hr) at the very head 
and foot ends of the bed but more quickly outside the irradiation 
volume. 
The room is approached through a semispiral maze. At the end 
of this maze is a ~rrought-iron gate that must be closed for the 
machine to be turned on. Opening the gate automatically shuts off 
the machine. Any person going through the gate will shutoff the 
machine before he can receive a significant exposure. The maze is 
sufficiently wide for patients' beds to be wheeled through, but 
patients are usually carried on a travelling cart. 
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Each of the sources can be turned on separately (Fig. 12). 
While this might be of value in later treatment problems, its primary 
purpose was to allow for dosimetry testing. These separate controls 
were covered and the only control necessary for the clinician is a 
clock and .the master control button. 
NEPBI Dosimetry. After initial background experiments were 
137 
concluded the eight 500 c Cs sources were loaded into the shields. 
One of the design features of this installation was to try for as 
uniform an exposure field to the patient as possible. Therefore, the 
eight sources were aimed to irradiate the subject from many different 
angles, each ported to expose the entire bed length. It was realized 
that scatter off the room walls and other variable factors might alter 
the desired unifonnJty, and a series of measurements was undertaken to 
investigate this possibility. The ion chamber was suspended at a 
point 12 cm above the bed center and was moved toward each end in 10 cm 
steps. The readings obtained are reproduced in intensity toward each 
end of the bed. The maximum rate of 7.4 r/min at the bed center 
would allow an exposure of 444 r/hr - a good deal more than the 250 
r/hr originally thought possible. 
With an excess of exposure rate available, the suggestion waS 
made to attempt to even the exposure field. For this purpose stacks 
of metal strips were made and installed to give an attenuated portion 
in the center of each beam. A pyramidal stack for each source with 
the thickest portion in the beam center gave the lower curve in Fig. 13. 
As illustrated, this curve is more uniform throughout its length and 
gives an exposure rate of about 300 rlhr. 
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Studies were also made in the lateral and vertical directions 
in the volume immediately above the bed. The variations of the 
field in these positions were not found to be large enough to require 
further compensation. 
Attenuating the rate of exposure to the patient by using 
increasing filter thicknesses proved to be an excellent means of making 
these adjustments. Nevertheless, the question of spectral changes 
resulting from the introduction of these filters was an important one 
to examine because of possible changes in the depth-dose relationships 
in the patient. 
The variations in spectrum with exposure rate were investigated 
using: weak (2 mc) mock sources, in order to keep the intensity down to 
a reasonable level. The background for such measurements, however, is 
not the "natural" background investigated earlier, but rather that 
existing when the 500 c sources are present but are turned to the "off" 
position. The count rates for these backgrounds (and later for the 
gross counts) were found to be very low, to such an extent that re-
cording of the count with a meter system was impractical. Therefore, 
17 spectral points of interest were selected and cumulative counts 
were made at each point for each filter setting. Some of these counts 
took as much as 10-20 min to complete, and a rather lengthy procedure 
resulted from the checking of 32 filter positions for 17 spectral 
points. This process was repeated again for the gross counts and the 
background counts were subtracted. 
After computation of the net counts, a series of curves was 
drawn representing the spectrum for each filter position. These curves 
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were transferred to and cut out of wooden sheets of uniform thickness. 
Incorporating the 32 resulting curves into a solid model gave the 
three-dimensional representation of Fig. 14. The three axes in this 
model represent energy (X), count rate (Y), and filter thickness (Z). 
The two black lines running down the face of the curves denote the 
137 primary Cs peak at 660 keV and the 120 keV scatter peak. The 660 
keV primary radiation falls off in the smooth exponential fashion 
expected from increasing incremental filter thickness. The scatter 
components do not follow this smooth fall-off so well. The scatter 
starts off as a dOllble-peak function, which drops rapidly in the first 
few filtrations to become a single-peaked curve at lower intensities. 
The initial rapid fall-off in the scatter component later becomes slow, 
whereas the attenuation of the primary peak continues unabated. This 
causes the scatter to persist even at the weakest intensities, where 
the primary peak is no longer visable. This residual scatter present 
may be the result of leakage around the edges of the filter, which is 
not tight against the source shield; or it may represent the degraded 
components of the primary radiation that finally trickles through the 
filters. 
Generally speaking, the relative shape of these curves is 
reasonably constant except when the heaviest filter sections are in 
position. Unless treatments are to be given at very low dose rates, 
no corrections for spectral changes are anticipated. 
The last series of measurements made before release of the 
facility for clinical use was to determine the exposure rates available 
for treatment. The ionization chamber was positioned 12 cm above the 
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center of the bed and successive readings were taken for each filter 
.. F 
thickness. Figu~e 15 illustrates the result of this investigation 
by plotting exposure rate against increasing filter thickness. The 
actual curve deviates substantially from the calculated attenuation 
line at heavier filtrations. Probably this results from the leakage 
of radiation around the sides of the filter and, moreover, from the 
scattered component, which is not considered in calculating the 
theoretical attenuation line, that leaks through the filter. 
The attenuating filters provided an intensity range of about 
160:1, which was more than adequate for clinical studies. For the 
convenience of the operators, a chart was prepared showing the treat-
ment times required to deliver various total exposures (corrected for 
decay) with any desired filter thickness. If a slow rate of treatment 
was 'desired, more filtration was added and the time lengthened. This 
relieved the technician of the responsibility of making a separate time 
calculation for each treatment, and thus minimized the chance of error. 
Initial therapeutic protocols called for midline exposures of 
50-100 R given within 1.5 hrs. The exposure rate was 1.5 R/mi? e~cept in 
a few instances where the clinical course of disease required larger 
total doses at higher rates. These protocols were later expanded to 
include fractionated therapy that called for 30 R/day, at 1.5 R/min for 
five consecutive days (total exposure 150 R), as well as either 30 R 
or 10 R (1.5 R/min) on a prn basis as mandated by disease progression. 
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2. LETBI 
Radiobiologic observations on dose fractionation and protraction 
in animals and man suggest that beneficial effects of TBI in chronic 
leukemia and other mye1opro1iferations may be augmented by low-exposure 
rates or dose fractionation. These observations provide the experi-
mental and clinical rationale for this new low-exposure-rate facility. 
The low-exposure-rate total-body irradiation facility (LETBI) 
diagramed in Fig. 16 consists primarily of a large concrete outer room 
in which a smaller inner exposure room is centrally positioned. The 
60Co sources located in the outer room, as shown, irradiate the inner 
room from all sides. 
The resulting radiation field enabled the inner room to be made 
sufficiently large (16 ft x 16 ft x 8 ft) for two patients to live in, 
as in a two-bed ward, for an extended time (days) during their 
exposure to 1. 5 R/hr (Fig. 17). The eight corner sources (Fig. 16) 
initially consisted of 26 curies each of 60Co and the central ceiling 
and floor sources of 4 curies each. These sources are operated and (Fig. 18) 
monitored remotely from an instrument console/located in an adjacent 
control room (Fig. 16C), that also contains closed circuit TV monitors, 
an intercommunication system for patient surviel1ance, and a physiologic 
monitoring system described elsewhere in this report. All these 
instruments, operational relays, safety interlock switches, interrupt: 
circuits are wired to an IBM 1800 computer in another adjacent room 
(Fig. 16D) for data storage and processing on a constant real-time 
basis during the facility's operation. Switches on the console permit 
the various interrupt levels in the IBM 1800 computer, located in the 
room below, to be activated so that prearranged programs for analysis 
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61 
of physiological signals can be called and executed. Figure 19 shows 
the signals that are now being fed into the computer. On the analog 
side, calibrated voltages in the % 10 millivolt range are being 
supplied from the conditioned physiologic monitor outputs. Other 
analog signals from the radiation monitor report on the operation of 
the individual sources. All these signals are recorded and analyzed 
by the computer programs. The computer is programmed to check the 
values of all analog signals and to signal an alarm if any physiologic 
signals or radiation levels stray outside preset limits or source-
containing pistons fail to return to their shields on demand. Digital 
switch closure signals (Fig. 19) from the console enable the computer 
to record when the sources are raised and lowered and the reasons 
interruptions in exposure occurred. 
The radiation is turned off automatically whenever the patient 
leaves the treatment room or when anyone enters the interlock-controlled 
area. When the patient leaves to visit the bathroom located off the 
entrance hall to the treatment room but does not leave the controlled 
area itself, the radiation devices are turned on automatically upon 
his return to the treatment room. If the exposure is interrupted for 
nursing care, meals, and other reasons, the radiation devices must be 
turned on by the nurse who records the reason for the interruption. 
These events and exposure times are recorded by the computer and 
nursing and technical staff (Fig. 20) for use in retrospective studies 
of therapeutic effectiveness and evaluation of possible radiation-induced 
effects. Hematologic studies and a system of dosimetry based on the use 
of tissue equivalent humanoid phantoms in LETBI are described elseWhere 
in this report. 
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Therapy protocol::) for this low-exposure-rate irradiation 
facility were designed so :that patients received 30 R/day (1.5 R/hr) 
based upon a 20 hr day. Total exposures ranged from 30 R to 250 R. 
After establishment of a clinical hematologic data base, some patients 
were treated with only 10 R/day ("'6.7 hrs). After source decay resulted 
in alteration of isodose configurations, the exposure rate was dropped 
(via source shielding) to 0.8 R/hr or total daily exposures of 16 R. 
A physiolggic monitoring system was developed for use in the 
LETBI facility to study vital functions of patients undergoing radiation 
treatment. The basic monitoring system is illustrated in the block 
diagram of Fig. 21. The system was initially developed to record the 
following six variables: 
2. 
3. 
4. 
5. 
6. 
EKG waveform (frequency response: 0.01 to 250 Hz). 
Heart or pulse rate (range: 0 to 200 beats/min). 
Respiration waveform (frequency response: 0.01 to 10 Hz). 
Respiration rate (range: 0 to 60 breaths/min). 
Rectal temperature (range 34° to 42°C). 
Time base (from start of irradiation). 
As shown in Fig. 22, signals from the patients were conducted through 
a flexible umbilical cable in the irradiation room and a 65-ft long 
signal cable running to the monitor console. The remote console 
location was necessary because of the gamma radiation field. Signals 
from the patient were conditioned by the monitor electronics and then 
transmitted for recording and analysis through cables to the computer 
room 10cated below the monitor. We investigated a number of electrode 
and sensor arrangements to obtain the most information with the least 
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inconvenience to the patient. The configuration shown in Fig. 23 
permitted us to record the first four of the listed variables with 
the use of only three electrodes attached to the patient. The EKG 
waveform and pulse rate were obtained with the use of a differential 
amplifier and a cardiotachometer of standard manufacture. The 
respiration waveform and bl!eathing rate were obtained, however, at a 
frequency of 50 khz so that the two types of information from the same 
set of electrodes will not mutually interfere. Wiring for future 
monitoring of galvanic skin resistance (GSR) was included in the cables. 
One of the problems with using the monitor is that radiation 
treatments were planned to last a week or more. Difficulties have been 
experienced in getting the electrodes applied for minimum irritation 
and in arranging the interconnecting belt and umbilical cord for least 
discomfort and restraint for an ambulatory patient. The electrode, 
belt, and cable arrangement shown in Fig. 24 overcame these problems. 
Usually the patient wore the belt over his hospital clothing as shown 
in Fig. 25 and guided the umbilical cord with his hands as he moved 
about the room. The umbilical cord contained a set of quick-disconnect 
connectors near the belt so that the patient or attendant could uncouple 
and reestablish the monitoring circuits without the need for removing 
the electrodes. 
Power-frequency interference was a major problem in recording 
low-level bipotential measurements and the physiologic measurements 
we made in the low-exposure-rate total-body irradiat.ion facility were 
not exempt from this difficulty. The interference Gn our recording 
charts resulted from the fact that electric currents and voltages can 
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j 
be induced in a patient from nearby equipment powered from the commercial 
I supply system. These artifacts show up most frequently in the EKG 
I trace, and other traces derived from it, because the information frequently bandwidth for the EKG ranges from 0.01 to 250 Hz and the 
I 6o-Hz power-line frequency falls in the middle of this band. The 
respiration signals were derived, however, .from a 50-kHz, 100-microampere 
:1 constant-current supply and were much less affected by signals at the 
I 
power-line frequency. 
The interference in the EKG trace is coupled to the patient in 
I two ways, similar to the broadcast and reception of radio signals. 
The first mode is by electric flux coupling, where charges in the 
I subject are set in motion by moving charges in wiring and nearby elec-
I 
trical devic~s. This type of coupling is illustrated in Fig. 26. In 
the upper portion of the figure a single-ended amplifier is shown with 
J capacitive coupling to a patient from a fluorescent lamp. Interference 
occurs because an AC voltage is induced through the lower resistor ~ 
I to ground. This is picked up by the amplifier at terminal A and 
I 
produces an output voltage Eo heavily contaminated with the power-
frequency component. The lower portion of Fig. 26 shows how this 60-Hz 
"'f compone~i!: can be greatly attenuated through the use of a differential , 
". 
amplifie!". The corranon-mode 60-Hz voltage is cancelled out by the diffe-
... 
rential amplifier characteristic. At the same time the differential 
';::....t' 
, 
t "" .. 
I L -; .Qi~;'" 
EKG voltage is amplified properly and the output voltage Eo is 
interference free. In operation, with the differential amplifier 
i 
I ~"'"C"!'j 
I ·1 
I I .,.. 
I ... " ,I' ~t e -~ r 
~ .... ,! iJ! fl. ... 
connected, we found that by making low resistance electrode connections 
and positioning them carefully on the patient good recordings could be 
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obtained. Our interference-free recording of a l~millivolt EKG 
I voltage in the presence of a 6o-Hz signal, many factors higher in 
I magnitude, demonstrated the efficacy of the differential amplifier 
circuit. 
I The second mode of interference transfer is by magnetic flux 
coupling, where currents are induced in the patient through a transformer-
I like action by currents and magnetic fluxes in nearby power wiring and 
I electrical equipment. Figure 27 shows how our present three-electrode patient connections act as two, one-turn secondary loops of a transformer 
Ii coil through the patient; an electrical device acts as the primary 
circuit and air is the transformer core. If there is am imbalance in the 
I, flux coupling between the source and the two patient loops, a differential 
), current and voltage will exist as terminals A and H that will be detected 
and amplified. Because this kind of signal is not rej ected by the 
\"'i 
differential amplifier circuit we have been particularly interested 
in locating and mapping the magnetic field sources and intensities 
I • ~" .! in the LETBI facility . 
1 !.' .~ To explore these magnetic fields a resonant probe was constructed as shown in Fig. 28. The probe consisted of a coil wound on an iron 
I' ! core that is made resonant to 60 Hz With a parallel capacitor. An 
oscilloscope with a high-sensitivity preamplifier was used as a read-
~I; out device (Fig. 29). The volume contained within the LETBI room was 
Jh . , d 
measured off in 2-ft increments and every electrical device was turned 
on to provide a "worst case" condition. Measurements were then made 
, 
I holding the probe axis vertical and with the oscilloscope located in 
I 
I , 
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77 
the outside hall with an interconnecting cable between the two. Values 
were recorded for planes parallel to the floor, ceiling, four walls, a 
vertical cross section 3-3/4 ft from the west wall, and a horizontal 
cross section 3 ft above the floor. 
Figure 30 shows a flux map made on a plan 3 ft above the floor. 
The flux was concentrated near the color TV set and near the wall corners 
and door where wiring is present. A magnetic flux map of the east wall 
(Fig. 31) showed two intense flux areas. One was located at the 
intercom and power switch panels and the other (highest intensity 
recorded in the room was 50 millivolts) located in the floor corner 
directly above some fluorescent-lighting ballast circuits. Figure 32 
shows the flux pattern obtained in a vertical cross section taken 
directly beneath a row of fluorescent lamps. These lamp fixtures give 
off an appreciable amount of magnetic flux and, as seen in the figure, 
this field falls off with distance. 
To determine the magnitude of the magnetic coupling, a two-loop 
wire probe was constructed similar in shape to the equivalent circuit 
shown in Fig. 27. This probe was held near one of the fluorescent 
lamps on the ceiling, positioned with one loop toward the lamps and 
the other loop pointed away. The unequal flux coupling produced a 
differential voltage of 50 microvolts on our measuring instruments. 
Although this intensity of magnetically coupled voltage was not 
detrimental to our present EKG measurements, it would have serious 
effects on EEG or other low-level physiologic signals which we might 
attempt to record in the future. 
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In light of these flux and voltage values we experimented with 
some convenient shielding materials to reduce the magnetic fields. 
Our search probe was positioned inside a two-foot cubic box of fine 
copper screen. This gave no reduction in the probe signal so a 
second box of galvanized hardware cloth was built over the first one. 
Even with this double-scret'm shield the probe signal was not reduced. 
We then placed a search probe in a canister of Conetic foil (a material 
having a high magnetic permeability) and again the signal was not 
reduced. We have concluded from these tests that any successful 
magnetic shielding of the room would involve covering all room surfaces 
with thick ferrour metal sheets - an impractical arrangement because 
of the needed gamma-ray exposure field coming through the room walls. 
A grounded screen shield would probably help reduce the electric field 
and might well be considered for future installation, but it would be 
ineffectual for the magnetic fields. 
During the course of these experiments we have found that 
electrode placement patterns for best signals and minimum power-line 
interference varies considerably with the condi'tion of the patient. 
The patients to be irradiated and monitored in the facility frequently 
have enlarged abdominal organs that congest the thoracic cavity and 
change the cardiac electrical surface patterns. Usually preliminary 
care in securing a gbod, low-resistance sternal ground electrode 
connection, together with trying the two active electrodes at various 
chest test sites, gave optimum results. 
LEPEI Dosimetry. The objectives of the low-exposure-rate 
total-body ir~ittor dosimetry study were to produce a large, uniform 
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exposure field with an exposure rate of approximately 1 R/hr and to 
1 accurately determine a patient's absorbed dose. 
I The initial step in this study was an investigation of the various source arrangements that would provide the desired exposure 
I field. The basic requirements were that the field be uniform (± 5%) 
throughout a treatment volume large enough to provide two patients 
I with comfcf£'table living quarters for extended exposure periods. 
I 
The calculations made to find an optimum source configuration 
incorporated two major assumptions: that the sources could be considered 
I "point" sources and that variations in the exposure rate are produced 
by produced by the inverse square law. Attenuation or scattering were 
I , not taken into account. Calculations were done for a single source 
I 
arrangement and several multiple-source configurations. 
A configuration of 10 sources in a rectangular array was selected 
I because the predicted exposure field was uniform within ±5% throughout 
a treatment volume of 14' x 14' x 6'. This arrangement provided the 
I greatest percentage of usable treatment volume per volume of shielding-
superstructure and consequently proved to be the most economical 
I structure to build. 
I Figure 33 compares the isodose or relative exposure lines predicted theoretically for the horizontal midplane .~,f the volume to be 
I occupied by the treatment room and the corresi·;onding measured isodose 
lines. Thesl; results indicate that the horizontal variations in the 
t field were predicted very well by theory. The measured vertical 
I ± 5%. 
variation, however, was ± 15% compared to a predicted value of only 
I 
I 
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The source manipulators were designed to vary the exposure rate 
by changing the fraction of the 3-in lo~g source positioned in the 
beam portal. Operating the manipulator with only a fraction of the 
source exposed was found to be the primary factor contributing to 
the vertical field gradient. The vertical gradient was reduced by 
positioning the entire source in the beam portal. The exposure rate 
was reduced to the desired value by placing cylindrical lead attenuators 
over the beam portal. 
The variation in the exposure field through the midplane of the 
completely furnished treatment room is shown in Fig. 34. E}lcept for 
the small shaded areas, all measurements are between ± 5% and only one 
measurement in 289 varied by more than = 10% of the exposure at the 
center of the room. Within 90% of the treatment volume the exposure 
rates varied by no more than ± 10% and furniture placement restricts 
the patient from occupying most of these areas. 
All the exposure measurements were made with a miniature Geiger 
detector with a selective shield, chosen for its sensitivity, repro-
ducibi1ity, energy independence, and small size. This instrument was 
also desirable because it could be operated remotely from the control 
area. 
Calibration was accomplished by measuring the exposure rate at 
the center of the room with a Victoreen condenser R-meter. On June 1, 
1967 the exposure rate at the center of the t'reatment room was 1. 50 R/hr. 
The ey-posure rate was kept approximately constant by decreasing the 
60 thickness of the lead attenuators to compensate for the Co decay. 
PBWEDING PAGE BLANK: Not ilLMEll 
I 
I 
! 
I , 
r , 
t 
I 
1 ~k~ 
I 
I 
f 
I 
I 
I 
I 
I 
I 
il 
'I 
I 
I 
I 
J 
I 
1 
'I J 
! 
I 
I " ,to ~ 
J 
'I" 1. : 
l. ~ .;:.... I·.: ...·La' 
86 
Spectral measurements made with aNal (T1) detector ~t several '\ 
positions within the treatment volume showed no significant variations 
in energy distribution. 
Patient and Phantom Dosimetry. During patient treatment thermo-
luminescent dosimeters are worn on the patient's wrists, ankles, and 
chest. The patient's absorbed dose is determined by correlating the 
measurements with surface-depth dose ratios ob~ained from phantom 
studies. Table 8 shows the comparison of surface exposures measured on 
the first eight patients treated in the facility and the phantom 
measurements. The surface exposures are less than the exposure measured 
in the center of the room (100 R) due to attenuation by the patient's 
body. 
An extensive phantom dosimetry study was undertaken to determine 
the average whole-body dose as well as the doses to individual organs 
for patients receiving TBI in all three of our TBI facilities. In 
this study a tissue equivalent phantom (complete with skeleton and 
density adjusted lung spaces, etc.) was used as a patient analog and 
individually calibrated thermoluminescence dosimeters were used to 
measure dose. To locate organ volumes, we compared radiographs of the 
34 transverse sections of the phantom with bone structure and organ 
location of anatomy reference works. Individually calibrated LiP 
dosimeters were placed in all available sites within the volumes defined 
as organs. Then we reassembled the phantom and exposed it in the same 
manner as a patient. The rad dose measured by each dosimeter was 
determined by analysis techniques previously reported (USAEC Report 
CONF-680920, 1969, p. 976). With the exception of the bone marrow we 
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TABLE 8 
LETBI Patient Dosimetry for Initial Year of Facility Operation 
Relative Exposures 
Position Phantom Pt 111 Pt 112 Pt 113 Pt 114 Pt 115 Pt 116 Pt 113* Pt IJ7 
" 
Room 
Center 100 100 100 100 100 100 100 100 
Chest 
I 
78 67 75 73 81 - 70 71 
Left 
Wrist 76 69 81 78 84 74 75 75 
Right 
Wrist 82 71 81 72 81 74 73 78 
Left 
Ankle 76 82 77 72 77 74 77 76 
-
Right , 
Ankle 76 - 78 78 78 74 77 75 
*The seco~d treatment of Patient No. 3 and the treatment of Patient No. 7 were 
administered simultaneously • 
100 
69 
78 
75 
71 
70 
Average 
100 
-
.1 73.0 
I 
76.7 
76.3 
75.8 
. 
75.7 
S.D. 
-
±-4.75 
%4.30 
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±-3.23 
±-2.15 
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assume that the average rad response of ~lll dosimeters in an organ 
equals the organ dose. 
In Table 9 the organ dose and their ranges are given for all 
three irradiators. Predi~tably, the bone marrow dose ranges are the 
most variable since the bone marrow is both near the midline and 
near the surface of the body. In LETBI, on comparing the dose distri-
bution with the other two facilities, we find that organs in the head 
and neck receive about 10% more, in the upper and central chest about 
10% less, and in the lower part of the torso about 15 to 30% less. 
In METBI, as compared with the variable-dose-rate irradiation facility* 
" (VDRIF), the organ doses are slightly higher in the head, about the 
same in the upper chest, and lower in the abdominal and pelvic regions. 
Since the active marrow is not uniformly distributed within the 
body in a simple, well-defined volume, it was necessary to know the 
spatial distribution of the marrow to determine average marrow dose. 
The distribution of active marrow for normal adults is expressed as 
the percent of the total amount located in a particular a~atomical 
marrow compartment, e. g., the ribs or skull. The distribution of the 
I 
dosimeters in the marrow comparments was not proportionate to ,the amount 
of marrow therein. For example, 19% of the 137 dosimeters were located 
in ribs which contained only about 8% of the total active marrow. 
Therefore, average total dose to marrow had to be calculated by fi.rst 
determining the average dose for a \::ifiC COMpartment and then 
using its percentage of total marrow aS~Weighti~g factor. Table 10 
lists the average compartment dose and its range per 100 R of exposure 
from each of the three irradi,ators. Table 11 sunnnarizes the average 
marrow dose calculations. 
*A facility owned by the University of Tennessee Comparative Animal 
Research Laboratory and used by ORAU for therapeutic exposures in 
patients prior to bone marrow. transplantation. 
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TABLE 9 
Organ Doses in Three Total-body Irradiation Facilities 
In Rads Per 100 R at Centerline of Patient 
Organ Facility 
LETBI METBI VDRIF 
Dose Range Dose 
--
Range Dose Range 
Bone marrow 60 42-94 64 53-86 72 61-83 
Cerebellum 79 75-81 77 74-81 71 66-75 
Cerebrum 82 77-87 75 70-79 70 66-74 
Heart 66 61-74 66 58-70 73 65-83 
Intestines 57 48-64 67 54-76 68 59-75 
Kidneys 54 '53-57 66 62-70 68 61-78 
Lenses of eyes 94 93-96 87 85-90 72 70-74 
Liver 62 55-71 67 61-78 72 67-81 
Lungs 67 59-81 67 58-77 77 65-90 
Skin (above sternum) 86 84-87 73 72-75 78 72-84 
Skill (front waist) 77 76-79 74 72-75 79 73-84 
Spleen 58 55-60 69 69-73 73 68-79 
Stomach 54 49-61 64 59-69 71 66-76 
Thyroid 82 80-84 76 75-77 74 73-76 
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I TABLE 10 
I Marrow Compartment Average Dose in Rads/100 R 
I 
IRRADI~TORS 
I LETBI METBI VDRIF Marrow Average Average Average 
Comeartment Dose Range Dose Range Dose Range 
I Head 82 73-89 78 71-85 68 61-74 
Upper Limb 
I Girdle 69 58-75 66 58-73 78 70-82 Sternum 75 73-77 69 65-71 77 74-77 
Ribs 63 46-76 68 62-72 75 70-84 
I Vertebrae 58 47-75 65 59-80 70 63-78 
Sacrum 45 41-46 54 50-56 75 67-83 
I Lower Limb Girdle 52 44-62 59 52-71 72 63-77 
I 
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TABLE 11 
Calculations of Average Bone Marrow Dose in Rads/100 R 
LETBI METBI VDRIF Percent 
Bone Marrow Active Bone Average Weighted* Average Weighted* Average 
Compartment Marrow Dose Factor Dose Factor Dose 
Head 13.1 82 1074 78 1022 68 
Upper Limb 
Girdle 6.4 69 442 66 422 78 
Sternum 2.3 75 173 69 159 77 
Ribs 7.9 63 498 68 537 75 
Vertebrae 28.4 58 1647 65 1846 70 
Sacrum 13.9 45 626 54 751 75 
Lower Limb 
Girdle 26.1 52 1357 59 1570 72 
Totals . 98.1+ 5820 6277 
Average 
Weighted Dosef 59 64 72 
*Weighted factor = average dose x percent marrow. 
t ~,verage weighted dose = E weighted factors total percent a'ctive bone marrow. 
fTotal percent is 98.1 because 1.9% of the marrow is located in the heads of the 
humeri where no measurements could be made. 
Weighted* 
Factor 
891 
499 
177 
593 
1988 
1043 
1879 
7070 
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Because most studies of total-body irradiations both in humans 
and animals, r,e1ate response to some "average-body dose," we have 
, 
. 
estimated the average torso-dose also. Our estimates are: LETBI, 
67 rads/100 R; METBI, 68 rads/100 R; and VDRIF, 74 rads/100 R. 
The importance of using ab~orbed dose as the ba~is of comparison 
is clear from Table 9, i. e., if two patients were exposed to 100 R, 
one in LETBI and the other in VDRIF, the VDRIF patient would receive 
about a 20% greater marrow dose but his dose to the 1ens;"',sof the eyes 
would be 20% smaller than the LETBI patient. Depending upon whether the 
biological endpoint was marrow suppression or cataract formation, we 
'" 
would either overestimate or underestimate by 20% the effectiveness of 
equal exposures given in these different irradiators. 
C. Physiologic Studies 
Irradiation therapy, regardless of its modality, requires shielding 
to protect hospital personnel from exposure during patient treatment. Low 
levels of total body irradiation therapy presented additional problems 
since patients could be isolated for considerable periods (days or weeks) 
during which physiologic contact for vital signs monitoring generate 
considerable volUrtles of physiologic data daily that require analysis and 
red~ction in their content. In our facility large volumes of cardiac (EKG 
waveform and rate) and pubnonary data were recorded real time (strip 
chart) and on analog tape for retrospective analysis, Each of these 
physiologic parameters presented special problems concerning data analysis, 
storage, and retrieval. 
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1. Pulmonary Impedance 
At the present state~:of-the-a;rt, the pulmonary impedance 
pneumograph is used to study respiratory patterns physiologically and 
to monitor respiratory function in remotely located persons, e.g., 
astronauts in space (4-7). We attempted to use this system of 
impedance pneumography to measure pulm,o:a.ary functions in patients 
undergoing total body irradiation therapy. However, no data-reduction 
system was available to facilitate medical interpretation of changes 
in pulmonary impedance pneumography as used clinically in remote 
monitoring. We made a preliminary study of the feasibility of using 
power spectral analysis for this purpose. Pulmonary impedance wave-
form was recorded on a Beckman Dynagraph (previously described) 
utilizing an electrode configuration described previously by others 
(8-13) using it to monitor the physiologic status of astronauts ill 
space flight or in simulated tests. 
We found that the pulmonary impedance changed periodically with 
time in away that was remarkably consistent and typical of anyone 
subject, if he was in an unstressed steady state in a well-controlled, 
constant environmental situation. Any physiologic demand that required 
a respiratory response caused a change in this periodicity. Visual 
inspection of the impedance pneumography wave form (Fig. 35) indicated 
that the cyclic nature of the respiratory response was considerably 
more complex: and difficult to describe and measure. 
Many other time series known to the physical sciences, engineering, 
and economics have an underlying periodic structure. These phenomena 
are amenable to statistical analysis using the mathematical technique 
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of power spectrum analysis (14-15). Interpretation of the results 
of such an analysis is not difficult, and it is possible to develop 
testing procedures to determine whether a change has occurred. 
Although power-spectrum analysis is connnonly used in communications 
engineering, seismology, radio-astronomy, and other physical sciences, 
its application in biology is new. Walter (16) has proposed spectral 
analysis as a method for analyzing EEG data and has demonstrated its 
use ~n experimental electroencephalography. Our preliminary study 
showed that power spectral analysis is a natural system for. reducing 
the vast amount of data in the analog tracings obtained in impedance 
pneumography. It minimizes the interpretive wor.kload and produces a 
measurement that is unique in respiratory physiology that seems related 
in some way to the physical work involved in breathing and meeting 
respiratory demands. 
Mathematically, the impedance pneumograph measured by Pacella's 
technique (17) can be COllsiderea as a trace of length T from an 
arbitrary origin and designated X.(t) where irefers to the ith trace 
l. 
and t is time (0 $ t < T). The function of Xi(t) is sampled at n 
equally spaced intervals of width ~t(~t=T/n). The resulting series 
Xit t-l, ••• , n is the subject of the present analysis. , 
,If X(t) could be considered as a deterministic periodic function 
of time, then classical harmonic analysis would lead to the following 
Fourier representation of n equally spaced points from the trace. 
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x = J1 + 
t j E {a.cos(w.t) + 6.sin(w.t)} =1 J J J J 
where 
m = (n/2) - 1, 
j = l, ... ,m. 
Then w. is the slowest cosine wave with a period of J 
one cycle per T minutes. 
The least squares estimates of the a.'s and 6.'s are 
J J 2 n 2 n 
a. = - E X cos(2~jt/n) 
J nt = It 
bJ. = - E X sin (2~jt(n) nt = 1 t 
Since the energy in a wave if proportional to the square of 
its amplitude, we can obtain the following relation (Parseval's 
Identity) between the power (energyt) in one cycle· and the Fourier 
coefficients. 
1 
or 
n 
n -
E{x + E{a.cos(w.t) + b.sin(w.t)}}2 
t=l J J J J 
n 
= nx2 + - E(a. 2 + b. 2) 
2. J J 
E(X - x)2 
t 
J 
1 
= - E(a. 2 + b. 2) = VarX
t 2. J J 
J 
tIhis energy concept is not specified physically and the implication 
is not intended that energy here is linearlY'related to the energy 
involved in the respiratory effort that produces the pulmonary 
impedance traces. 
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The quantity 1/2 (a. 2 + b. 2 ) may be considered as the 
J J 
contribution to the total power from the jth frequency band, the 
width of which is 2~/n. Then, 
I (w.) = 6t . n (a. 2 + b.2)/4~ 
n J J J 
defines the Schuster periodogram. A plot of I (w.) vs. frequency is 
n J 
known as a harmonic analysis. Jenkins (18) shows that 
lim E I (w.) = P(w.) 
n J J 
n++ oo 
and discusses the difference between this approach to time-series 
97 
analysis and the statistical approach, which considers X(t) as a sample. 
function from a stochastic process. The harmonic analysis breaks down 
completely when applied to a statistical fluctuation, since I (w) does 
n 
not converge to p(w) as n becomes larger. 
However, if X(t) is a stationary time series and E{X(t)} = 0, 
then C(.) = E{X(t) x (t + .)} is the autocovariance function, (9) 
and its Fourier transform 
00 -i2~fT 
P(f) = Ie 
_ 00 
00 
C(.)d. = 2.cos(2~f.) c (.)d 
o 
is the power spectrum of X(t). Then if 
• = 0 in eq. 1 
00 
C(O) = var{X(t)} = 2 IP(f)df 
o 
(10) 
so that 2P(f)df represents the contribution to the power of the process 
from frequencies between f and (f + df), where only positive frequencies 
are considered. 
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When a record of X(t) of length T is available and is sampled 
at equally spaced intervals of time, the discrete time series 
Xt , t = 1 n may be used to estimate the autocovariance and the , ... , 
power spectrum. The; value of 6t and T chosen will depend primarily 
upon two factors: 
1. The Nyquist frequency, wn ~ n/6t radians/minute or 1/26t 
cycles/minute. All frequencies above w will be aliased with those 
n 
in the range (O,lll ). 
n 
2. The resolution required in the estimated range (O,w ) and 
n 
the lowest frequencies of interest. 
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The aim of our analysis is to estimate the aliased spectrum for 
frequencies from ° to 1/26t cycles/minute. To obtain estimates that 
converge, it is necessary to use a lag window in the time domain or the 
equivalent spectral window in the frequency domain. 
We use here the Blackman-Tukey estimation procedure (19) with 
hamming. The calculations may be briefly summarized as follows: 
1. 
2. 
V = 
r 
3. 
Calculate estimates of the autocovariance function: 
1 n - r 
C = l:XtXt + r r = 0, 1, .... m 
r 
n - r 
t = 1 
Calculate raw power-spectrum estimates: 
26t m - 1 
{C + 2 l: Ckcos(kr/m) + C cos(rn)} 
0 k= 1 m 1T 
Calculate the smoothed power-spectrum'estimates (hamming): 
P(f) = P = .23V 1 + .S4V + .23V +1 
r r- r r 
r 
Where f = ____ cycles/minute 
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The smoothed estimate P(f) may also be interpreted as the con-
tribution from the jth frequency band to var {Xt } (19). 
Thus, it is possible to consider respiration in the frequency 
domain that is physically more meaningful than the trace in the time 
domain. 
Figure 35 shows the pulmonary impedance traces produced while a 
patient was experiencing different subjective degrees of pain expressed 
as none, slight, and severe. The power spectra produced by the analysis 
of these three traces are presented in Fig. 36. They indicate that as 
pain increased the amplitude of the low frequency cycles showed a 
substantial increase. Complete results of these initial efforts are 
summarized in a report by Lushbaugh et a1. (20). 
ppod:rooma.Z Synd:roome. Later we applied these techniques of pulmonary 
impedance power spectral analysis on patients undergoing total-body 
irradiation therapy. The purpose of this study was to see if pulmonary 
impedance power spectral analysis could be used to detect the onset 
and course of gastrointestinal distress induced pharmacologically or 
by total body irradiation. 
Traces of pulmonary impedance were obtained before, during (in 
the case of exposure protraction), and after therapeutic levels of 
total-body irradiation of leukemic patients with 137cs or 60co gamma 
rays. The radiation facilities used have been previously described. 
Briefly, fractionated exposures of 30 R/day were carried out in a 137cs 
total body irradiator at a rate of 1.5 R/min, while protracted (30 R/day) 
and fractionated (10 R/day) exposures were administered utilizing a 60Co 
total body irradiator at the rate of 1.5 R/hr. The voltage changes in 
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pulmonary impedance were recorded on strip chart and on analog tape 
from which 4-minute data segments were selected, converted into 
digital form and analyzed using an IDM-1800 computer. In our system, 
in its present stage of development, digital data processing can be 
done in real time or in retrospect. After digital conversion, the 
data were processed with a power spectral ana1ysi,s program which 
computed power spectral estimates and respiratory variances that were 
graphed automatically. 
Selected impedance pneumograph traces obtained from a patient 
receiving 30 R/20 hr day at an exposure rate of 1.5 R/hr are shown in 
Fig. 37. The total exposure was 250 R over an 8-day period. These 
traces illustrate that normal, regular breathing occurred throughout 
all monitoring periods. The regularity of these impedance pneumographs 
is reflected by low-power spectra and nonvarying frequencies as shown 
in Fig. 38. During the entire exposure the patient, who had received 
no previous radiation therapy, felt well and did not develop nausea 
or loss of appetite. In Fig. 39 the pre- and postexposure pulmonary 
impedance traces from a patient receiving 30 R/day (1.5 R/min), 
total exposure 150 R, became increasingly irregular postexposure with 
increasing exposure accumulation up through day 4. The effect of the 
last fractional dose (30 R) appears to have been suppressed by 20 mg 
chlorpromazine administered prior to exposure. The changes in 
pulmonary impedance are more easily visualized in the power spectra 
computed from them (Fig. 40). All five postexposure pulmonary 
impedance traces were obtained within 30 min after irradiation. 
Subjective levels of postexposure gastrointestinal distress experienced 
by the patient are shown in Table 12. These symptoms correlated well 
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TABLE 12 
Patient Evaluation of GI Distress that Followed 
Treatment with 30 R (1.5 R/rnin) Daily for 5 Days 
""'''~~--I 
. ' 
. . 
Accumulated Exposure Described GI Distress 
Post 30 R 
Post 60 R 
Post 90 R 
Post 120 R 
Post 150 R 
None 
Mild 
Moderate 
Severe 
Mild 
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with the strip chart traces and the changes in their power epectra1 
reductions. There is (Fig. 40) a progressive increase in the shift 
of pulmonary impedance waves to lower frequency and higher ap1itude 
and power as radiation exposure accumulates. The patient reported 
that recovery from the postexposure nausea, reflected by these changes, 
occurred 2-8 hrs later. The relative absence of symptoms and pathologic 
pulmonary-impedance patterns and power spectra also correlated, as seen 
in Figs. 39 and 40, for day 5. The daily pretreatment pulmonary im-
pedance traces and their power spectra are remarkably uniform and 
normal, substantiating, apparently, the patient's claim that symptoms 
of radiation sickness were absent at those times. 
The comparison of dose rate effects was enhanced by the fact 
that the patient who received the fractionated radiation therapy (see 
above) returned for additional radiation treatment but the exposu're 
(150 R) was protracted (1.5 R/hr) over a 5-day period. Pulmonary 
impedance strip chart traces recorded before, during, and immediately 
after the therapeutic irradiation period indicate that respiratory 
alterations occurred prior to and early into treatment and consisted 
primarily of high amplitude (deep) breathing (Fig. 41). Power spectra 
of pulmonary-impedance waveforms (Fig. 42) reflect these findings and 
show that no significant pulmonary alterations occurred throughout 
exposure after the initial changes. No low-frequency components are 
present in the power spectra obtained in relation to this dose 
protraction) however, low frequency shifts did occur in this same 
patient when the e:.cposure (150 R)was fractionated (see above). 
These findings are interpreted as being due to psychologically-induced 
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nausea related to the severe nausea experienced previously by this 
same patient when given fractionated irradiation therapy six months 
prior. The fractionated exposure (150 R) which induced nausea in 
this experiment is well below the 300 rad dose (single exposure) 
previously reported by Lushbaugh, et al. (Rad. Res. 30(7): 398) 
that resulted in a mean vomiting-onset time of 144 ± 66 min. While 
this particular patient may have a low radiation-induced GI distress 
threshold, the dose rate influence on the human radiation prodrome is 
illustrated. 
In order to compare radiation and pharmacologically induced 
gastrointestinal distress, we obtained power spectra of pulmonary 
impedance waveforms from a normal male volunteer, aged 22, who was 
administered an emetic (ipecac). Power spectra of these pulmonary 
traces are shown in Fig. 43 and illustrate shifts to high-power, 
low-frequency components at those times when the subject experienced 
severe nausea (17-20 min) and when emesis occurred (49-52 and 57-60 
min, respectively). These data demonstrate similar respiratory 
phenomena occurred regardless of its means of induction. The quantity 
of analog data obtained in this experiment encouraged us to modify the 
computer program to afford great.er data reduction. This modification 
is based on the fact that the area under a pulmonary impedance power 
spectrum is the total variance in terms of amplitude and frequency of 
respiration. This single number can be computed and used. as a 
one-dimensional expression of the level of respiratory efforts. 
When this number is plotted as it changes with time a continuous 
graph is produced of the variance in respiratory effort throughout the 
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monitoring period. This new method requires one-half the previous 
computing time; the output consists of two indices (a mean and the 
l' 
~ 
ri I I variance of the power spectrum) that can be used without graphing the individual power spectrum. In this cas-,e., the mean is the average 
I transthoracic voltage as measured by the impedance pneumography coupler, 
while the variance is directly proportional to the area under the power 
I spectrum. The power spectrum of the pulmonary impedance waveform is 
1 
not graphed in this new system unless requested by the investigator or 
clinician. In addition, this new method provides separate analysis of 
t each of four consecutive minutes of pulmonary impedance data instead 
of one combined analysis of four minutes of data. An average mean and 
j average variance (four l-minute data periods /4) also is provided. We 
J 
have defined the minut~-by-minute variance as the continuous variance 
and its average over four minutes as the average variance. 
I Data obtained from the volunteer with pharmacologically induced 
GI distress (see above) and analyzed by the new method are shown in 
J Fig. 44. Increased continuous variance corresponds exactly to the I 
I 
minute with the occurrence of severe nausea (18th minute) and emesis 
(50th and 59th minute). These changes in respiratory function are also 
I well protrayed by the average variance which tends to smooth the data 
without losing fidelity. Inferences drawn from data analyzed by both 
I the old and new methods were the same; that is, periods of gastroin-
I 
testina1 distress were accompanied by high-power, low-frequency shifts 
in the power spectra. 
Again, plotting only the average variance, the radiation prodromal 
syndrome is also well demonstrated in the physiological data taken at 
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II 
various times over several days before and after irradiation preparatory 
II I , to bone marrow transplantation. Figure 45 shows data from a pati~nt 
il ii 
who received 500 R (40 R/min) total body gamma irradiation. Average 
variance of the pulmonary impedance was very stable over a period 10 
I days before and during irradiation. However by 50 min postirradiation 
the patient demonstrated a shift in this variance that correlated with 
I nausea and emesis. The changes subsided within 24 hr and did not 
I 
return as indicated by 12-15 hrs of pulmonary impedance data collection 
on each of four consecutive days postirradiation. In another patient 
I who received 500 rads (694 R, 38 R/min) prior to bone marrow transplan-
tation no nausea or vomiting was experienced and pulmonary impedance 
I power spec.tra analysis confirmed the lack of these signs and symptoms, 
that is, a relatively constant average variance was recorded over 
I several days pre- and postirradiation. The only significant increase 
I was during a severe chill and atrial fibrillation beginning about 3 hrs postirradiation and continuing for some 4 hrs. The patient was, however, 
I heavily sedated with thorazine just prior to receiving the 500 rads. 
We also had the opportunity to determine the effect of 
I accidental radiation-induced nausea and vomiting on pulmonary impedance 
I in a young, health male (aged 31 yrs) who received 260 rem (350 R/min) total body gamma irradiation. Physiological monitoring commenced 4 hr 
I postirradiation and periods of amplified average variance of the j 
I I 
I 
~ I ! 
, I t 
l I 
j j 
j 
i 
j 
lj 
1 
pulmonary impedance correlated well with nausea and emesis (Fig. 46). 
(The accident victim had vomited several times before the initiation of 
physiological monitoring.) Continuous monitoring of the physiological 
status of this accident victim. revealed that during periods of sleep 
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It 
the variance diminished, spiking when the victim roused, and increased 
i significantly upon awakening the following morning. Emesis again 
t 
occurred when breakfast was brought into the patient's room although 
nothing was eaten. By 24 hrs postirradiation nausea 'and vomiting had 
J subsided. 
These data on pharmacologically-induced, therapeutic and 
J accidental radiation-induced nausea and vomiting demonstrate inordinately 
,1 I ,~ " 
1 
1 
well the capability of pulmonary impedance power spectral analysis to 
reflect periods of gastrointestinal distress. 
1 
~ . I 
-.f.. 
" 
1 j 
I 
i Physiaal Perfo~anae. 
1 
I 
\-~;; i 
4: 
A. Controlled Exercise Stress in Irradiated Man. 
, 
t 
J Having successfully measured radiation-induced gastrqintestinal .~.: 
i 
distress using pulmonary impedance power spectral analysis, we attempted, 
using this same system, to measure radiation-induced fatigue. It is common 
I knowledge that both therapy patients and accident victims experi
ence post-
irradiation episodes of easy fatiguability. However, descriptions of 
I "" this easy fatiguability have only been qualitatively described and 
I 
shown to vary greatly with r~spect to subjective severity and duration. 
We attempted to detect and quantitatively measure this easy fatiguability 
I using changes in pulmonary impedance waveform 
as previously described. 
All subjects (normal volunteers and therapy patients) participating in 
I ~ , ' these exercise studies were fully informed of the procedures, their 
I 
experimental nature, risks involved, etc. before rendering their 
consent as described by the U. S. Department of Health, Education and 
I' Welfare and review by our Human Use Committee on a
n annual basis. 
In evaluating the performance decrement effects of total body 
~! I ~~ , 
, I ~ .~ - "J """"~ 
irradiation, we first determined that the stress of exercise modified 
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pulmonary impedance in a way that power spectral analysis could 
measure. Normal (non-leukemi~volunteers exercised, under controlled 
conditions, on a bicycle ergometer for specific periods at standard 
workloads and were monitored before, during, and after exercise stress. 
Postexercise monitoring was ger.erally continued for at least 30 min 
following cessation of exercise. Typical results, shown in Fig. 47, are 
from a volunteer exercising against a workload of 60 watts, pedaling at 
a speed of 50 RPM for 8 min. Increased respiratory demand, reflected 
by deep, high frequency breathing, during and immediately following 
exercise is indicated by increases in both continuous and average 
variances of the power spectrum. The continuous variance plot indicates 
that periods of deep breathing cycled with periods of normal breathing 
approximately every 5 min. The average variance plot likewise reflected 
increased respiratory demand after exercise. 
To compare the response of irradiated men and unirradiated 
volunteers, normal males (aged 30 to 40 yrs) were monitored during con-
trolled bicycling at workloads comparable to those used for patients. 
In a typical study, each of five normal males, who had not had previous 
experience with bicycle ergometry, exercised under controlled ergometry 
two or three times weekly for four consecutive weeks. The results in 
Fig. 48 show that normal man typically responds to moderate exercise by 
an increase in pulmonary impedance (as measured by its average variance). 
A decrease in the evaluation of pulmonary impedance during controlled 
work developed progressively during the first week and a half after 
which the exercise-induced response was relatively constant, probably 
due to adaptation to the exercise workloads. This effect is similar to 
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"training" but differs in that training would probably require 8 to 10 
weeks during which the ~TOrk levels would be progressively increased. 
All normal persons monitored showed this decrease during their second 
and third exercise period (first week of controlled exercise testing). 
There were no significant changes in the pulmonary impedance measured 
prior to each exercise period or at ~15 min postexercise over the one j 
l j 
~ j 
I 
month test period. 
The pulmonary impedance variance generated by controlled exercise 
i 
j 
] 
stress differed in one s1..gnificant way from the induced by gastro-
intestinal distress. That is, during exercise stress the variance is 
I 
due to high frequency «20 cpm) breathing while that induced by GI I 
distress is primarily due to low frequency (>10 cpm), breath holding 
respiration. This basic difference thus allowed our system of analysis 
, 
to recognize and descriminate (under laboratory conditions) between GI 
distress and exercise stress. 
Following these initial studies, pulmonary impedance was measured 
in selected patients exercising on the ergometer before, duri.ng, and 
after total-body irradiation therapy. Only patients in chronic states 
of their disease without malaise of other symptoms of distress, were 
monitored in this study. Patients exercised at submaximal work levels 
comparable to nonirradiated volunteers, determined by preexposur.e 
tests to be within their capabilit~es. They were not in the radiation 
field during the exercise test~period. Increased respiratory demand 
after exercise in irradiated patients was similar to that of the non-
irradiated test subjects. However, the increase was amplified after 
radiation exposure was illustrated in typical performance profiles from 
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" 
two therapy patients (Figs. 49 and 50). Fatiguability increased 
(performance decrement) on the third day postirradiation and appeared 
11 
' , 
to subside within 10 days to two weeks. 
We have defined these periods of increased respiratory effort 
" 
I' I: (amplified impedance) as diminished exercise capacity (DEC). A compari-
son of pulmonary impedance data from therapy patients who participated 
'I in controlled exercise stress testing (and demonstrated DEC) with 
l 
I normal, control volunteers is shown in Fig. 51. When the response to I I exercise (variance during exercise stress) was normalized to pretreatment 
I 1 I values, therapy patients began to adapt to submaximal stress loads, as 
did controls, but this adaptation was interrupted by exposure accumulation 
t I t apparently in a dose rate dependent manner. Not all exercise-stressed 
I therapy patients experienced DEC. Of 11 participating in controlled ergometry 8 responded with DEC and generally these were men as opposed 
I to women even though workloads were comparable. 
Our hypothesis that DEC is indicated by amplified pulmonary 
I impedance variance (due to increased respiratory effort to perform at 
I non-varying workloads) is supported by studies that demonstrate a direct relationship between work and impedance. That is, as workload on the 
I ergometer is increased, respiratory effort increases and therefore 
pulmonary impedance. Furthermore, there appears to be a linear rela-
I tionship between workload (up to subject's maximal efforts) and pulmonary 
f 
, I ;' , 
impedance as illustrated in Fig. 52. These typical data were generated 
by alternate 2 min work/rest cycles and also illustrate cardiac rate 
L"' I changes. In light of the response of radiation therapy patients to 
controlled exercise stress, it is therefore po~sible that amplified 
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pulmonary impedance during and after irradiation reflects a physio-
logical deconditioning (DEC) to a non-varying workload. Although we 
did not solicit verbal opinions from these therapy patients (for fear 
of biasing the results) two of them did ask if the workload had been 
increased or decreased. In each case this inquisitiveness correlated to 
a significant increase or decrease in pulmonary impedance respectively. 
A s,imilar time-course study of radiation-induced performance 
decrement was made using this method after the accidental TBI of a man 
to 260 rem of 60co gamma rays for approximately 40 sec at 350 R/min. 
His estimated bone marrow depth dose, based on thermo luminescent dosimetry, 
was 115-155 rads. Pulmonary-impedance measurements during controlled 
exercise were obtained commencing three days postexposure and on a regular 
basis for a total of 60 days. Initially he exercised to his subjective 
tolerance against a workload of 50 watts. There was one minute of 
exercise on the third day but tolerance progressively increased to 30 
min until on the 7th day postexposure the workload was doubled to 100 
watts. At this exercise level, his exercise tolerance time remained 
relatively constant at rv6 min. The zenith of variance in pulmonary 
impedance was reached within the first 6-8 min of each exercise test 
period. The results are summarized in Fig. 53. Decrement in performance 
occurred at days 7 through 13 and then at unpredictable times thereafter. 
Surprisingly, during the first week after exposure we failed to 
demonstrate any significant changes in the respiratory variance of 
this man even though he said he was exercising to tolerance. His 
subjective symptoms of fatigue were apparently not respiratory as in 
the radiation-induced fatigue of our irradiat.ed patients. This obser-
vat ion suggested that radiation-induced fatigue was not always directly 
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related to shifts in the pulmonary-impedance power spectra and their 
variance. Perhaps in persons in good physical condition respiratory 
reserves are too large for our system of exercise stress to elicit signs 
of performance decrement even though respiratory or vascular changes 
have been induced by irradiation. This dichotomy in our results may be 
explained on the basis of creatine phosphokinase studies in this accident 
victim. Following the first exercise period the serum level of this 
muscle enzyme rose significantly and remained high for a few days. When 
creatine phosphokinase levels returned to normal pulmonary impedance 
increased. It is unclear if creatine phosphokinase served as a "protec-
tive agent" against DEC. (These enzyme data are fully discussed in 
Chapter V, C.) 
Irradiation therapy in the absence of exercise stress failed to 
cause any significant shift in pulmonary impedance variance when 
measured before, during, or after exposure. These basal, resting 
pulmonary impedance values are illustrated in Fig. 54. In patients 
subjected to both radiation and exercise stress there were some increases 
in basal resting pulmonary impedance during and shortly after therapy. 
Whether these basal changes were due to metabolic alterations, transient 
pulmonary edema or pulmonary vascular inflammation is not clear. 
Finally, these studies using pulmonary impedance waveform analysis 
demonstrate that this noninvasive and remote monitoring technique can 
qualitatively recognize radiation-induced DEC and that the performance 
changes measured thereby are significant but reversible in man 
accumulating up to ~300 R. 
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B. Controlled Exercise Stress in Irradiated Ponies 
Many physiologic studies in the past involving man have demon-
strated that in the 'event of unusual environmental stress (e.g., 
zero-G, total bed-rest) the exercise-conditioned man demonstrates a 
greater loss of exercise tolerance (more deconditioning) than the 
untrained individual. This phenomenon has been seen in NASA astronauts 
who demonstrated various levels of severe deconditioning upon return 
to earth gravity following extended manned-spacecraft missions. 
A collaborative study was undertaken with the UT-AEC Comparative 
Animal Research Laboratory to determine in a large experimental animal 
the effect of conditioning exercises on the expected changes in 
pulmonary impedance waveform. Irradiated and nonirradiated Shetland 
ponies subjected to controlled exercise stress were used. These 12 
ponies had been studied over a six year period beginning in 1966 to 
determine the effect of a p-rompt radiation exposure upon exercise 
tolerance and were scheduled now to be killed. In the previous study 
six ponies received 650 R TBI exposures of gamma radiation and six served 
as: unirradiated controls; their pulmonary and cardiac rates and rectal 
temperature were measured and used to evaluate physiologic response to 
exercise and temperature stress. The results showed only that irradiated 
ponies did not dissipate body temperature normally when worked in hot 
environments (>85°) and no other well-defined physiologic effects of 
irradiation. could be demonstrated. 
In the current study we exposed eight of these ponies to 270 R 
at 30 R/day. The ponies were paired according to the following scheme, 
where the first number indicates prior irradiation and the second 
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number the exposure received in the current study: 0 + 0, 650 + 0, 
o + 270, 650 + 270. In addition, six of the twelve ponies were exercise 
conditioned for six weeks priQr to irradiation (current study), the 
other six exercised only one week prior to irradiation. The exercise 
consisted of pulling a brake-loaded cart and is desctibed later. 
j 
j j 
Creatine phosphokinase data from these ponies (see Table 16, Chapter V) 
while quite variable, demonstrated again (as seen in our human studies) 
I 
j 
! 
that irradiation and/or exercise stress result in increases in CPK 
levels. Animals that had received 650 R previously (with or without 
an additional 250 R or no additional irradiation or exercise conditioning) 
demonstrated the greatest change in CPK response, suggesting that some 
permanent biochemical lesion had resulted. The possible significance of 
this change is discussed later in relation to changes in pulmonary 
impedance variance in this group of ponies. 
To measure the effects of exercise conditioning prior to irradia-
tion and its effect on performance decrement, two of four teams of ponies 
were preconditioned six weeks prior to irradiation (270 R): the other two 
teams exercised under controlled conditions only one week prior to 
irradiation. One team of controls was exercise conditioned, the other 
was not. 
Controlled exercise testing was accomplished using matched, trained 
teams of ponies accustomed to pulling a brake-loaded cart around a circular
 
track. Each pony worked against a workload equal to a resistance of 3/4 
horsepower for 30 min each human workday (M-F) for constant periods of 
time. In the preconditioned group of ponies, the total work period studied
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was five weeks prior to and six weeks after irradiation; in the non-
conditioned ponies, it was one week prior to and six weeks after 
irradiation. 
In all ponies that participated in this study, the pulmonary-
impedance variance data were similar to that seen in the normal man when 
subjected to controlled exercise testing. There was a general trend for 
the pulmonary-impedance variance to decrease (or remain relatively 
constant) over the conditioning period. In preconditioned ponies this 
gradual reduction in pulmonary-impedance variance was interrupted by the 
onset of TBI (30 R/l -hr day), and was reflected by an increase in 
pulmonary-impedance variance. This increased variance in irradiated, 
preconditioned ponies was evident for three to four weeks postirradiation 
after which the variance values began to decrease. However, a similar 
shift in the pulmonary-impedance variance was noted in a preconditioned 
control pony that was forced to stand in its stall for 16 hrs/day to 
simulate the postural restriction of the ponies during their irradiation. 
This result suggests that the mechanism for irradiation-induced fatigue 
may be similar to that physiologic response induced by the prevention 
of supine rest (l6-hr duration) in the pony. 
When compared to preconditioned ponies, pulmonary-impedance 
variance of non-preconditioned ponies did not appear to be as severely 
affected by TBI. Indeed, non-preconditioned ponies did not, as a group, 
demonstrate an increased pulmonary-impedance variance postirradiation, 
with the exception of one animal that showed significantly increased 
variance during the nine-day irradiation period. As in the precon-
ditioned control pony, non-preconditioned controls demonstrated 
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increased pulmonary-impedance variance in response to standing 16 hrs/day. 
These data are summarized in Figs. 55, 56, and 57. 
No definite correlations were found in pulmonary-impedance 
variance data of these ponies that would indicate that a permanent 
physiologic lesion was present as a result of the 650 R exposure five years 
prior to the current study (270 R). The results do, however, suggest 
that exercise preconditioning may lower the radiation threshold for in-
creased fatigability. This influence of preconditioning may be important 
in light of the demanding preflight conditioning and the phenomenon of 
postflight cardiovascular deconditioning noted in NASA manned-space-flight 
personnel. 
At the end of the study all ponies were killed and necropsied to 
permit evaluation of the extent of any vascular radiation effects. 
Specimens of lungs, kidneys, testes, and skin were studied histologically 
for this purpose. Lung and kidney were chosen to study late radiation 
effects and testes to evaluate the levels of acute damage and subsequent 
repair of the effects of the two exposures. The skin was studied to 
determine whether Brown's*observation that irradiated ponies were 
relatively heat intolerant during exercise might be related to damage 
induced in sweat-gland structure. 
Objectivity was obtained in this histologic study by coding all 
slide preparations so that individual ponies and their irradiation 
histories were not identifiable. After all the histologic appraisals 
were finished, a diagnostic interpretation was made as to whether or not 
the changes seen were related to any irradiation, 650 R only, 270 R 
only, three months or six weeks prior to necropsy, and 270 R in combination 
*Dr. Dan Brown, D.V.M., formerly with UT-CARL. 
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,~, 
with the previous 650 R exposure. This appraisal and its interpretation 
,I were then decoded and compared with the actual histories of the ponies. 
II The results of this study, in summary, were as follows. Changes seen in pulmonary alveolar-wall collagen and glomerular 
II and arteriolar vasculature did not correlate with either the degree of 
change in individual physiologic response to exercise or with the irrad-
:1 iation history. In the one pony in which the histologic changes in lung 
I and kidney were extreme and obviously due to radiation, the animal could not be tested physiologically because he was lame. Remarkably, 
I only three instances of unquestionable pulmonary and late renal vascular 
effects related to the irradiation experience of the animal were found. 
I In the kidneys of most ponies the relation of vascular changes to 
I 
irradiation was obscured by the presence of changes typical of intercurrent 
or chronic int~rstitial nephritis or chronic pyelonephritis. In the lungs, 
I the unfortunate presence of chronic bronchiolar inflammation and peri-
bronchial lymphoid infiltration in most ponies made evaluation of 
I minimal degrees of alveolar sclerosis impossible. 
I 
The histologic appraisal of the changes in the testes, however, 
correlated directly with the irradiation histories. The ponies that 
I had received only 650 R exposure had prominent foci of regeneration of. testicular tubular germinal epithelium scattered among severely atrophic 
'I f. tubules. Those that had received a recent second exposure of 270 R, in 
f- I I 
addition to the 650 R, had lost these regenerative foci, while those 
with no previous exposure and only a recent 270 R exposure showed 
r I I I ( germinal epithelial atrophy without accompanying tubular sclerosis. 
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The unirradiated ponies had histologically normal testes. Of purely 
histologic interest, one pony had an adenomatous focal epithelial change 
that could be interpreted as being neoplastic, and several others had 
such an extreme focal increase in interstitial cells (Leydig) that doubt 
was cast on the validity for this species of the widely held radiopatho-
logical concept that the histologic increase in these cells after 
irradiation is apparent and not real. This increase in Leydig cells was 
most extreme in those animals that received the smaller more recent 
,exposures. 
Although the sections of skin were all taken from the same anatomical 
locus in all animals, the number of sweat glands in them was highly 
variable and did not correlate with radiation history. 
The negative results of this histologic study strengthened our 
belief that the changes we have been finding in the exercise tolerance 
of irradiated men reflect reversible metabolic rather than irreversible 
anatomical changes. 
2. Cardiac Rate/Oxygen Consumption 
While our studies of pulmonary impedance power spectral analysis 
proved useful in assessing levels of radiation-induced GI distress and 
diminished exercise capacity, we continued to search for other physio-
logic indicators that were more tried and tested for measuring changes 
in stress response. Two such physiologic parameters, particularly for 
measuring exercise stress responses, are cardiac rate and respiratory 
gas analysis. Cardiac rate analysis was primarily confined to exercise 
stress testing and not to periods of GI distress since few significant 
changes were noted in patients experiencing radiation-induced nausea 
and vomiting. Those cardiac rate alterations during nausea and vomiting 
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were generally sinus rhythm in nature resultant from parasymphatic 
(vagal) looping accompaning low frequency, deep breathing. In only on~ 
nonexercise stress, irradiated patient did we record significant a1tera-
tions in cardiac rate. This occurred during atrial fibrillation in the 
early postirradiation hours in a man exposed to 694 R (500 rads) 
whole-body gamma irradiation prior to bone marrow transplantation. Over 
a period cOIlUIlencing abour four hours postirradiation and continuing for 
two-three hours, the cardiac rate increased from 85 to 185 beats/minute. 
This patient had previously experienced atrial fibrillation and this 
current episode was controlled by conventional chemotherapy. 
Efforts to correlate cardiac rate, pulmonary impedance, and 
expired (alveolar) CO2 changes during exercise stress showed (Table 13) 
good data fit. However, pulmonary impedance was subject to minor motion 
artifacts as we had discovered earlier in ergometric testing. Periods 
of controlled stress were characterized by increases in pulmonary 
impedance variance, cardiac rate, and expired CO2 as would be expected 
during increased respiratory demand. Figure 58 graphically illustrates 
the relationship between pulmonary impedance and alv~olar CO2 concentration 
in another study. Finally, with the acquisition of a system for 
measuring 02 consumption rates, we attempted to correlated 02 consumption 
(V02)With pulmonary impedance variance. Figure 59 shows typical results 
of this V02: impedance correlation. This correlation can be obtained 
only when the investigator is reasonably sure that no motion artifacts 
are present in the pulmonary impedance waveform. Thus, these correlations 
of pulmonary impedance variance with cardiac rate, CO 2 production, and 02 
consumption indicated that impedance measurements could provide meaningful, 
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TABLE 13 
Relationship Between Pulmonary Impedance, Alveolar CO2 
and Cardiac Rate in a Normal Volunteer 
Exercising on a Bicycle Ergometer 
Ratio 
Pulmonary CO2/ Heart rate/ impedance basal CO2 basal heart Monitoring Eeriod variance rate 
Preexcrcise* 41 1.00 1.00 
During exercise 497 1.45 1. 70 
End exercise + 4 min 301 1.25 1.20 
End exercise + 8 min 61 1.01 1.13 
End exercise + 12 min 58 1.00 1.12 
End exercise + 16 min 46 1.00 1.07 
End exercise + 20 min 64 1.00 1.08 
End exercise + 24 min 51 1.00 1.08 
End exercise + 28 min 65 1.00 1.05 
*Data measured at 5 min prior to bicycle ergometry (50 watt 
workload). 
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remotely monitored, physiologic information regarding human physical 
performance postirradiation. Notwithstanding, we continued to search 
for more useful methods of assessing radiation-induced performance 
decrement. Since V02 is the most common parameter used to assess 
physical status and response to exercise, we studied V02 in a patient 
exposed to 100 R (0.8 R/hr, 16 R/20 hr day) and controlled exercise 
stress. This patient, male, aged 44 years, had been recently diagnosed 
to be in the early stages of lymphosarcoma and was otherwise in very 
good physical condition. Performance was measured in response to a 
submaxima1 workload of 612 ki1opound meter/min.* During the six days of 
irradiation therapy the patient responded to controlled ergometry with 
an increasing maximal eardiac rate (up 14%) although the workload re-
mained constant. Following ceasationof irradiation therapy, the 
maximal cardiac rate returned to preirradiation levels over as-day 
period and the patient demonstrated a slight tendency toward training 
over an intermittant stress period of about 2-1/2 months. These cardiac 
rate data were used to predict maximal 02 consumption (V02 max) using the 
method of Astrand (21). When corrected for age and sex these predicted 
V02 max data indicated a decrease from 2.32 liters/min (preirradiation) 
to 1.83 liters/min when 100 R were accumulated (Fig. 60). There was no 
significant change in the actual V02 (612 Kpm) required to perform at 
the submaxima1 workload. Actual 02 consumed during all 26 exercise 
testing periods was well within the expected values. When averaged for 
all 26 controlled, submaximal exercise test periods the V02 measured 
(1.64 ± l2l/min) was well within the expected values as reported by the 
World Health Organization (22). Thus, it would seem that any radiation 
*1 watt ::: 6.12 KpmPRECEDLNG PA.G~ BLAN&: NOT ~II,MEq. 
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affect experienced by this patient was not at the tissue level of actual 
02 consumption but in the ability of the cardiovascular system to supply 
oxygen to the active muscles. This hypothesis is supported by the mode 
of death (irreversible hypotension) seen in radiation accident victims 
who receive very high exposures (>5000 R). It would appear that the 
threshold for cardiovascular deconditioning is quite low and the effect 
of whole-body exposures appreciably less than 5000 R are transient and 
completely reversible. 
In attempting to model these 02 consumption data from the 
irradiated patient we found a remarkable similarity between irradiation 
effect and data reported by Sa1tin et a1. (23) for bedrest studies. 
Sa1tin's study demonstrated inordinately well the effects of 21 days 
bedrest on trained and untrained male volunteers. Following the three-
week bedrest period, these volunteers experienced a fall in stroke volume, 
cardiac output, maximal oxygen consumption, and an increase in cardiac 
rate to perform at the same workload used prior to bedrest. Our data 
are compared to those obtained by Sa1tin and are summarized in Table 
14. We included data from a normal, healthy control male matched by 
age, body build, and weight to the therapy patient. 
These data prompted us to retrospectively study cardiac rate 
a1terati9ns in therapy patients who had or had not previously partici-
pated in controlled exercise stress testing. Maximal cardiac rates 
recorded during the final minute of an exercise stress period were 
compared for pre- and postexposure differences. Although the exercise 
protocols used in these stress tests did not conform exactly (in length 
of stress time in some cases) to those usually associated with oxygen 
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TABLE 14 
COMPARISON OF CARDIOVASCULAR DECONDITIONING AS A RESULT 
OF BED REST* OR TOTAL-BODY IRRADIATION 
21-day Bed Rest Study 
Cardiac 'rates t 
1. Pretreatment 
2. End of treatment 
129 
154 
Oxygen Consumption (V0 2 max) 
1. Pretreatment 3.3 l/min 
2. End of treatment 2.4 l/min 
3. Recovery time "'9 days~ 
* Saltin, et al. 
U 27%) 
100 R (16 R/day) 
132 
151 
2.3 l/min§ 
1. 8 l/min 
11 days 
(1-22%) 
Control for Irradiation Study 
(wvrk1oad 612 Kpm/min) 
120 
120 (measured on 6th consecu-
tive day of stress testin~ 
2.8 l/min 
2.8 l/min 
I ~ 
I ~ 
t Measured at 600 Kpm/min in bed rest study, 612 Kpm/min in irradiation study. 
§ Predicted from submaximal workload (612 Kpm/min. I ~ Untrained individuals only. 
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consumption studies, we used these cardiac rates to predict oxygen con-
sumption again according to the methods of Astrand. These data, 
summarized in Table 15, revealed that maxima.l cardiac rates increased 
four to fourteen percent in therapy patients exposed to total body 
irradiation up to 250 R. The response did not seem to be dose or dose 
rate dependent and not all patients demonstrated significant increases 
in cardiac rates. Likewise, the maximal cardiac rate in a man accidentally 
exposed to 250 R total body ir~adiation increased 15% during repetitive 
con.trolled exercise stress. Significant increases in cardiac rates were 
not noted in patients exposed to irradiation up.to 250 R but not subjected 
to physical stress. At stress loads similar to those patients were 
subjected to a group of centro 1 males demonstrated a decrease of 11% in 
maximal cardiac rates. 
These results suggested that radiation-induced cardiovascular 
deconditioning (CVD) might be responsible for increased cardiac rates 
recorded during these stress sessions and support the hypothesis that 
radiation-induced "easy-fatiguability" may be revealed symptomatically 
only when the irradiated person is stressed physically. They do not, 
however, provide any information concerning whether or not these 
physiologic phenomena would be additive to those previously experienced 
by astronauts during prolonged low G activity. 
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TABLE 15 
EFFECT OF TOTAL-BODY THERAPEUTIC OR ACCIDENT IRRADIATION 
ON CARDIAC RATE DURING CONTROLLED EXERCISE STRESS (UPRIGHT ERGOMETRY) 
AND MAXIMAL AEROBIC CAPACITY 
IRRADIATION PROTOCOL MAXIMUM CARDIAC RATE 
lOR/Day (1.5R/Hr) 
30R/Day (1.5R/Hr) 
30R/Day (1.5R/Min) 
l6R/Day (O.8R/Hr) 
Accidental Irradiation 
-260R(350R/Min) 
Control (normal males) 
Control (patients not subjected 
to stress; lOO-250R, 
1.5R/Hr) 
t"'ll% (3-5)t 
t'" 7% (1 week post) 
t'" 4% (2) 
t"'14% (5) 
t "'15% (5, 2 week) 
-}",11% (2-4 week) 
-}tl-2% 
tTime in days to reach peak response after 
initiation of irradiation insult 
*Extrapolated from submaximal work loads 
MAXIMAL 
AEROBIC CAPACITY* 
down 22 96 
down 10% 
down 10% 
down 26% 
down 19% 
up 19% 
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CHAPTER V 
ANCILLARY CLINICAL LABORATORY AND EXPERIMENTAL STUDIES 
A. Red Cell Size Relation to Radiation Effect on Erythrob1asts in Man 
and Mouse 
Studies in experimental hematology use radioactive cell-labels in 
characterizing changes in the hematopoietic organ after irradiation and 
also employ modern electronic cell sizing and counting apparatus for detecting 
end points for radiation effects. 
We investigated the usefulness of electronic cell-sizing in clinical 
and experimental hematology. Our studies were classified as (1) clinical 
and experimental applications and (2) experimental observations on the 
nature of the electronic two-peak red blood cell (RBC) population phenomenon. 
The system used to accomplish these studies is described in detail 
in a previous publication. Briefly, the components of the system are built 
around the Coulter Counter, Model B, and its ass'Dciated glass transducing 
assembly consisting of the aperture tube, electrodes, mercury liquid 
volume measurement device and pump. The pulses, formed as each cell is 
driven through the aperture by differential pressure, are taken off the 
Coulter electronics just before reaching the Coulter oscilloscope circuit. 
They are sorted and stored by a 40o-channe1 pulse-height analyzer 
appropriately altered to accept the characteristically slowly rising pulses 
that are produced. Each stored pulse is simultaneously counted by a pre-set 
Coulter until 100,000 cell volumes are measured and the analysis auto-
matically terminated. 
The accumulation of "cells" of the same volume in each ana1y~:er 
channel is displayed "live" on an oscilloscope screen. At the end of an 
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analysis, a.photograph is made of the resulting frequency-distribution 
curve for the purpose of a visual record and the data are automatically 
typewritten for later computation. For clinical purposes the ratio of 
mean channel number to mean cell volume as derived from the hematocrit 
and red blood cell count and determined statistically with a large number 
of observations, is a sufficiently accurate means of calibration. This 
determination is accomplished as shown in Fig. 61 by graphing fo.~ each 
blood sample the hematocrit-derived MCV, and the electronically determined 
mean channel. Where extremely precise measurements are desired and apertures 
small in diameter are usable, Dow latex particles of bacterial size (0.87-
1.31 micron diameter) can be employed. After this. conversion factor has 
been determined, it can be used to transpose channel number to cubic microns 
providing the experimental and electronic conditions are kept constant. 
Preliminary studies demonstrated the reliability of the hematocrit 
determined MCV and electronic MCV. These studies in neonatal mice are 
demonstrated in Fig. 62. Initial studies also demonstrated this capability 
of electronic MCV determinations to monitor RBC changes induced by total-
body irradiation therapy and Methotrexate therapy. These thereapeutic data 
are shown in Figs. 63 and 64. 
In clinical hematology the technique was used to: (a) in routine 
diagnostic work-up of new patients to approaise the status of their 
erythron and (b) during therapy of RBC diseases to gauge the rate of 
return of RBC size distribution in polycythemia rubra vera (PRV) after 
radiation therapy. These techniques of RBC sizing for clinical hematology 
were extended by studies of new patients and in long-term patients after 
repeated therapeutic trials over long periods. The results substantiated 
our. tentative conclusions that remission induced in PRV by irradiation and 
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other methods of suppressing erythropoiesis was accomplished by the produc-
tion of new RBC's of normal size. As these cells with a life expectancy of 
120 days were delivered into the blood and old microcytic cells were 
removed, the initial abnormal sized RBC distribution changed progressively 
toward a normal one. Whether or not a completely normal size profile is 
obtained, however, depends on the duration of the period during which red 
cell production rate and iron stores are in balance; if iron deficiency is 
present (because of intestinal hemorrhage, for example) and goes untreated, 
iron stores are adequate for only a short time and production of microcytes 
soon begins and reverses the trend toward normal in the RBC size profile. 
In other blood dyscrasias with suppressed RBC production and iron stores 
normal or above, we found no abnormality in RBC size distribution and total 
body radiation exposures were not followed by change in RBC size. 
In experimental radiation therapy and h l;mato1ogy, we used this technique 
to measure the macrocytosis of mice chronically irradiated at low dose rates 
where colonies of stem cells are formed in the spleen and abnormal hemo-
globin is produced. The macrocytic shift in RBC size distribution correlates 
\ 
well, temporally, with splenic stem-cell colony proliferation and abnormal 
hemoglobin production but not with splenic stem-cell colony formation 
without proliferation. This finding suggests that when these colonies 
proliferate under stress they form macrocytes containing abnormal hemog1obin.s • 
This correlation allows electronic RBC sizing to be used for selecting 
irradiated mice for biochemical hemoglobin assay. Results of these studies 
on stem cell colony formation in irradiated mice will be discussed ~n 
considerable detail in Section D of this chapter. 
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Our electronic cell-sizing apparatus, appropriately set upper and lower 
analyzer gates, was also used to exclude agglutinated RBC masses from being 
I counted in studies of the rate of replacement of an irradiated human 
recipient's own RBC by new RBC from transplanted bone marrow. Since the 
I size distributions of the two RBC populations (donor versus recipient) 
differed, we could also follow the growth of the new RBC mass by obtaining 
I' sequential RBC size distribution studies. These seemed to correlate well 
I with 'che findings of the in vitro hemagglutinin system, but were not as 
easily quantitated in percentages. 
I Studies on the nature of the well-defined two-peaked distribution of 
electronic pulses generated from normal blood when the electrical current 
J is high (>1.0 but <3.0 microamps) helped justify our use of high currents 
I in practice because it allowed us to differentiate REC of two or more different model sizes easier than lower currents do. Sometimes we wished 
J to compare the RBC of two persons with different MCV's by mixing a sample 
from each and comparing the two-peaked size distribution visually; the 
~ presence of two bloods in the sample was more clearly demonstrable with 
I a high current than with a small one. While there are numerous explanations for the presence or absence of 
I two peaks dependent upon current, none have been shown experimentally to 
-~ 
i i " 
hold true under all the conditions of our measurements. Most explanations 
are based on physical theory and mathematical solutions rather than direct 
I 
I ]: r J;, r 
experimentation. The latest purports to show that the two peaks result 
from tumbling of some of the saucer-shaped red blood cells in the flow 
I 
f' i I. ~l l 
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t I t. t 
l' I L 
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through the sensing volume of the aperture tube. We showed experimentally 
that this explanation is inadequate. When glutaraldehyde was buffered and 
in less than 2.5% concentration, it can fix RBC rapidly (within 15 min) 
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without microscopically detectable alteration in their size or shape. 
With 4% formalin in saline similar RBC fixation without distortion is 
obtained in 18 hours. We sized unfixed RBC suspensions and those fixed in 
these two solutions during periods in which all the variable parameters of 
the electronic sizing system were kept constant. By the time the RBC mem-
brane became "fixed" the two-peaked distribution was not obtained even though 
the fixed RBC's were still disc shaped and just as capable of tumbling as unfixed 
cells. We believe that the two-peaked RBC size distribution results from 
alterations in the amount of intracellular fluid in the RBC caused by an 
effect of the electrical current on the ionic charges of the living, pliable 
RBC membrane that affects the sodium-ion water transfer pump. The single 
direct experiment that proved our explanation, however, continued to elude 
us. We attempted to gain more clues by using the well-known progressive 
chemical alterations that occur in blood-bank blood stored in acid citrate 
dextrose solution. Here the selective permeability of the RBC membrane 
decreases progressively and transpprt of substances across it depend finally 
only on Donnan state of equilibrium. The amount of intra-RBC sodium rises 
progressively over a 30-day period and mean corpuscular volume increases as 
the RBC swell. We obtained electronic RBC size distributions of blood from 
nine patients with PRV drawn into ACD at intervals over 30- to 70-day periods 
of storage at 40°F (Fig. 65). While the changes observed in cell volume 
were progressive, they were not linear with time, being slow at first and 
gradually becoming more rapid. These studies answered a practical question: 
How soon after a blood sample is drawn from a patient must the RBC sample 
be sized if in vitro changes are to be avoided? Sizes or distribution in 
the specimens did not change significantly during the first five days, but 
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after that, all the RBC size distributions shifted progressively toward the 
right as the cells swelled. In Fig. 65 the squared difference index for" 
the consecutively determined RBC size distributions of these bloods are 
shown. The index of zero can be assigned to each bottle of blood at the 
beginning of each experiment because the initial size distribution of each 
blood served as its own reference point for comparison with subsequent 
measurements of the same (aging) sample. On comparing the repeated frequency 
distribution histograms of these samples with the originals one sees that 
the higher peak comprised of the smaller cells in the initial RBC distribu-
tion became progressively lower, broader, and shifted further to the right 
(large size), finally merging with. the original low,broad peak of large RBC. 
These changes logically fit our hypothesis: that passage through electrical 
current alters the cell membrane charge so that sodium and water leave the 
cell, making the cell shrink; that small cells with relatively little water 
and sodium show the greatest proportional shrinkage iwluced by electrical 
current while large cells swollen with water and comparatively rich in sodium 
are decreased least in relative size. Because passage time thl:'ough the 
" -
high density current in the aperture tube is constant, only a constant amount 
of sodium and water can be removed per passage. This is relatively faster 
and is a greater percentage of the total present initially in small dense 
cells. After blood bank storage RBC imbibe sodium and water when their 
ability to glycolyze fails in parallel with a fall in high energy phosphates; 
the amount imbibed is limited only by the cell membrane and all cells of 
the same individual swell toward this limit, hemolyzing when it is exceeded. 
Consequently, the RBC remaining in the bottle becomes more alike in sodium 
and water content and size; the proportional effect of the current upon 
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the cells decreases and the differentiation of the RBC size into two peaks 
i of distribution becomes progressively poorer. 
These studies suggested that electronic RBC sizing might be useful 
t in studying the pliability of RBC membranes and their hemolytic fragility 
i as well as variations in size of individuals in total RBC population vari-
ations. In addition it would seem feasible to use this system to rapidly detect 
l undesirable changes in normal blood during blood bank storage. This might 
have an advantage over other methods because of its simplicity and the 
I rapidity with which results can be interpreted. 
t B. Anti-proteolysis Radiation Effect and Dose Rate Dependence 
1 
Measurements to evaluate the effects of various therapeutic regimes 
generally rely excessively on quantitation of subjective symptoms. 
f 
Commonly, such evaluations depend on a battery of chemical determinations 
and peripheral blood counts. The latter still reveals the most about how 
, the hematologic patient is responding, for example, to total body irradia-
tion. Their prognostic, as well as diagnostic value, is high but in many 
t of the diseases we study and attempt to treat, the blood cell values are 
I highly pathological and define the disease, but may obscure reaction to the disease or to concurrent infections. The pret'reatment levels of specific 
1 cells in patients with the same disease, for example, chronic lymphocytic 
leukemia, also vary so much from patient to patient that therapeutiaal1y-
t induced responses are difficult to compare. It would be desira~le to have 
l additional reference measurements that would be normal in healthy people, but progressively abnormal as a person becomes ill and approaches death; 
") the pathologic results in this measurement should s1 bside toward normal 
when clinical management is successful or spontaneous recovery occurs. The 
t study reported here was useful as an objective measure of cell substance in 
f r ~ .. ~r..i:i;.. 
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the blood with levels related to hematopoietic functions. 
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The importance of serum trypsin-inhibitor (TI) levels in health 
I and disease is highly speculative. Numerous teleologic reports suggest that 
I TI plays a role in promoting normal growth processes by limiting random, 
nonspecific proteolysis and that its most important role is in protecting 
J the pan~reas and the small intestine from undesirable tryptic autodigestion. 
Measurement of serum trypsin-inhibitor levels has been useful in clinical 
J laboratory only in pancreatic disease where its correlation with clinical 
I status has been established. The results reported here were obtained by measuring TI levels using 
I the serum and plasma of all persons who had some other measurement made on 
samples of their blood in the Medical Division laboratories. Experimental 
I design was li.mitedto that required for making the determinations. After 
I all the measurements were completed, the sources of the serum samples were identified by disease and clinical condition and the results graphed in 
I ;: relation to calendar date. Those measurements from the same patient were 
connected by lines to see how the levels changes as the disease progressed 
I or was arrested. 
I 
The amount of trypsin inhibitor was determined by measuring ~he 
amount of hydrolysis of a-N-Benzoyl-L-Arginine ethyl ester (BAEE) obtained 
I under standard conditions by 0.653 units of trypsin with and without 10 
microliters of serum present. The method was modified and adapted in our 
I laboratory. 
I 
As shown in Fig. 66, normal persons and patients without serious 
disease, or without symptoms of a previously established malignant disease, 
I 
i 
had similar TI levels around the normal mean of 32.5 TI units/ml, ranging 
up to "'45 units and down to "'units. Patients hospitalized because of 
, I uncontrollable progression of such diseases as acute and chronic myelocytic 
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and lymphocytic leukemia, myelomas, lymphomas, myelofibrosis, Hodgkin's 
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disease, and carcinomas had levels commonly above 50 units, and those who 
died of their disease during this time had progressively rising levels 
occasionally in excess of 90 units (~3 x average normal). Several persons 
with persistent values above 60 units have survived but have been difficult 
therapeutic problems. Two patients who died of vascular accidents associated 
with their malignant disease process or its therapy, were the only ones to 
succumb with approximately normal levels. 
Metastatic spread of epithelial neoplasms has been reported to be 
accompanied by a progressively rising TI preceding death; an example is 
shown in Fig. 67. 
We a1.so saw this premortem rise in patients who died from Hodgkin's 
disease and myelofibrosis. However, such a rise is not always irreversible; 
a patient with malignant plasmocytoma, who had had moderately elevated TI 
levels for about two months, developed rapidly rising values paralleling 
a similar rapid incre~se in blood urea nitrogen (BUN) and oliguria. Inten-
sive cytotoxic chemotherapy produced a return to normal TI values over a 
two-week period. The TI value remained normal during the rest of the study 
period of one month, during which the patient was relatively symptom free. 
Similar reductions of TI values have followed radiation and chemotherapy 
in other patients. It is not yet clear whether Prednisone has an effect on 
TI levels; it seems so far that corticosteroid therapy is accompanied by TI 
levels in the 50 to 60 un.it range but this correlation has not been 
sufficiently studied. In chronic lymphcoytic leukemia (eLL) and polycythemia 
vera, when active disease was present but life was not immediately threatened, 
TI levels were often found to be much less than normal (20 down to 10 units). 
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The clinical significance of this observation eludes us since the patients 
with CLL and acute leukemia who died during this observation period 
developed abnormally high TI levels shortly before death in spite of 
initially low base lines. 
Later, the effect of total body irradiation on TI levels was studied 
in laboratory animals and in humans exposed to a wide dose range of thera-
peutic irradiations. 60 Ten to l5-week-old BL/6 mice were exposed to Co 
total-body irradiation at a rate of 40 R/min. Total exposures ranged 
from 250 R to 1000 R. Trypsin inhibitor determinations began at three 
hours postirradiation and were complete at 21 days postir'l:'adiation. 
Mice given 250 R TBI had normal TI levels (1.84 ~g/~l) through six 
hours postirradiation which gradually decreased to ~68% of normal at 72 hr 
with no sign of recovery. The groups of mice receiving 500 R, 750 R, or 
1000 R TBI all showed substantially lower TI capacity by three hours post-
irradiation, with the 750 R group having only 27% of normal at this earliest 
time. In all of these groups, the initial suppressed level was followed by 
fluxuations in the TI levels marked by recoveries to almost normal levels 
and further decreases to a minimum of 17% normal (750 R group). Neither 
amplitude nor rate of the changes in TI were dose-dependent, and we saw 
no real return to normal TI levels in these groups within our study period. 
Fina: ~y, we measured TI levels in 10 patients who received 100-694 R 
TBI as partial therapy for CGL, eLL, or PRV. Fifteen normal persons had a 
mean TI capacity of 0.89 ~g trypsin inhibited per ~l plasma (S.D. = ± 0.11 
~g/~l) ranging from 0.70 to 1.17 ~g/~1. All of the diseased humans had TI 
levels above the upper limits of normals. With low level radiotherapy 
(1. 5 R/hr) most patients demonstrated a rapid moderate depression and 
i 
j 
I 
I 
I 
I 
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recovery in TI levels, sometimes followed by a slight overshoot. Prac-
tica11y no change in TI capacity occurred during METBI (1.5 R/min) radio-
therapy. The levels of TI after radiotherapy commonly correlated with 
the patient's overall hematological response, modified by secondary clinical
 
developments. These data are graphically represented in Figs. 68 and 69. 
During the course of multiple varied disease phases and concommitant 
therapeutic manipulations which these metastatically diseased patients 
received, their TI levels frequently changed apparently in response to 
many different stimuli. These included, in addition to irradiation, 
administration of urugs, blood, or plasma, decreased urinary output and 
electrolyte imbalance, changes in blood chemical levels, and presence of 
acute GVH disease. Our study of the relation of TI levels in malignant 
disease, and the effect of TBI, indicates that the level of this protein 
is increased with worsening of clinical status, is decreased with clinical 
improvement, is acutely increased during many infections, and is affected to
 
a quite limited extent by exposures to gamma radiation levels described 
herein. 
C. Effect of Irradiation on Serum Creatinine Phosphokinase Levels 
Exposure to ionizing radiation, particularly total-body irradiation, 
results in a variety of in vitro biochemical changes dependent on dose and 
dose rate. Some familiar examples include circulating levels of serum 
iron, lactic acid dehydrogenase (LDH), and trypsin inhibitor (TI). Our 
efforts to find data to correlate biochemical/physiological changes with 
altered pulmonary impedance changes in irradiated patients led us to initiat
e 
clinical chemical determinations of serum creatine phosphokinase (SCPK) in 
control volunteers and patients. This particular enzyme (CPK) was chosen 
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because of its relationship to muscle physiolog~ particularly its re1ation-
ship with rapid production of ATP during increased physical activity. 
Creatine phosphokinase (CPK) is responsible fo~ the following 
reaction in muscular tissue: 
creatine phosphate + adenosine dephosphate ++~-+~CPK 
creatine + adenosine triphosphate 
with ATP being the primary source of energy for the contraction process. 
Our initial efforts to measure SCPK were directed to a radiation 
accident victim (previously mentioned) who received ~260 rem (350 rem/min) 
cobalt irradiation. The SCPK levels on the day of the accident (day 0) and 
the following day were 25 mU/ml and whhin the normal expected runge as 
determined by a UV (366 nm) assay method available through the Boehringer 
Mannheim Corporation, New York. Controlled exercise stress testing was 
initiated, following complete cessation of prodromal symptoms, three days 
postirradiation. On day 4, the SCPK level was 343 mU/ml and on day 5, 
455 mU/ml, a 13.7 and 18.2 times increase, respectively when compared to 
preexercise values. Eight days postirradiation the SCPK levels returned 
to normal and remained within normal ~ges throughout the remaining 
monitoring period as shown in Fig. 70. It is not clear from these results 
if the exercise stress testing on day 3 was responsible for the significant 
rise in SCPK or why the level suddenly dropped back to normal levels 
although exercise testing continued. However, when SCPK levels were 
elevated changes in pulmonary-impedance variance were minimal (see Chapter 
IV) even though the victim's tolerance to stress was minimal. Whether or 
not irradiation enhanced the response to exercise-induced hypoxia or 
caused a dumping of CPK into circulation remains obscure. 
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Results of SCPK determination in the accident victim led us to 
begin measurement of CPK levels in irradiated patients exposed to a variety 
of exposures and exposure rates, normal volunteers, and irradiated labora-
tory animals (mice and Shetland ponies). The effet~t of exercise stress on 
SCPK levels was likewise evaluated. 
All persons (patients and normal volunteers) demonstrated significant 
increases in serum creatine phosphokinase levels when subjected to controlled 
exercise stress and/or irradiation. Serum creatine phosphokinase levels 
(shown in Fig. 71) in normal volunteers exercising under submaximal stress 
conditions showed increases in this enzyme comparable to those for 
exercising men reported in recent literature (24). Generally, SCPK levels 
rose two to two-and-one-half times the preexercise levels and although they 
remained elevated throughout the four-week test period, they appeared to 
be returning to normal during the fourth week, possibly indicating an 
adaptation to the constant workload. 
Next, serum creatine phosphokinase levels were determined in (1) 
irradiated patients who did not exercise and (2) patients who were similarly 
exposed and tested by controlled exercise. In nonexercising patients exposed 
to 100 R (30 R/day, 1.5 R/hr) significant increases in enzyme activity 
occurred duri~g the exposure periods. The enzyme activity returned to normal 
within two weeks after exposure in all but one patient studied (Fig. 72). 
Similar changes in SCPK activity occurred in nonexercising patients exposed 
to 150 R in LETBI (Fig. 73). Only one of the patients exposed to 100 or 
150 R failed to demonstrate the rise in SCPK levels. In nonexercising 
patients receiving fractionated exposures (10 R/day, LETBI) SCPK levels rose 
significantly in those receiving 150 R but not in one who received only 
100 R (Fig. 74). This increase in SCPK activity was not evident until a 
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few days «1 week) after irradiation and was much higher than in patients 
with similar but protracted exposures. A similar disparity between 
fractionated and protracted therapy and their affect on SCPK (Fig. 75) 
was noted in a patient who received both therapeutic protocols (6 months 
apart). Therapeutic exposureS of 250 Rand 792 R (Figs. 76 and 77, 
respectively) likewise resulted in elevated SCPK levels but not to any 
greater extent than did lower exposures. Exposures of mice (C3BF1) to 450 R 
(3.36 R/min) resulted in SCPK levels (Fig. 78) similar to those seen in 
irradiated humans as did protracted exposures of 30 R/day (total exposure 
of 270 R) in exercising Shetland ponies (see Table 16). 
Efforts to correlate SCPK levels with periods of diminished exercise 
capacity (DEC) in humal's was possible in only one therapy patient, other 
than the radiation accident victim, and revealed that DEC was not evident 
when CPK levels were ~!evated (Fig. 79). 
Our limited data on changes in SCPK levels suggest that some relation-
ship exists between exercise response and energy output levels that are 
creatine-phosphokinase dependent. It is not yet clear which is cause and 
effect. For example, in one patient DEC, during fractionated (10 R/day) 
irradiation therapy, was followed by a significant increase in SCPK and 
then by recovery from radiation-induced fatiguability (Fig. 79). We feel 
that the increase in circulating SCPK level may be a systemic response to 
stress that feeds back to prevent or delay fatiguability, but further 
studies will be required before any such role can be substantiated. 
These CPK studies reinforce our opinion that an irradiated patient 
does not respond to controlled exercise in the same way that normal unir-
radiated mqn does. The differences noted in irradiated patients could be 
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TABLE 16 
Jt~ CREATINE PHOSPHOKINASE (CPK) LEVELS IN PONIES 
'Itc~1}vG P . EXPOSED TO 270 R TOTAL-BODY GAMMA IRRADIATION 
'~G}]}J~ _ . 
~, 
0+0 
-+ -+ t .j. 
*l-Preconditioning 
------ ------ ------ ------
I-No Conditioning 
650 + 0 
-+ -+ -+ -+ 
I-Preconditioning 
------ ------ ------ ------
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due to their disease sta.te but this seems highly unlikely since (1) none 
of the patients studied were acutely ill and (2) the patients tended to 
dlFonstrate degrees of DEC proportional to their irradiation exposure. 
D. Low-Dose-Rate Radiation Lethality Syndrome - Human Extrapolations 
184 
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While these models are quite variable with regard to LDSO estimations, we 
anticipated that our studies in humans exposed to therapeutic irradiations 
would, add to the existing data base. This data base has generally been 
constructed from lower animal extrapolations based upon damage to the 
gastrointestinal (GI) tract and the bone marrow. 
In parallel to our studies in man, we made experimental studies in 
mice to determine the accumulation rates of gastrointestinal and marrow 
damage when we used the discontinuous METBI fractionated daily exposures 
and the continuous LETBI exposures. Mice were used because of the 
approximately equal dosage to marrow and all parts of the gut from the same 
exposure field whose strength was easily determined by thermoluminescent 
dosimetry. Multiple cellular replicating systems were studied in them 
simultaneously to see whether the length of the radiation-free interval would 
allow their more rapidly repairing systems to negate the greater damaging effect 
of the higher dose rate. The same daily dose level was studied with CS7 and 
Blk 6 Cum mice irradiated continuously at 0.8, 1.6, and 3.2 R/hr in LETBI 
and others pair-irradiated with identical doses per day delivered at about 
4.0 R/min. Multiple criteria for determining GI and bone marrow repair 
levels were used: intestinal crypt mitotic index, intestinal weight, histo-
pathology of necropsy sections, peripheral blood-cell counts and morphology, 
splenic weight, formation of endogenous erythroblast colonies in the spleen, 
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3 ~ H-thymidine incorporation in replicating cells and testicular weight. 
These data were correlated with changes in total body weight and after-
survival times in relation to accumulated dose. Two ages of mice were used: 
50-day-old (radiosensitive) mice, and l20-day-old (radioresistant) mice. 
Our findings did not support our initial thesis that the mouse would 
withstand the fractionated high-dose-rate daily exposures better than the 
continuous low-dose-rate ones. The germinal epithelium of the mouse testis 
and the white blood cell levels proved too radiosensi'tive to show any 
evidence of repair in either system of exposure at the dose rates used. 
Changes in intestinal length, weight, and crypt mitoses, on the other hand, 
seemed to indicate equal levels of good repair. Significant differences in 
response were found in changes in total body weight (Fig. 80), RBC indices 
./ 
and size distribution, spleen weight (Fig. 81), and numbers of endogenous 
erythroblast colonies, and in mean-after-survival times. At a dose (35 R/day) 
that was half that critical for the adult (70 R/day) the young mice showed 
these responses to a pronounced extent. 
Obviously, more data was needed for the lowest exposure groups, while 
data from the other two exposure levels show that almost all deaths were 
due to erythroblastic failure to replenish RBC lost through senescence. As 
anemia developed, progressive loss in total body weight occurred. Splenic 
size increased and then decreased as endogenous splenic erythroblastic 
clones arose and disappeared. Red blood cell sizing showed that these 
abortive splenic colonies were correlated in time with the appearance of 
macrocytic red cells that approached mouse fetal RBC in size. No deaths 
due to infection were found even though all mice had severe leukopenia and 
thrombocytopenia at all these expose levels and patterns. In addition, 
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none had granulocytic myelopoietic hyperplasia as a measurable reparative 
response. 
All signs of reparative responses and failures in these systems just 
described occurred at lower accumulated doses and elapsed times in the mice 
exposed to 35 and 70 R/day discontinuously at 4.0 R/min than in m:i.ce eXJ?osed 
to the same daily dose continuous at 1.5 R/hr. 
The results of these early experiments seem to show that in the mouse, 
as well as in man, discontinuous radiation exposures at high dose rates are 
more deleterious than the same daily dose given continuously at a low dose 
rate. Since no differences are seen qualitatively in the repairing systems, 
:l.t would seen that the lower continuous exposure causes less cellular 
damage by providing time between "hits" for intracellular repair to occur 
before the second hit. As a result, less lethal cellular damage results 
and less replication by surviving cells was demanded in the critical 
cellular system. 
Our observations on changes in body weight suggested that the higher 
1"'" 
radiosensitivity of the young animal may be due to greater somatic growth 
demands for protein synthesis in addition to that of its smaller, still 
developing, stem-cell population as previously demonstrated by Yuhas and 
• 
Storer. Such demands would be a drain on its smaller stem-cell pool 
while, conversely, adequate reparative cellular replication would reta,rd 
muturation of other systems. 
Next, we extended these observations to studying the onset time of 
splenic colony formation, the number and size of colonies found, and the 
corresponding changes in splenic weight. 
C57 black 6/cum. male mice were placed in irradiation groups under two 
regimens: (1) mice were irradiated cl;mtinuously (20ta 24 hrs/day) at three 
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rates of exposure (0.8, 1.6, ana 3.2 R/hr) and received 16-19, 32-38, or 
64-77 R/day; (2) other mice wer,e pair-irradiated) at 3.6 RIm in , daily 
receiving the three same total exposures per day. Animals were killed 
when they had assumulated specific doses. Spleens were weighed, fixed in 
Bouin's fixative, and colonies counted. Although it is usual procedure to 
ignore the small colonies all were counted. Small ones are difficult to 
count and their quantitation is less dependable than that of those greater 
than 1 mm in diameter but their appearance time is biologically significant. 
In Fig. 82 these results are shown as spleen weight, time of spleen 
colony appearance (S), and ·time of large colony development (L) in relation 
to accumulated exposure in R. In mice exposed at 18 Rlday, spleen weight 
decreased initially about 25% and then remained constant until approximately 
2200 R had accumulated. Then spleen weight began increasing in mice exposed 
in both the continuous and discontinuous modes. Although the rate of 
increase in spleen weight was greater in continuously irradiated mice, 
formation of discrete colbnies was not observed in them, but was seen at 
this time only in the discontinuously irradiated mice (2200 R). 
At 35 Rlday (the approximate human therapeutic exposure rate in LETBI) 
mice exposed in the continuous mode respond to an accumulated dose of 700 R 
with a 30% decrease in spleen size and with initiation of colony formation. 
Those exposed discontinuously respond dramatically to the same accumulated 
exposure as exhibitied by reduced spleen weight (50% of normal) and by 
the initiation of spleen colony formation. With both modes of irradiation 
at this daily rate, as well as at 70 Rlday, increase in spleen weight was 
related to colony proliferation (L), not colony formation (S).· Colony for-
mation was begun during or immediately following the time of minimum spleen 
weight; maximum proliferation corresponded to greatest spleen weight. 
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Spleen weight in 70 R/day mice never achieved the maximum values 
observed in the two lower exposure rate groups. Only at this highest ex-
posure rate, however, did colonies become sufficiently large and numerous 
(up to 40/spleen estimated) to become confluent over the surface of the 
spleen. Mice exposed to 35 R/day in the discontinuous mode were the only 
other group that approached this degree of proliferation of spleen colonies. 
We interpreted these results in terms of radiation damage and recovery 
to mean that: at 18 R/day, the rate of damage induction is depreciated by 
cellular repair mechanisms so that accumulated R "overestimates" residual 
damage. The level of accumulated ~esidual damage does not induce 
formation and proliferation of splenic colonies until 2200 R or more have 
accumulated. Since this "turn on" occurs only in mice irradiated discontin-
uously, and since the delayed peak in spleen weight is greater in the 
continuously exposed mice, we assumed that residual damage has outweighed 
repair in the discontinuously exposed mice while in the continuous regimen 
repair had maintained at least an advantage over damage and may have even 
been producing a state of "over compensation." 
At 35 R/day the rate of damage induction apparen.tly exceeded repara-
bility early (1100 R) and formation and proliferation of splenic colonies 
was a vigorous response to systemic demands for blood cell formation, a 
response which produces an abortive splenomegaly and macrocytosis of the RBG 
and which temporarily delays the onset of a lethalanemia~ 
At 70 R/day the reparative processes are quickly o~erwhelmed and 
damage accumulates sufficiently to elicit formation of ~pleen colonies 
almost at once (500 R) but their proliferation, as shown by the appearance 
of large colonies, is suppressed until 1500 R have accumulated. At this 
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level the 70 R/day mice began to exhibit the severe radiation-induced 
anemia which eventually ~as the main cause of death. 
These results suggested that at low dose rates the physiologic level 
of hematopoietic damage depends'.upon dose rate and not dose, that recovery 
from such radiation damage was triggered by the rate at which residual or 
unrepaired damage was accumulated, and that endogenous stem-cell prolifera-
tion was also highly dose-rate dependent. Our findings concerning spleen 
colony formation and proliferation confirmed previous observations in 
which we compared the response of mice to continuous and discontinuous 
radiation using survival, splenic weight, and total body weight as endpoints. 
Mice in the discontinuous mode receive the radiation over a short period of 
time at a medium-exposure rate (3.6 R/min) and have a long radiation-free 
period during the day, while the mice in the continuous mode were exposed 
at a low-exposure rate and had a short or no radiation-free interval. Spleen 
colony formation and proliferation in mice irradiated in these two modes at 
18 R, 35 R, and 70 R/day demonstrated that dose-rate effects predominate 
regardless of the length of radiation-free periods. Disc9ntinuously 
irradiated mice exhibit damage earlier (spleen colony formation) and repair 
later (colony proliferation) than the continuously irradiated. 
Thus, our data suggests the fact that because the rodent spleen has a 
tremendous capacity to increase its hematopoietic cell output, its role in 
the survival of mice and rats irradiated acutely (single large exposures) 
has been extensively studied. Although it was thought that removal of the 
spleen would hinder recovery of the blood-forming system, several investi-
gators have shown that splenectomy not only does not reduce the acute LD50/30 
of rodents, but in some studies has been radioprotective. This is 
apparently due to th.e removal of the source of a splenic factor that inhibits 
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bone marrow mitotic activity necessary for recovery. 
The importance of the spleen to survival of exposures to continuous 
irradiation has not been previously determined in mice. Several studies 
have been made elsewhere on adult rats given 50 to 85 R/day continuously 
up to total exposures of 4000 R. As in our mice, intact irradiated rats 
develop a massive splenic erythroid hyperplasia and marrow cellularity 
becomes progressively reduced. Because the postirradiation hematopoietic 
recovery patterns of intact and splenectomized rats are similar, the role 
of the spleen in tolerance to prolonged continuous irradiation was not 
definable. In another similar rat study, a difference was found in the 
recovery patterns of the mononuc1ears and platelets. The platelets response 
seemed to be improved by splenectomy and resulted in a greater mean-after-
survival time when irradiation was at 84 rads/day. This increased survival 
was attributed to enhanced maintenance of the platelet counts in the 
splenectomized rats. 
In our studies on the survival mechanisms of C57BL/6 male mice under 
continuous irradiation, sufficient numbers of splenectomized mice were 
irradiated at 0.8 R/hr, 1.6 R/hr, and 3.2 R/hr for statistically significant 
results. Daily exposures were 18.5, 37.0, and 70.0 R/day, respectively. 
Splenectomies were performed when the mice were '1.1120 days old and irradia-' 
tion started 30 days after surgery. In addition to mortality experiments 
where all animals are exposed until death, serial-sacrifice studies were 
performed on mice irradiated at 1.6 and 3.2 R/hr. These studies included 
measurement of 59Fe-ferrokinetics, WBC and RBC counts, hematocrit, and 
hemoglobin. Platelet counts and WBC differentials were not made. Results 
of the mortality experiments are shown in Fig. 83. At the highest exposure 
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rate (3.2 R/hr) there was no different mean-after-surviva1 (MAS) between 
splenectomized (MAS ~58 days) and intar.t irradiation mice (MAS ~58 days 
also) of similar age. A significant difference in survival was seen during 
the 1. 6 R/hr exposures. The MAS (1213 days) of the splenectomized mice was 
only 83% of that (155 days) of intact irradiated controls. Repetition of 
this experiment has confirmed this depression in survival rate. The MAS 
of the splenectomized mice in the second study was only 79% of that of intact 
mice. At our lowest exposure rate (0.8 R/hr) we found no significant 
difference in the survival times of intact (MAS ~293 days) and splenectomized 
mice (MAS 298 days). 
Thus, the radioprotective effect described after splenectomy and 
acute irradiation in mice and after splenectomy and continuous irradiation 
in rats was not found in Qur study using continuously irradiated C57BL/6 
mice. To the contrary, splenectomy was detrimental to those irradiated at 
the 1.6 R/hr rate, which is the rate that produces the greatest splenic 
erythrob1astic response. We analyzed histologic data to explain the in-
consistency of the detrimental effect of splenectomy on the tolerance of 
mice for continuous radiation. Terminal histopathology of the mice in the 
mortality experiment at 1.6 R/hr consisted of an almost complete depletion 
of all hematopoietic elements in marrow of the splenectomized mice. Since· 
the marrows of the intact mice contained myeloid and erythroid foci and 
the spleens of these mice often have significant hematopoietic foci, it is 
possible that the spleen is needed to reseed the marrow. The results 
obtained in the serial sacrifice experiments showed that the alterations of. 
the peripheral RBC and WBC populations of the splenectomized mice coincide, 
both in time and magnitude, with those of their analogous intact irradiated 
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controls at both 1.6 and 3.2 R/hr, so we were unable to quantitate any effect 
of splenectomy on hematopoietic regenerative capacity in usual hematologic 
terms. 
We had not previously studied lymphopoietic repair during low-dose-rate 
exposures, although it was well known that extensive lymphoid atrophy of 
all organs develops. We chose as a first approach to the problem ~f 
lymphoreticuiar repair to study the survival time patterns of ~everal mouse 
strains under continuous irradiation at rates used clinically in total body 
irradiation therapy. We obtained lethality curves in relation to accumulated 
"doses" (R) in five strains of mice: C3BFl , C57BL/6 Cum, C57BL/Cum, BALB/c, 
and AKR. Our studies on radiation suppression of erythropoiesis have been 
done principally on C57BL/6 Cum, because it is a long-lived radioresistant 
strain and upon C57BL/Cum, its radiosensitive parent strain. Our inclusion 
also of AKR strain mice was suggested by the recent study of Perkins et al. 
(25) who showed that the AKR mouse had an unusually low level of immuno~ 
hematopoietic competence. This strain, well known for its 90% incidence of 
a virus-associated thymic lymphoma, has an exceedingly short (approxL~~tely 
275 day) mean life span. It has a low resistance to promptly given single 
doses of radiation (LD50/ 30 = ~600 R).For unknown reasons BALB/c is more 
radiosensitive even though much longer lived. Perkins et al. showed that ' 
the immunoincompetence of the AKR mouse is expressed in part by an inability 
to sustain thE: growth of exogenous colony-forming units .in its spleen, a 
capability that we believe is required for compensatory erythropoiesis 
during continuous low-dose-rate irradiation. The AKR mouse seemed therefore 
to offer a unique opportunity in our system to study whether human therapy 
levels of irradiation would (1) alter the high lymphoma incidence of this 
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strain, (2) affect the leukemic process once it was initiated, and (3) 
decrease mean survival time by some process other than aplastic anemia. If 
the unusual immunoincompetence of this strain was worsened by irradiation, 
one might expect an earlier onset of thymic lymphoma in some animals along 
with a decrease in its incidence because of radiation-induced thymic 
destruction in others. Possibly also the reported immunoincompetence of 
this strain might be expressed as poor splenic production of endogenous 
erythroblasts with early death from aplastic anemia. 
Fractionated doses of radiation (150 R at three weekly exposures) can 
shorten the latent period and increase the incidence of a similar leukemia 
in C57BL/6 mice and that 24 R/day (our lowest human therapeutic dose per 
day is approximately 10 R ill LETBI) given to this mouse strain will increase 
the leukemia incidence from about 12% to about 60%. In AKR mice, however, 
previous studies of leukemogenesis have included leukemia induction time 
without alteration of the high incidence. 
Two ages of AKR mice were available to us: 4D-day-old females and 
"retired-breeder" females of uncertain age (about 120 days old). The two 
age groups were div:t,Jed into three subgroups: unirradiated controls, 
irradiated mice at 1.6 R/hr or 37 R/day, and irradiated mice at 3.2 R/hr 
or 74 R/day. We observed the mice closely to obtain prompt necropsies for· 
histologic study of the thymus, lungs, liver, spleen, and sternal bone 
marrow; yet about half were too autolyzed for histologic study but contributed 
data for determining the length of survival. Figure 84 is a graph of the 
percentage mortality of the AKR, C57BL/Cum, BALB/c, C57BL/6 C~, and C3~Fl 
strains under continuous irradiation at 1. 6 R/hr, asa function of 
accumulated dose. The steeply rising curves of the other four strains 
stand in marked contrast with the slowly rising curve of the two age groups 
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of AKR. At this low-dose-rate, surprisingly, there was no difference in 
apparent sensitivity between the 40-day-old and the "retired-breeder" AKR. 
This relatively slow rising curve for number of deaths per dosage-increment 
indicates a wide varian~~ in radiosensitivity among different animals and 
suggests that more than one lethal mechanism may be operative. The first 
differentials of the other sigmoid curves are single-peaked distributions 
indicative of only one lethal process. The apparently sharp lower threshold
s 
and the steepness of both seem to be related to homogeneity of the mice, 
here expressed as radiosensitivity. While the data are too few for 
mathematical differentiation of the AKR mortality curve, this irregularly 
rising line is roughly the sum of two separate subgroups of deaths that occu
r 
with peak incidences at quite different accumulated doses. 
Gross anatomical and histologic studies in all groups were indicative 
of deaths occurring after more than 4000 R due to splenic and marrow atrophy
. 
The data from the histologic study of irradiated AKR mice at death 
were obtained for the young and adult groups exposed continuously at 1.6 
and 3.2 R/hr. The data from 48 necropsies and histologic studies are 
summarized in Table 17 as percent incidence of lymphoma, thymic atrophy, 
lung adenosis and adenomas, complete splenic atrophy, and presence of spleni
c 
erythroblastic colonies. The approximate mean accumulated doses for the . 
four groups are shown along with the average survival time. Unirradiated 
AKR mice have a mean life-span of about 275 days and their natural incidence 
of lymphoma is about 90% for females. Here the highest incidence of 
lymphoma was 40% and occurred in the adult mice at the lower exposure 
rate. We completely suppressed lymphoma in the 4o-day-old mice exposed 
to 3.2 R/hr but this may simply mean that they did not live long enough to 
PRECEDING PAGE BLANK NOT FILMED 
j 
! 
! 
i 
1 
I 
'~; j 
1 1 ] ii, 
, ~f.' 
if 1 " ~ I 
j 
1 ,~ ~ 
:< 
1 
'" I 
c' 
• ' H'",""*,." r ~ -~~~...,.,...,.~-. , 
.
. -. ~., .. -. 
- .. ----.~ 
- -
.. 
-
.. .... 
-
__ IIIIIiIiIiiif 
...., 
-
~ ..... ~ ~ /4iiIIiiIijol ~ ~ i~ 
TABLE 17 
Incidence of Histopathologic Endpoints at Death 
of AKR Mice from Continuous Irradiation at 1.6 and 3.2 R/hr 
~ AtroEh~ ;+;a 
t::J Age MAD* Average survival Splenic Lung 0 R/hr (days) (R) time (days) Lymphoma Thymus Spleen erythroblastosis adenoma ~ 
~ 
Q Percent 
"'d 1.6 40 3100 84 (124)t 17 82 53 39 44 ~ 
t?:1 1.6 120 3700 100 ('V220) 40 40 20 40 30 
~ 3.2 40 2600 35 (75) 0 100 77 23 55 ~ 3.2 120 2700 36 ('V150) 27 72 72 10 18 
~ *MAD = accumulated dose at average survival time. 
fi 
tNumbers in parentheses represent age at average survival time. 
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show it. The AKR mice of both age groups given 3.2 R/hr were the most radio-
sensitive that we have observed; mean accumulated dose at death was about 
2600 R and complete thymic atrophy occurred within their 35-day survival 
period. Seventeen percent of these young mice irradiated at 1.6 R/hr 
developed lymphoma between 50 to 60 days of continuous irradiation, when they 
were 90 to 100 days old. The 27% of adult mice, on the other hand, that 
developed leukemia did so between accumulated doses of 1500 and 2500 R 
at 3.2 R/hr (20 to 34 days). However, accumulated doses between 2900 and 
5000 R at 1.6 R/hr (78 to 135 days) were associated with the induction of 
lymphoma in 40%. Some of these late lymphomas could have been spontaneous 
rather than augmented by irradiation because these animals after 135 days 
of exposure were approaching their normal life span of 275 days. It is 
noteworthy that the thymus of only one mouse was nonleukemic and nonatrophic, 
in an adult female dying for unknown reasons after only 765 R with an 
apparently effective erythropoietic response of marrow and spleen. All 
other thymuses were either enlarged and lymphomatous or extremely small due 
to loss of lymphoid and histiocytic cells, sometimes with only the primitive 
epithelium remaining. This atrophy of the thymus was unrelated to presence 
or absence of a splenic erythropoietic response. Splenic erythropoiesis 
was quantitatively poor in all animals compared to similarly irradiated 
C57BL/6 Cum mice. When thymic lymphoma was present, its metastatic spread 
masked any normal splenic response to radiation-induced marrow damage. 
The reduced lymphoma incidence in the adult mice was not accompanied at 
the lower exposure rate by a d·~~crease in induction time but was when they 
were exposed at the higher rate. The majority of mice at both ages and 
rates of exposure, that were, free of lymphoma, appeared to die from complete 
marrow and splenic atrophy. For the first time in our experience in these 
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low dose rate studi.es, we noted that some of the early nonlymphomatous deaths 
'I i 
were associ&ted with bacteremias. 
i 
The occurrence of pulmonary adenomas (Table 17) was completely unex-
1 pected and, as far as we know from a cursory search of the literature, has 
not been reported in AK.R mice even though this strain was de-rived urigina11y i 
from strain A mice having an extremely high incidence of these tumors. An 
I 
~ atrophic thymus (or the absence of lymphoma?) seemed to be a necessary 
condition for this process to occur. Previously, others (26) have shown 1 
in young Swiss mice that after thymectomy there is an increase in both 
the spontaneous incidence of lung adenoma and the ease with which it is 
induced by carcinogens. This effect has been attributed to the impairment 
of immunocompetence that follows thymectomy and the observation may explain 
why the incidence of pulmonary adenomas was less in our adult AKR mice than 
in the young, since it is well known that thymic ablation has much less 
effect upon immune mechanisms in adult mice than in young ones. These 
lung tumors were minute and obviously just beginning to develop in many 
instances. Many would have been overlooked if only gross examinations had 
been made. In no instance were the tumors large enough to cause morbidity 
or death, although an occasional one filled a single lobe co~p1ete1y. 
These observations at two dose rates of continuous radiatIon expo--
sure suggest that: (1) AKR thymic lymphoma, if it develops duriug the 
treatment, is not suppressed by the irradiation, (2) if radiation-induced 
thymic atrophy develops quickly enough, leukemogenesis is prevented, and 
(3) radi.3_lion-induced thymic atrophy is s.imilar to surgical thymectomy in 
releasing pulmonary-twnor formation from some normally constraining 
mechanism. The quantitative and qualitative differences in the responses 
of the two age. groups probably reflect the well-known age differences in 
, 
immunocompetence. '-~ 
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CHAPTER VI 
A. List of Reports and Publications Generated by Program 
1. Lushbaugh,C. C., Hofstra, R., Roth, R. E., and Andrews, G. A.: 
ED50 for Gastrointestinal ReSponses in Man. Radiation Res. 25: 
114, May 1965 (abstract). 
2. Andrews, G. A., Auxier, J. A., and Lushbaugh, C. C.: The Importance 
of Dosimetry to the Medical Management of Persons Accidentally Exposed 
to High Levels of Radiation. In Personnel Dosimetry for Radiation 
Accidents, IAEA, Vienna, August 1965. 
3.. Lushbaugh, C. C., Comas, F., Saenger, E. L., Jacobs, M.: Radio-
sensitivity of Man by Extrapolation fr~m Studies of Total-body 
Irradiation of Patients (invited lecture, February 15, 1966). Radiat. 
Res. 27: 487-488, March 1966. 
4. Andrews, G. A.: Treatment of Radiation Injury. J. Mississippi Med. 
Assoc. 7: 534-538, 1966. 
5. Andrews, G. A., Lushbaugh, C. C., and Knise1ey, R. M.: Proceedings 
of a Panel on Effects of Total-Body Irradiation in the Human Being. 
IAEA, Vienna, May 17, 1966. 
6. Dalton, C. P. and Cloutier, R. J.: An Arrangement of Radioactive 
Sources for a Low-Exposure-Rate Total-Body Irradiation Facility. 
Physics in Medicine and Biology 12: 116, 1967. 
7. Dalton, C. P. and Cloutier, R. J.: Source Arrangement for a Low-Exposure-
Rate Total-Body Irradiation Facility for Man. USAEC Report ORINS-52, 
May 1, 1967, 205 pages. 
8. fanger, H. and Lushbaugh, C. C.: Radiation Death from Cardiovascular 
Schock Following a Criticality Accident: Report of a Second Death from 
a Newly Defined Human Radiation Death Syndrome. Arch. Path. 83: 446-460, 
May 1967. 
9. Lushbaugh, C. C.: Editorial, Radiation and Shock. JAMA 200: 181, 1967. 
10. Langham, W., editor: Space Radiation Study Panel: Radiobiologic 
Factors in Manned Space Flight. Jl,ly 1, 1967. 
(1) Lushbaugh, C.C., Andrews, G. A., and Langham, W.: Prodromal 
Response, p. 76-90. 
(2) Conrad, R., Andrews, G. A., and Langham, W.: He.mato1ogic Effects, 
p. 90-105. 
(3) Langham, W. and Lushbaugh, C. C.: Early Lethality, p. 105-124. 
(4) Thompson, J. and Andrews, G. A.: Chemical and Biological 
Protection, p. 218-230. 
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11. Lushbaugh, C. C., Comas, F., and Hofstra, R.: Clinical Studies of 
Radiation Effects in Man: A Preliminary Report of a Retrospective 
Search for Dose-Response Relationships in the Prodromal Syndrome. 
Radiat. Res. Supp1. 7: 398-412, November 1967. 
12. Andrews, G. A.: Radiation Accidents and Their Management. Radiat. 
Res. Supp1. 7: 390-397, November 1967. 
13. Lushbaugh, C.C.: Some Biological Endpoints of Dosimetric Value 
Derived from Clinical Data. In First International Symposium on 
Biological Interpretation of Dose from Accelerator Produced Radiation, 
March 13-16, 1967, E. J. Vallario, editor, DTIE CONF-670305. 
14. Lushbaugh, C. C.: Recent progress in Assessment of Human Resistance 
to Total-Body Irradiation. In Proceedings of a Symposium Postattack 
Recovery from Nuclear War- Held at Fort Monroe, Virginia, November 
6-9, 1967. 
15. Lushbaugh, C. C., Comas, F., Edwards, C. L., and Andrews, G. A.: 
C1ini.ca1 Evidence of Dose-Rate Effects in Tota.1-Body Irradiation in 
Man. In The Proceedings of a Symposium on Dose Rate in Mammalian 
Radiation Biology, held April 29-May 1, 1968, Oak Ridge, Tennessee, 
CONF-680410. 
16. Beck, W. L., Callis, E. L., and Cloutier, R. J.: Phantom Depth-Dose 
Measurements with Extruded LiF in a Low-Exposure-Rate Total-Body 
Irradiator. In Proceedings of the Second International Conference on 
Luminescence Dosimetry, September 23-26, 1968, USAEC Report CONF-680920, 
1968, pp. 976-989. 
17. Comas, F.V.: The Time Factor in Fractionated Irradiation of Mouse 
Skin. In The Proceedings of a Symposium on Dose Rate in Mammalian 
Radiation Biology, held April 29-May 1, 1968, Oak Ridge, Tennessee, 
USAEC Report, CONF 680410, pp. 18.1-18.12. 
18. Comas, F. V., Andrews, G. A., and Nelson, B.: Spleen Irradiation in 
Secondary Hypersplenism. Amer. J. Roentgeno1. 104: 608-673, 1968. 
19. Lushbaugh, C. C., Comas, F. V., and Andrews, G. A.: 
Dose-Response Relations Derived from Clinical Data. 
15(2): 165-166, 1968 (abstract). 
Radiation 
Health Physics 
20. Bonn., V.P., Osborne, J. W., Lesher, S., Lushbaugh, C. C., and Hornsey, S.: 
Panel Discussion on Mechanism of Intestinal Radiation Death. In 
Gastrointestinal Radiation Injury, Report of a symposium held at 
Richland, Washington, September 25-28, 1966. Excerpta Medica, March 
1968, pp. 352-373. 
21. Ur, A. and Lushbaugh, C. C.: Some Effects of Electrical Fields on 
Red Blood Cells and Electronic Red Blood Cell Sizing. Brit. J. 
Haemat. 15: 527-538, 1968. 
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22. Andrews, G. A.: Th~ TherRpeutic Use of Bone-Marrow Transplantation. 
In Proceedings of the International Conference on Leukemia-Lymphoma, 
Ann Arbor, 1967, edited by Chris J. D. Zarofonetic, Philadelphia, Lea 
and Febiger, 1968, pp. 423-432. 
23. Lushbaugh, C. C.: Theoretical and Practical Aspects of Models 
Explaining "Gastrointestinal Death" and Other Lethal Radiation Syndromes. 
In Report of US/Japanese Symposi!JIll on Comparative Cellular and Species 
Radiosensitivity held in Kyoto, Japan, May 20-23, 1968. Edited by 
V. P. Bond, M. D. and Tsutomu Sugahara, M. D., Igaku ,Shoin Ltd., 
Tokyo, Japan, March 1969, pp. 288-297. 
24. Lushbaugh, C. C., Frome, E. L., Davis, H. T., and Bibler, D. S.: 
The Power Spectrum of the Impedance Pneumograph: A Data Reduction 
System Producing an Analytical Parameter of Potential Clinical Use-
fulness. Aerospace Med. 40: 425-429,,1969. 
25. Upton, A. C. and Lushbaugh, C. C.: The Pathological Anatomy of 
Total-Body Irradiation. In Atomic Medicine, 5th Edition. Charles F. 
Behrens and E. Richard King, editors, Williams and Wilkins Co., 1969. 
26. Andrews, G. A., Kniseley, R. M., Vodopick, Helen, Bergner, P.-E. E., 
and Lushbaugh, C. C.: Hematologic Responses to Total-Body Irradiation, 
presented at Gese11schaft Fur nuclearmedizin, Wiesbaden, Germany, 
September 28, 1968. 
27. Lushbaugh, C. C.: Reflections on Some Recent Progress in Human Radio-
biology. In Advances in Radiation Biology, Vol. 3, edited by 
28. 
L. G. Augenstein, R. Mason, and M. Zelle, pp. 277-314, 1969. 
Lushbaugh, C. C. and Auxier, J.: 
Levels at Hiroshima and Nagasaki. 
Reestimation of human LDSO Radiation 
Radiat. Res. 39, 526, 1969 (abstract). 
29. Morris, A. C., Jr., Barclay, T. R., and Lushbaugh, C. C.: Monitoring 
Physiologic Response During Total-Body Irradiation Therapy. Second 
International Conference on Medical Physics, August 11-15, 1969, 
Boston, Mass. Phys. Med. Bio1. 15: 192, 1970 (abstract). 
30. Beck, W. L., Cloutier, R. J., Comas, F. V., and Lushbaugh, C. C.: 
Human Depth-Dose Estimates in Multidirectional Gamma-Ray Fields. 
Ibid. p. 144. 
31. Upton, A. C., Cosgrove, G. E., and Lushbaugh, C. C.: The Induction of 
Glandular Carcinoma of the Stomach in Mice by Whole-Body Irradiation. 
US-Japan Conference on Experimental C~rcinoma of the Glandular Stomach, 
Ganrl'Monograph, 1970. 
32. Corrill, L. S., Stokes, T. R., and Lushbaugh, C. C.: Accumulation 
Rates of GI and Marrow Damage in Pair-Irradiated Mice During Continuous 
and Fractionated Daily Exposures. Radiat. Res. 43, 271, 1970 (abstract). 
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33. Lushbaugh, C. C., Corri11, L. S., Stokes, T. R., Humason, G., and 
Lushbaugh, D.: Mouse Splenic Stem-Cell Response to Protracted 
Radiation Exposure. Radiat. Res. 43: 212-213, 1970 (abstract). 
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34. Cloutier, R. J. and Watson, E. E.: Radiation Dose from Radioisotopes 
in the Blood. In Medical ,Radionuc1ides: Radiation Dose and Effects. 
R. J. Cloutier, C. L. Edwards, and W. S. Snyder, editors. AEC 
Symposium Serie.3 No. 20, CONF-691212, 1970, pp. 325-346. 
35. Ba1ish, E., Pearson, T. A., and Chaskes, S.: Irradiated Humans: 
Microbial Flora, Immunoglobulins, Complement (C'3), Transferrin, 
Agglutinins, and Bacteriocidins. Radiat. Res. 43: 729~ 756, 1970. 
36. Comas, F. V., Edwards, C. L., and Vodopick, H.: Splenic Irradiation 
in Chronic Granulocytic Leukemia: Changes in Leukocyte Values. 
Radiat. Res. 42: 413-423, 1970. 
37. Andrews, G. A., Ba1ish, E., Edwards, C. L., Knise1ey, R. M., and 
Lushbaugh, C. C.: Possibilities for Improved Treatment of Persons 
Exposed in Radiation Accidents. In Symposium on Handling of Radiation 
Accidents, IAEA-SM-119/56, 1970. --
38. Ricks, Robert C., Lushbaugh, C. C., and Frome, E.: Changes in the 
Power Spectrum of the Impedance Pneumograph Trace During Radiation-
Induced Gastrointestinal Distress in Man. Fed. Proc. 29(2): 451, 
1970 (abstract). 
39. Ricks, R. C. and Edwards, C. L.: The Effects of Dose Rate and Exposure 
Fractionation on Plasma Iron Kinetics in Rats and Man. Radiat. Red. 
43: 240, 1970 (abstract). 
40. Beck, W. L., Stokes, T. R., Cloutier, R. J., and Lushbaugh, C. C.: 
Dosimetry for Clinical Total-Body Irradiation. Am. Assoc. Phys. Med., 
Quart. Bull. 4: 2, 1970 (abstract). 
41. Andrews, G. A., Comas, F. V., Edwards, C. L., Knise1ey, R. M., 
Lushbaugh, C. C., and Vodopick, H.: Hematologic and Therapeutic Effects 
of Total-Body Irradiation (50R-100R) in Patients with Malignant 
Lymphoma, Chronic Lymphocytic and Granulocytic Leukemias, and 
Polycythemia. USAEC Report ORAU-112, 1970. 
42. Andrews, G. A., Knise1ey, R. M., Vodopick, H., Bergner, P.-E., and 
Lushbaugh, C. C.: Hematologic Responses to Total-Body Irradiation. 
In Radioisotope in Pharmakokinetik und k1inischer Biochemie, 
F\ K. Schattauer Verlag, Stuttgart-New York, pp. 517-527, 1970. 
43. McDow, A. E., Jr. and Ricks, R. C.: Uses of a Time-Shared Computer in 
Quantitative Nuclear Medicine. In Proceedings of Symposium on Sharing 
of Computer Programs and Technology in Nuclear Medicine, Oak Ridge, 
1971. USAEC Report CONF-710425, pp. 155-167. 
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44. Lushbaugh, C. C., Stokes, T. R., and Corrill, L. S.: Dose-Rate 
Dependence of Mouse Endogenous Splenic Colony Formation and Prolifera-
tion During Continuous and Fractionated Daily Irradiation at Low 
Exposure Rates. Radiat. Red. 47: 344, 1971 (abstract). 
45. Ricks, R. C., Lushbaugh, C. C., McDow, E., and Frome, E.: Pulmonary-
Impedance Power Spectral Analysis: A Facile Means of Detecting 
Radiation-Induced Gastrointestinal Distress and Performance Decrements 
in Man. Proc. Nat. Symposium on Natural and Manmade Radiation in 
Space. NASA TM X-2.440, pp. 238-248, January 1972. 
46. Yuhas, J. M., Stokes, T. R., and Lushbaugh, C. C.: Multifactorial 
Analysis of Human Blood Cell Responses to Clinical Total-Body Irradia-
tion. Ibid., pp. 233-237. 
47. Beck, W. L., Stokes, T. R., and Lushbaugh, C. C.: Dosimetry for 
Radiobiological Studies of the Human Hematopoietic System. Ibid., 
pp. 974-980. 
48. Lushbaugh, C. C.: Predicted Levels of Human Radiation Tolerance 
Extrapolated from Clinical Studies of Radiation Effects. Ibid., 
pp. 398-415. 
49. 
50. 
51. 
52. 
53. 
54. 
55. 
Lushbaugh, C. C. and Ricks, R. C.: Some Cytokinetic and Histopathologic 
Considerations of Irradiated Male and Female Gonadal Tissues. Proc. 
Symp. Mt. Sinai Cancer Clinic, 1970. University Park Press, 1972. 
Ricks, R.C., Lushbaugh, C. C., and McDow, A. E., Jr.: Correlationof 
Heart Rate and C02 Production with Pulmonary Impedance During Exercise 
Stress in Man. Fed. Proc. 31: 311, 1972 (abstract 544). 
Ricks, R. C., Lushbaugh, C. C., and McDow, A. E., Jr. Pulmonary 
Impedance Power Spectr.al Analysis: Its Correlation with Heart Rate 
and Expired C02 During Exercise Stress in Man. J. Assoc. Med. lnstrum. 
6: 186, 1972. 
Stokes, T. R., Lushbaugh, D., Humason, G., and Lushbaugh, C. C. 59Fe 
Studies on the Erythroblastic Response of Normal and Splenectomized 
Mice to Low Level Continuous Radiation. Radiat. Res. 51: 472-473, 
1972 (abstract). 
Beck, W. L., Cloutier, R. J., and Watson, E. E. Personnel Monitoring 
with Film and Thermoluminescent Dosimeters for High Exposures. Health 
Phys. 25: 421-425, 1973. 
Cloutier, R. J., Watson, E. E., Rohrer, R. H., and Smith, E. M.: 
Calculating the Radiation Dose to an Organ. J. Nucl. Med. 14: 
53-55, 1973. 
Lushbaugh, C. c.: Human Radiation Tolerance. Chapter 10. In Space 
Radiation Biology and Related Topics. C. A. Tobias and P. Todd, eds., 
Academic Press, New York, 1973, pp. 475-522. 
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56. Ltishbaugh, C. c.: Contribution to: HZE-Partic1e Effects in Manned 
Spaceflight. D. Grahn, ed. Radiobiological Advisory Panel, 
Committee on Space Biology, Space Science Board, National Research 
Council, Washington, National Academy of Sciences, 1973. 
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57. Lushbaugh, C. C.: Book Review: Manual on Radiation Haemato1ogy. A 
joint undertaking by IAEA and WHO, Technical Report Series No. 123, 
IAEA, Vienna, 1971. Health Phys. 24: 456, 1973. 
58. Frome, E. L., Fredrickson, E. L., and Ricks, R. C.: Power Spectrum of 
the Respiratory SYBtem via the Pulmonary Impedance Pneumograph. In 
Proceedings of the 10th Biomathematics and Computer Science in the 
Life Sciences, Houston, Texas, 1973. 
59. Beck, W. L., Stokes, T. R., and Lushbaugh, C. C.: Dosimetry for 
Total-Body Irradiation Therapy. In Health Physics in the Healing Arts, 
Seventh Midyear TQpica1 Symposium, Health Physics Society, San Juan, 
Puerto Rico, December 1972. DHEW Publication (FDA) 73-8029, p. 423, 
1973 • 
60. Cloutier, R. J. and Watson, E. E.: Radiation Doses from Nuclear 
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B. Medical Division Documented Computer Programs for NASA Study 
These programs were written by Earl McDow, Edward Frome, Paulette 
Aarom, and Mona Smith and are available on request from the Computer 
Facility, Medical Division. 
1. Greater Than Eight Days Nursing Notes Program - Summarizes 
the nurses notes for response to nausea, anorexia, and/or 
vomiting. A modification summarizes for less than eight day 
exposures. 
2. Greater Than Eight Days Hematology Program - Lists data for 
WBe, platelets, and RBC for the period of exposure plus 45 
days. A modification summarizes for less than eight day 
exposures. 
3. Total Audit Program - Gives a general audit ·of the data in the 
Retrospective Studies Data Bank with respect to the number of 
patients, cases of exposure, males, females, etc. Modifications 
make audits of the groups of exposure such as greater than eight 
day exposure, less than eight day exposure, Heublein exposure, 
and single exposure. 
4. Hematology Plot Program - Plots the WBC and platelet count 
values for a patient's period of exposure in linear and logrithmic 
form. Multiple plots are made for exposures of greater than 42 
days. 
5. Probit Analysis Program - Calculates the value for a and b in the 
equation y = a + bx, the probits, and the confidence limits for 
given input data. A plot is then made of the line and the 
confidence limits. 
6. Identification Summary Program - Summarizes the identification 
data for the greater than and less than eight day exposure 
patients. 
7. Diagnosis Addition Program - Adds the diagnosis codes to the 
already existing summary tapes. 
8. Tape Correction Program - Hakes any corrections to existing 
data bank tapes in maintenance of the data bank. 
9. Nursing Notes Progr;:un for Portal Irradiation - Summarizes responses 
of anorexia, nausea, and vomiting for portal irradiation exposures. 
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10. Response Summary Program for Portal Irradiation - Writes 
to magnetic tape summary of positive nurses' notes responses 
and gives listing of all patient summaries. 
11. Portal Irradiation - Weibu11 Function Program - Studies 
radiation sickness using the Weibu11 model. Calculates 
responses and nonresponses for each dose from 1 to 40 and 
calculates cumulative response'. Does linear regression 
analysis using the Weibu11 mod~l. 
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12. Portal Irradiation Frequency Program - Calculates the frequency 
of positive response to anorexia, nausea, and vomiting for each 
patient and groups the frequencies, calculates the pretreatment 
response frequencies, and does a grouping for all patients 
according to those frequencies. 
13. POUSP - Plots the raw power spectra of the pulmonary impedance 
data in three dimension for publication. 
14. VARPT - Plots the average variance of the pulmonary impedance 
waveform as a function of frequency in final form for publication. 
15. ECOSV - Maintains the integrity of the digital output groups 
when used by multiple users. 
16. GT8MO, GT8M1, GT8M2, GT8M3, GTSM4 - Plots the greater than eight 
day multiple exposure NASA data. 
17. LMP1, LMP2, LMP3, LMP4, LMP5 - Formats the hematology data on 
the LETBI and METBI patients and plots various blood values as 
a function of time. 
lS. MDISK - Provides the FORTRAN user with a fast and easy method 
of assessing complete disk sectors.within a disk data file. MDISK 
uses DISKN and provides both READ and WRITE functions on the 
file protected data files. 
19. LETBI (PULM, RR, BTIME, LETB2) - A combination of INSKEL sub-
routines which handle the real time data acquisition from the 
LETBI console. 
20. GRIST - Plots a histogram of the RR interval frequency table. 
21. MTCLS and MTSET - Used to maintain on disk a current disk file 
of all LETBt tape numbers. 
22. MPCOR - Plots on the IBM 1627 the total variance of the pulmonary 
impedance as a function of mean heart rate for each one minute 
interval and each average over 4 minutes. 
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23. PSPEC - Plots the percent frequency of the RR interval frequency 
table as a function of heart rate. 
24. LETAN - Maintains the LETBI tape files and calculates the 
variables required by the investigator. This program is changed 
by adding additional subroutines as the desires of the researcher 
change. 
25. MRDDF - Reads a requested record from the LETBI disk file LETBD 
and formats the data into array TBUF which is stored in COMMON 
for use by all other LETBI programs and written on tape for 
permanent storage of LETBI data. 
26. SDIFF - Calculates differences between elements in an array 
vector. Used in the calculation of the power spectral estimates 
of the pulmonary impedance. 
27. FAFT2 - Used by FTREA in the calculation of the Fourier trans-
formation of an array X. 
28. QRXI - Provides access to the digital output points used to 
control the function lights on the LETBI console. 
29. FTREA - Calculates the Fourier transform of a real valued series 
using the FFT alogrithm. 
30. MVAR - Calculates the variance (low, medium, and high frequency), 
total average variance, and mean from the values in array PS. 
31. IDXPN - Takes the digital identification data from the LETBI 
control box packed in five words and formats the data into seven 
words for inclusion in TBUF. 
32. RHIS - Will expand two eight bit binary numbers packed in one 
word to two l6-bit words, i.e., /XXYY is expanded to /OOXX and 
/oayy. 
33. MLIST - Prints the results of the analysis of the pulmonary 
impedance and RR interval data. 
34. MEANR - Calculates the number of observed events, the mean, and 
the standard deviation,of the mean from a given frequency table. 
MEANR is used by the LETBI analysis program to calculate the 
number of heart beats, the mean RR interval, and 'the standard 
deviation of the mean interval. 
35. ID99 - Removes all records with greater than 99 days exposure 
record from hematology tapes. 
36. SERCR - Reads and selects from concatenated data sets all records 
of a chosen format; records data collectively on magnetic tape. 
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37. PRBIN - Selects required data according to a given method for 
a probit analysis from collected data. 
38. MANLY - MANLY can perform two functions: If (1) the operator 
requests analysis of the LETBI data and (2) analysis has not 
been done on a set of data, MANLY does the analysis using the 
required subroutines and then writes the tape record (TBUF). 
If analysis has been done or is not desired, the subroutine 
writes the record with TBUF unchanged. When four data sets 
(1-4) have been analyzed, MANLY calculates the average RR and 
pulmonary values for four minutes and sets NSET=5 and writes 
TBUF (average values) on tape. 
39. MPSA - Calculates the power spectral estimates of the pulmonary 
impedance data obtained from the LETBI data acquisition program. 
40. MLOGL - Prints on the 1053 a log of the LETBI data processed. 
r· 
i 1 ! i 
I f 
It 
I d 
IJ 
:) 
" , 
~. t 
J 
) 
I 
I 
I 
I 
CHAPTER VII 
APPENDIX 
A. List of Cooperating Institutions in Retrospective Studies 
Hospitals Participating in Study 
Albert Einstein Medical Center 
Baylor University: Jefferson Davis Hospital 
V.A. Hospital at Houston 
Texas Medical Center 
Burge Protestant Hospital 
Cincinnati General Hospital 
City of Hope Medical Center 
Charity Hospital 
Colorado General Hospital 
Ellis Fischel State Cancer Center 
Franklin Hospital 
Jefferson Medical College 
Long Beach Connnunity Hospital 
Los Alamos Hospital 
Mary Imogene Bassett Hospital 
Massachusetts General (MeG) (LR) 
M.D. Anderson Hospital 
Medical College of Virginia 
New York Memorial Hospital (CH) (N) 
Oak Ridge Associated Universities Medical Division 
Penrose Cancer Clinic 
Peter Bent Brigham Hospital 
Portland: Emanuel Hospital 
Dr. Hyman's Clinic 
Portland Medical Center 
Princess Margaret Hospital 
Providence Hospital 
Rhode Island Accident 
Spokane: Deaconess Hospital 
Rockwood Clinic 
Sacred Heart Hospital 
Milo Harris Clinic 
Swedish Hospital 
Temple University 
Thomas M. Fitzgerald Mercy 
U.S. Naval Hospital 
U. of California Medical School, S.F. 
U. of Michigan 
_ U. of Washington 
V.A. Hospital at Denver 
V.A. Hospital at Long Beach 
V.A. Hospital at New Orleans 
PRIDEDING PAGE BLANK NOT FIlMED 
Vancouver: British Columbia Cancer Institute 
Royal Columbian Hospital 
Vancouver General Hospital 
White Memorial Medical Center 
r 
I. t ' 
, 
I 
I 
I 
I 
J 
I 
J 
I 
I 
I 
I 
I 
.\ "., - ,,' :-- ;;:., 
r- --~--- -- ------
214 
B. List of Contributing Medical Division Staff Members 
Medical 
E. G. Ammerman 
G. A. Andrews 
Edward Bird 
F.V. Comas 
C. L. Edwards 
Dieter Emrich 
Kong-oo Goh 
F. A. Goswitz 
K. F. Hubner 
R. M. Kniseley 
C. C. Lushbaugh 
B. Nelson 
Etna Palmer 
Ryosaku Tanida 
M. Van Woert 
H. A. Vodopick 
Lucy Amburn 
Margie Bagley 
Carol Bingham 
Margaret Blackburn 
Ervin Bobo 
Helen Brinker 
Ruth Capshaw 
James Cozart 
Mary Nell Craig 
John Dean 
Thelma Eden 
Eria Hartman 
June Geldmeier 
Mable Helton 
Rita Holt 
R'afus Jackson 
Earl Jacobs 
Sandra Landry 
Martha Laxton 
Bedford Mayott 
Barbara Nance 
Benua Pack 
Garfield Porter 
Naomi Presnell 
Mary Rogers 
Bernice Salley 
Lillie Simmons 
Marilyn Smith 
Elaine Stoetzel 
Mary Sutliff 
Eugene Weaver 
Martha Williams 
Lillie Woods 
Paramedical 
E. A. Anderson 
Normal Asbury 
Mildred Bailey 
Frances Banner 
T. R. Barclay 
W. L. Beck 
Per-Erik Bergner 
Sarah Cecil 
C~rol Chabot 
Kay Clayton 
Martha Clevenger 
R. J. Cloutier 
Shirley Colyer 
Lydia Corrill 
J. T. Crockett 
Evelyn Cunningham 
Glenda Fritts 
Dorothy Gaither 
W. D. Gibbs 
J. H. Harmon 
Joyce Hewins 
Wanda Hodge 
Harold Hodges 
Elizabeth Holloway 
Julia Hopper 
Mildred Hyp 
Gretchen Humason 
Jane Kimbro 
Barbara LeClerc 
Kathryn Lore 
Willa Fae Loveday 
Dorothy Lushbaugh 
Kathryn McCulloch 
Maryrose McGown 
Jean McIntyre 
A. C. Morris 
Francine Pennington 
Evalyn Repplinger 
Robert Ricks 
Emily Roemer 
Elizabeth Rupp 
Billie Ryan 
Evelyn Sipe 
Vivian Smith 
T. R. Stokes 
Katherine'Stubbs 
Mary Thomas 
Mary Watkins 
Allen Webb 
Sondra Wilson 
Computer 
Paulette Aaron 
Thomas Akin 
Robert Beaver 
Linda Brown 
Ed Frome 
Arthur Glaster 
Martha Hansard 
Janice Ishee 
Earl McDow 
Daniel McFaddin 
Richard Queener 
Mona Smith 
Jinunie Sanders 
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CHAPTER VIII 
FIGURE LEGENDS 
The cumulative onset of anorexia for all patients, plotted 
on probability-log scales. The time scale represents treat-
ment days, not number of fractions. In the probability scale 
is represented the percentage of patients who have had anorexia up 
to the designated day. 
The cumulative onset of anorexia for patients who were anoretic before 
irradiation (open circles) and for those who were not previously 
anoretic (closed circles). See legend on Fig. 1 for further details. 
The cumulative onset: of nausea for all patients. See legend on 
Fig. 1 for details. 
The cumulative onset of nausea for patients who were nauseated before 
irradiation (open circles) and for those without previous nausea 
(closed circles). Shee legend of Fig. 1 for further details. 
The cumulative onset of vomiting for all patients. See legend on 
Fig. 1 for details. 
The cumulative onset of vomiting for patients who were vomiting 
before irradiation (open circles) and for those ,.:rho previously did 
not vomit (closed circles). See legend on Fig. 1 for further 
details. 
Cumulative probability of onset of anorexia, nausea, and vomiting 
in patients receiving portal irradiation. 
Conditional probability of onset of anorexia, nausea, and vomiting 
in patients receiving portal irradiation. 
Co~ditional probability, in patients receiving portal irradiation, 
to become anorectic or nauseated or to vomit for the second time. 
Fig. 10 Overall probability of three kinds of responses in patients re-
ceiving portal irradiation. 
Fig. 11 Cutaway model of the ORAU total-body irradiation facility. 
"Radiation-safety" measurements with all sources "OFF." 
Fig. 12 Entrance to maze intp ORAU total-body irradiation room. 
Fig~ 13 Effect of beam-shaping filters. 
Fig. 14 Gamma-energy spectrum vs. filter thickness. Increasing shades 
of darkness shows the introduction of a thicker filter series. 
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Fig. 15 Exposure attenuation curve. 
Fig. 16 Cutaway diagram of low-exposure-rate total-body irradiation 
facility (LETBI) showing: 
A. Concrete shielded radiation containment .room. 
B. Centrally positioned radiation exposure living room. 
C. The remote control room for operation of the 60co sources 
(only sources numbers 1, 2, 5, 6, 7, C and F are shown), 
radiation exposure level supervision, nursing, and 
physiologic surveillance of the patient. 
D. The on-line computer and data processin.g room. 
Fig. 17 A simulated closed-circuit TV view of a patient in the radiation 
exposure living room (Fig. 16, room B) showing the two centrally 
placed studio couches and other furni.shings. 
Fig. 18 Drawing of the LETBI console. The source controls and radiation 
monitors are located to the left, the TV monitor and intercom are 
in the center panel, and the physiologic monitoring and recording 
sections are located to the right. 
Fig. 19 Interfacing diagram showing the types of analog and digital 
signals flowing from the LETBI console to the IBM-1800 computer. 
Fig. 20 
Fig. 21 
Fig. 22 
Fig. 23 
Fig. 24 
Fig. 25 
Fig. 26 
Fig. 27 
LETBI console unit in operation. Progress of the patient's 
irradiation is being monitored by the operator and attending nurse. 
Block diagram for the physiologic monitor in the LETBI facility. 
Cutaway side view showing the arrangement of the monitoring and 
computing equipment for a radiation treatment. 
Electrode and amplifier block diagram showing the method of 
obtaining cardiac and respiratory signals from the same set of 
applied electrodes. 
Position of monitoring electrodes on a patient. 
Patient wearing the interconnecting webbed pelt and the umbilical 
cord. The quick-disconnect assembly located about a foot down 
the umbilical cord permits the pati'ent to use lavatory facilities 
in an adjacent room without having to disengage his electrodes. 
Electric field interference schematic. 
Magnetic field interference schematic. 
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Fig. 28 Flux probe diagram for l50 Hz magnetic interference measurements 
in the LETBI facility. 
Fig. 29 Magnetic field measurements being made in the irradiation room 
with the resonant flux probe. 
Fig. 30 Magnetic field intensity measured three feet above the room 
floor. 
Fig. 31 Magnetic field intensity measured along the irradiation room's 
east wall. 
Fig. 32 Magnetic field intensity measured in a vertical cross :section 
directly below a row of ceiling fluorescent lamps. 
Fig. 33 Comparison of the,relative exposure lines predicted theoretically 
(upper half) for the horizontal midplane of the volume to be 
occupied by the treatment room and the corresponding measured 
(lower half) isodose lines. . 
Fig. 34 Variation in the exposure field through the horizontal midplane 
of the completely furnished treatment room. 
Fig. 35 Pulmonary impedance traces from patient experiencing different 
subjective degrees of pain. As pain increases the amplitude of 
the low frequency cycles showed a substantial increase. 
Fig. 36 Diagram of sequential power spectra of pulmonary impedance signals 
produced by a patient experiencing pain in her chest from unknown 
causes. The large increase in amplitude (power) in the low-frequency 
respiratory cycles during severe pain is we.ll demonstrated by the 
power spectrum. Each spectrum was estimated with the use of the 
Blackman-Tukey procedure with n = 960, ~t = 0.0416 minutes, T = 
4 minutes, and m = 120 (m = number of lag ter.ms in autocovariance). 
Fig. 37 Strip chart tracings of pulmonary impedance recorded before, 
during (mid-treatment), and after treatment with 30·R daily at 
1.5 R/hr. 
Fig. 38 Graphic representation of pulmonary impedance power spectra obtained 
before, curing (mid-treatment), and after treatment with 30 R daily 
for 8 days at 1.5 R/hr for a total exposure of 250 R. 
Fig. 39 Strip chart tracings of pulmonary impedance following 150 R in 
five equal daily fractions at an exposure rate of 1.5 R/min. 
Fig. 40 Graphic correlation of severity of nausea with pulmonary impedance 
power spectra before and 15 minutes after 20-minute exposure to 
30 R (1.5 R/min on five consecutive days, tota.l exposure 150 R). 
On the 5th day the patient was administered oral chlorpromazine 
(20 mg) therapy for radiation sickness • 
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Fig. 41 Pulmonary impedance tracings from patient exposed to 150 R (30 R 
daily) at 1.5 R/hr. Figures in parenthesis indicate accumulated 
R at time of pulmonary monitoring. 
Fig. 42 Power spectra of pulmonary impedance waveforms obtained at specific 
intervals before, during, or immediate after exposure to 150 R 
Fig. 43 
Fig. 44 
Fig. 45 
(30 R/day) at 1.5 R/hr. Figures in parenthesis indicate accumulated 
R at time of pulmonary monitoring. 
Power spectra of pulmonary impedance waveforms obtained over a 1 hr 
time period in a normal volunteer following administration of an 
emetic (ipecac). 
Time series graph of average and continuous pulmonary impedance 
power spectral variances obtained over a 60 minute period in a 
normal subject following ingestion of ipecac. 
Effect of nausea and vomiting on pulmonary impedance in a female 
patient exposed to 500 R (40 R/min) total-body gamma irradiation 
prior to bone marrow transplantation. 
HETBIsame as VDRIF (high exposure rate total body irradiator). 
Fig. 46 The effect of nausea and vomiting on pulmonary impedance in a 
radiation accident victim exposed to 260 rem total body gamma 
irradiation at the rate of 350 R/min. 
Fig. 47 Changes in pulmonary impedance (power spectral) variance in a 
normal volunteer monitored electronically before, during, and 
after exercise on a bicycle ergometer. 
Fig. 48 Graphic representation of normal man's response to controlled 
exercise on a bicycle ergometer. The progressive early reduction 
in average pulmonary-impedance variance during exercise is 
indicative of adaptation to the controlled ergometry. No 
significant changes are notable in the response before and after 
exercise. 
Fig. 49 Average changes in pulmonary impedance (power spectral) variance 
during standard exercise periods obtained before:. during, and 
after to.tal body irradiation at 1. 5 R/hr in a patient treated 
with 100 R for chronic leukemia. (Exercise load was 60 watts, 9 
min duration.) In one "each specific performance period the first 
data point represents the preexercise pulmonary impedance, 
followed by the exercise phase and subsequent recovery. 
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Fig. 50 Average pulmonary impedance (power spectral) variance for exercise 
periods obtained before, during, and after total-body irradiation 
at 1.5 R/hr in a patient treated with 150 R for idiopathic 
thrombocythemia. (Exercise load was 25 watts, 5 min duration.) 
On each specific performance period the first data point represents 
the preexercise pulmonary impedance followed by the exercise phase 
and subsequent recovery. 
Fig. 51 Exercise-tolerance profiles from patients receiving protracted or 
fractionated irradiation therapy and who Were subjected to controlled 
exercise stress. Each patient performed the same workload on 
successive trials. Results are normalized to preirradiation values 
and demonstrate the difference in the response of the normal, 
unirradiated and irradiated man to exercise stress. Normal man 
rapidly adapts to stress whereas the irradiated man shows periods 
of performance decrements dependent upon exposure. 
Fig. 52 Composite graph illustrating the effects of a stepwise increase in 
exercise workload in pulmonary-impedance variance, cardiac rate, 
and alveolar C02 concentration. Test subject was normal male aged 
32 years. Exercise period consisted of alternate 2-min work/rest 
cycles at 50-, 100-, 150-, and 200-watt workloads, respectively, as 
indicated by peaks in cardiac rate. 
Fig. 53 Graphic representation of exercise tolerance profile and tolerance 
time in a normal man accidentally exposed to 260 rem gamma radia-
tion. Due to thrombocytopenia no exercise stress was applied from 
days 23 through 38 although physiologic monitoring was continued. 
Fig. 54 Pulmonary-impedance power-spectral analysis from nonexercising, 
irradiated patients before, during, and after protracted total 
body exposures. Except for patients receiving 250 R (whose higher 
variance may be due to splenomegaly) those exposed to 100 R or 
150 R demonstrate little pulmonary-impedance change in the absence 
of controlled exercise stress. 
Each subject was monitored in a sitting position for 15 min to 
assure basal physiologic conditions and then for periods up to 30 
additional min. These data indicate that the performance-decrement 
effects of total body irradiation are not expressed until the 
individual is stressed (although only low levels of exercise are 
required) • 
Figs. 55, 56, 57 Changes in pulmonary impedance variance in Shetland ponies 
exposed to 270 R (30 R/16 hr day) whole body gamma irradiation. 
Half of the animals in each group were conditioned for 6 weeks prior 
to irradiation insult, the others were stressed for only one week 
to establish baseline data prior to irradiation. Controls were 
forced to stand to simulate conditions during irradiation in non-
control groups. 
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Fig. 58 Graphic representation of the relationship between variance of 
pulmonary impedance and simultaneously measured alveolar C02 
concentration in a normal male volunteer stressed under controlled 
exercise conditions. Data for C02 recorded breath-by-breath on 
a Beckman LB-2 medical gas analyzer and averaged every 15 sec. 
These data can be used to further determine the difference in 
exercise response between the i'rradiated and normal man. 
Fig. 59 Graphic correlation between pulmonary impedance variance and oxygen 
consumption measured during submaxima1 exercise stress. 
Fig. 60 Effect of total-body irradiation on cardiac rate and predicted 
maximal O2 consumption during controlled 
exercise stress testing. 
Fig. 61 Graphic correlation of hematocrit and mean analyzer channel number 
for various-sized RBC showing method of establishing-the scaling 
factor for converting channel number to cubic microns. 
Fig. 62 Graph showing progressive decrease in MeV of RBC of neonatal mice, 
comparing the hematocrit/RBC data with those obtained electronically. 
Fig. 63 Normal frequency distribution curve of RBC volumes compared with 
those of the RBC of a patient nine days after 300 r total body 
gamma irradiation. 
Fig. 64 Normal frequency distribution curve of RBC volumes compared with 
those of the RBC of a patient with folic acid blockade produced 
by Methotrexate. 
Fig. 65 Graph showing the rates of increase in eryth1:'ocyte sizes in blood 
stored in ACD at 40°F for 30 to 75 days. The blood was obtained 
by phlebotomy during the course of therapy of nine patients with 
polycythemia. Initially all were microcytic. The increase in 
size is expressed by the squared difference index, a statistical 
measurement of the degree of difference between the initial and each 
new measurement. 
Fig. 66 Histographic distributions of the serum trypsin-inhibitor levels 
found in 30 determinations in normal persons, 56 in patients with 
anemias but without hematopoietic malignancies, 15 in patients 
with active or inactive toxic goiter, 13 in 5 patients with active 
thyroid carcinoma, 13 in 10 patients whose thyroid carcinoma is 
arrested, 46 in 4 patients with active Hodgkin's disease, and 3 
with Hodgkin's disease suppressed by therapy; and multiple 
determinations in 4 patients with myelofibrosis and 5 patients 
with polycythemia vera. All were measured in the same 5 consecutive 
calendar months. See text for further explanation. 
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Graph of the serum trypsin-inhibitor measurements in patients 
with thyroid disease (shown in Fig. 66) according to the calendar 
dates of their measurement. The dots connected by lines represent 
measurements in the same patient. The mean normal value and two 
standard deviations of the mean are shown at 3/25. The cross 
designates the death of one patient. 
Fig. 68 Serum trypsin-inhibitor levels in patient receiving periodic 
whole body irradiation therapy (10 R each treatment, 1.5 R/min). 
Fig. 69 Serum trypsin-inhibitor levels in a patient who received 500 rads 
prior to bone marrow transplantation. 
Fig. 70 Serum CPK enzyme levels obtained from a radiation accident victim 
exposed to 260 rem TBI. 
; 
Fig. 71 Serum creatine phosphokinase levels from four normal male volunteers 
performing ir. two or three controlled exercise periods per week 
over a one-month period. (Pulmonary-impedance response shown in 
Fig. 48.) Values are normalized to thepretes.t sample value. 
Results are typical for expected SCPK levels for non trained individuals 
stressed at submaximal levels for shorter periods. 
Fig. 72 Serum creatine phosphokinase levels in four nonexercise-stressed 
patients exposed to 100 R protracted irradiation therapy and 
normalized to preexposure levels. Although no exercise stress 
was administered, these patients responded as stressed; the radio-
biological mechanism is not understood at this time. 
Fig. 73 Serum creatine phosphokinase levels in four nonexercise-stressed 
patients exposed to 150 R protracted irradiation therapy and 
normalized to preexposure levels. The magnitude and timing of the 
response is similar to those seen when 100 R is administered (Fig. 
72) • 
Fig. 74 Serum creatine phosphokinase levels in three nonexercise-stressed 
patients exposed to 100 R or 150 R fractionated irradiation therapy 
and normalized to preexposure levels. Individual responses are 
similar to those seen during protracted exposures. 
Fig. 75 Serum CPK enzyme levels obtained from a nonexercising patient who 
received both protracted (150 R, 30 R/2o-hr day) and fractionated 
(15 daily 10 R fractions) TBI. 
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Fig. 76 CPK values obtained from a patient exposed to 250 R TBI. 
Fig. 77 CPK values obtained from a patient exposed to 500 rads prior to 
bone marrow transplant. 
Fig. 78 CPK values obtained from C3BFl mice exposed to 450 R TBI. 
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Fig. 79 Graphic representation of the relationship between SCPK levels 
and DEC in a patient exposed to 140 R total body therapeutic 
irradiation and controlled ~ercise stress. Values for SCPK are 
normalized to preexercise levels. These isolated data indicate 
that rising creatine phosphokinase levels may reverse the 
physiological process responsible for radiation-induced fatigue. 
However, the mechanism is not explained by this limited data. 
Fig. 80 Smoothed averages of the body weights of mice exposed discontinuously 
and continuously to total body irradiation with the same daily doses. 
In every instance the mice given their daily exposure quickly 
.~ 
I 
1 j 
J 
(3.7 R/min) lost weight more rapidly than those exposed for 22 hr/day. 
I j 
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Fig. 81 Smouthed averages of changes in splenic weight of mice during dis-
continuous (METBI) and continuous (LETBI) gamma irradiation. They 
are expressed as spleen/total-body-weight ratios to correct for the 
fluctuations in total-body weight shown in Fig. 80. 
Fig. 82 Graphic illustration of spleen weight in mice correlated with 
accumulated exposure and colony formation. 
Fig. 83 Cumulative percent mortality of splenectomized and intact C57BL/6 
male mice irradiated continuously (~23 hr/day) at 0.8 R/hr, 1.6 
R/hr, or 3.2 R/hr. 
Fig. 84 Percent mortality as a function of accumulated dose for five 
strains of mice irradiated continuously (23 + hr/day at 1.6 R/hr). 
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